ࡱ>   !"#$RdO)?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     DocumentSummaryInformation8h Current User*/]+*B ܄rIF,%:r]spg ҄ $kNC ʌ9KϪ=0!c;OcsEBM(egVξ?S#%kN;zSs])$-"ꝧs%ُ7책ts#sDNB艐@lXO*]V; >43=^[M(w?0?E;}jއȵsg/6As'2l`.8*Ak7l| kzu ! 3HS#RoYCw&\g'2%9b`Ǚ8 {bК4-L4姄X6jvs!FO0?C/HU~_t4O&L4Xg${嚁Y߈0æwqXI ^bПU"c &ڕ̇Co;rI-3(b7J,q-Pa,{(VT04rsI}KV|m0ήgD W$V\9k$Azi1+gcdH5^w3%AJnZ e6V/P p=PHIJ"@.p(a{iGnәΐ;gAm*ĥ$^Gv`Avb?O(Һv- e̋ e_Lo5dڮ]0ReL8( i=T4`;Kp 4VDr% k!6 ,B,iS$?-H`j#!{E):ʓ}~g?[rq)(jz!b0 Zh{{L6vȺwycca&zbLKMu+k.J!@d{&5 iZC+|Gb- ӜLQ촀= 1$1 @Yhf21j/[rQ!²lΙh'F8;5L4O&s N8ӑiPa d\`Rj'l=f>`;3>̚No@md`wWx 07 Â=gk ǣ̐Ae}   $4_e3`߫ ]{;yqzuiGA4% ED pDBVM % n}o w[^|3*X8o'oh_cC#Hapk0i~vعAآ/E8uaF_4?#Xh.HrRDoaƚY*"Ȇl;X*K$OylD]j]@\>y̯zgZ{@bCh +v5!s`Qjcn6EʩKʰo&XR(.1DE♥cٟJv3ީ뮮3Of!Ԣ-ZSv`aΓ7#^LH)un ,"M[d0DnBG(P3ľ-%>xnZ+2t䢻 ߬rs h TOlrV}S`-x_h[]JIF ƕwQH#ߌ-ŎhX"s6jia+=QmY^Ǫ!:C/]\żsIW޾Vq_kߺ1A8cĝ5r/V]n5\_!y 8!%1-yx{b"K;z{bj+RE'>'Fb&KuĞ#sהl=8'1VX% %0iX1%13bz`1X' s1*ޣc.U#$Nm_P/`qFG瞔eDogʄ$Nls.9+粓XBAg L\z~\TY9%sxzﴚG6fzIy$!T3~1K}泑x>lyûkof9Mvp3#38I$HblHHl2blH Il2blHdIWMT-7 S1@ɐ"Q(a*NG6R1 LmfQc 4 |R38@EbQ|~=cbQ$1Шʎjb@r'#s͟"ep2ɎV?YIAyO.2/d=v3UVT-NN͕gyLәsXlo_ƬY/yڍP 3Sa} kU/{ڌNsAiT!gCg0^g%\o;PovoׂZUx{3Otyʔu>fսbLe}5O:;o؛j޴eCMW_7BHV|E(Md7<ƞxPob,'K\H=Mo",gDNSizo<'T&C?&SyMVIff bXqP3 jX1["Dcv>b;<&FzZ@/(P (_mfh~iPzù&>dJ-(Pg:=yR TEmfP/Bu.s{?pb6YQ fTCm}wdRzDYz#WPw?;?]WP?HGR3vI:Zi vo:ƕ+Z&b>>ڗ&b?$*y'R%qV~VLEt Sy=@gŬ$K'.4'b.gHuiOE%3}"KuJ= jϊ>Y=N= N}bUiT>*沚>*^>*户]Oc\OjFOD/#b1ɨzDa6S_ވU˙#T?__/㾑j ?53P/٘w> S?h޸7fWaVQYտ~M)5oy?~"Xɇ:H@oTѳżk}m"zÈ)BXTS|ÉެkdD*{ެvd䤞DEb=zz)Q=b2:O]$z򹆰{zzcRGDo@ozc3J@iو lDD~h ~i"!xmPt3d(a/Zd/YYEM1Xl&᥷91 ɈU4 4.6g7:>!nD*_(#'t]>6nyA c۰| bPNG  IHDR}wSf pHYs  gAMA|Q cHRMz%u0`:o_F@IDATx1 @пF QRj9< B<`adC63v¼2jsu, Qh6$! jfePE$/9vʟ8Jb=n0e{npc0og^ };ԗJl7^wr:&4|%z9c1/Ax7V2]k]6+OqdfOJGە/gԬ.!XTVmnCC[B!/ػ @Q11X<=b#n#TXH{J*i,yf%7xD  !6AO?D8 H2i< ٘q:hh:#?hF(`Q0 F:@x#e4a44:= F(`Q0@lGa Ie&& k ͈9:=.zQ0 F(`D"܈WqBImRpIYK YFt Y,# Y 5ܖ4#b$ CYݣ`Q0 F(`"ش #;4xF0JȚd>##5HNOA֘f`Q0 F( 7HIkE#Έl#?Rl|S?s)0ۘ1 F(`Q0 F. "DGӌ O5aA@630c@ j$lF[ KI8fQ0 F(` O@[ aM䬉D3!_w if&!6A"T@yQcF(`Q0 FD; r _~Ap(#1w9 F\Mid7œёQ0 F(` `#W $?fГ>@_cmdא8zkYѣ`Q0 F(#Q !m#9,7GYB;wYSB!'t&Q0 F(` 5O?lOںh(42A~dҺhf`JhϪ`Q0 F(Q#Ѡa#҈ L7ѯRA X=51/! T8 F(`Q0@ժk K0Hl{G:񮉆^r ?3f]1 F(`Q0@ Ös0w7:8084}gߠ9$(kE3 0gddpQ0 F(`"n$mrf&q)nĒ ߌ[ 5A#W#d4|.a^$:zB(`Q0 FDTKt{ _BdC/Rsa#4 3ߠsp*9 LG`Q0 F( ^?f2t7h93bkd)mC31?z(`Q0 F;@brb}ےh+\IMv]8+î{DWr݀m&"~`qk-gJ- 1<R#ֈ%œP~F:r `Q0 F(#koA1v7b]55=atc(`Q0 FDܚhh#tHܫȼ Fh'|! ~@nVQ0 F(`5O߄2c6 _ 2_c?(?]0:= F(`Q0r@}:WckL)G/ n,O3 騽Q0 F(`Q02@= j;C:PۢFFn:Z}4PG9'CΪX8 F(`Q0b@ #m&;L$^<̈îq7!ň8tߣ`Q0 F(#MZ.Y7OՀ4@# h&|9WøV4ߐ +`Q0 F(#э_~؊@C& R BkAAi'ˈlёQ0 F(` F40ihFhKf$ ?bM4#iКdBlk\pA1pQ0 F(`d"?QL 6pb-6!a1q z0"9cQ0 F(`db!V!l?d1\H^<%/0`W=zu8#iq5b$ztc(`Q0 FDt#?odBFn-D?<Ʒ_z3Cو3H܉@}+`Q0 F(#эhP \c[a R6A? Y!1Cb͛'n5̩D[-JHΜ"ʔG.vγDŦyѳ~!{ m(.oœ`ݥo04Le+_'O]VzEH.#67,aU_=$1YP_ơ)5&Rׂ'i׽5\krmsqx \w80-b=) QJ__%PF!ܲ+}OuƢ&EF~' LZN>[L2EFk]=OKYɹZLL!B"m9_0dho p#:R hxA }; 1oБ~Q0 F(`Q0 F4!< \fab]h<#/@\ [7d9h4.@vŧ2Q0 F(`Q0 HjDfb U5Q ?؆5xA#Ơ#@@~&^ԎQ0 F(`Q@k@q?Ãp/VQ0 F(`Q0\@؈P`Q0 F(#`i%/> n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JBFE)NvyO q>V%h @K<-S`Q0 F(эhS!N؀Fw#@ `Ocaߍ8|fm|4Q0 F(`@@D/PAF7^xJT_ O 7(2 -`y0R{:@g/FA5$xQΊ5L0.9a7Q,L' aQ0 F(`J@݈-8}5] ; t;ozыAN=nQ0 F(`PI O?x n [`!:mZJoE`Q0 F(-YPC@H2:/9qACAJ&PcNQ0 F(`Q02@1<8yh- OL`Q0 F(`awǰDֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%bJJ'qQ0 F(` cǰ020%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`atql_YzAOuX13ݖpf}=qh#zQ0 F(` FAaP|_o k hA #`5G5h= F(`Q0 H`A4'cbO arPF(`Q0 FbPDkAkAd8'''X(1 ݡh= F(`Q0L 툶?N85Aj ;;@6G(`Q0 ȧR.F^|D0sF01+n1@6G(`Q0 xϟQF5b,,(|\2ՠ7GF(`Q0 F+~ n#Zt>hH7tyȣѸT Fѣ`Q0 F(C ΰlbkaz``)/ՀAGep4ڈ`Q0 F(btc! [j@#o֘&ft6L\#դ5@6G(`Q0 `gg9jLh@A [BC;FakmF(`Q0 F.}6z8:N!, mDQ0 F(` F4@\ Q `# Yh4h Fѣ`Q0 F(C d\tB)I6* @Q0 F(`!O@o86IL 76|z @6G(`Q0 (m0.ιm!6H=@6G(`Q0 ]΁?l`}c!2 :@ 65Ah#zQ0 F(`PQvǻ38<@_$0Fn #7 mDQ0 F(` A $$3p֠ s 98XcGbFˑ7a4^~][kFA#ȍfZt*h= F(`Q06 kLC=r[5l7anE66J bȣ v0\+3F[pAn-$P xH4H0-)U՛;VR;u >"n"3w R|3FJ)d{8J@Xfm I4^?S@9|K2Dv.$Gyۉr@Q0 F(`!@Ug^NG-FAb0U@Q0 F(`؈5 6`@|QmF1hmh= F(`Q0Qn0ÖRO eh#zQ0 F(`2hD6< _ǰ,@vX`E S[ǰ(h@vX`E S[ǰ(h@vX`E S[ǰ(h@drIENDB`nj?Hz+ PNG  IHDR}wSf pHYs  gAMA|Q cHRMz%u0`:o_FIDATxUnAyÎI" pw!G~;_8qr@  ƻ3ө-V⍃lz=]UmGWxdd FRP d"|D\zvk‹ɘx VKBj9`Gc3 ->|>QaHz|9#T!( =o9UП?DadI@y^ k;J@+D5bR!lz`@A@~$jC"jdJ%<Z@oI6H[6$y0|$ WV=N3&;? s=9L)DjˑzWQ+?Em},5$ AGhVZ=`Jra T]f 9["%OƳ fJ~UX ©=o1.0拆[BZ o&&K^[c'|Ww2B=TaF 2лlQBB_'W`YT9~Kcބ҄x"w:Fy:wi Ai*}dԎ-mcD>Ɔ?HFAsDlpϗ򦦶9+~ĈػA.Э+iwZV@z!C Lh̫AXJ{̪DNC3!٨j.\>!d~Bb TߗXѪqF &,-z`溵@9Ub B}124xi\6C^ts0;72 *Q4py>yY:`NIQ0exRi,?5Ϙ1cFk`\v(:lLteb;b"ӖRXh: K4ǹwh8 v6yr:PsO 63IL\Gjnl/]sb%c"tX@m6j W]Q#pT< {1ӱjU҃SB_8~V:wΫxhiC^)S4:w@`󊗡oEI6lqݳ7^ʌi) )|z>M=G6U(qkCG ]IK(sa~eM# 2uf&I=5D^{j!SsYVa=ij%D+{`ۡ^%*+pJ-ܑ /mSE8wѳ @A9ɛPlKF@4ʀqRN8LWM> w f].z_k,ŪH$aRt!.2>+V VܕAKN?)[nB+w,(l'=mڴijwػAiaco\3&ƴUZ[մr/q'Ԋ͘ ͅe4;s]AsI[^*iSiEhUf4:ԙ*hV_lnSS۲=?hc I`tʼnj}u+'7 Z7wM'~ 0(蚉#NmcA7qqMӅ)jÅ3o{ _G=ػah6(X̶ڸMKGmK~Yjm4d*ُ8@~1=rJZd[:L1@4[6Xg ^/] q]HuwZ] ɺ=ŞQ!fNmsgqI\,#JËy2W Q5iFdY=[-|Bj0/_~O0h]]@0 Tn6!2/z^Ƹ_&MaH9bhEu"'Z95pu|8{>RC7ܻe[jkK*GPjM2ڹk& "M?[oDX7yJWW.o:h/y;6ViS|L(:G CE Ě2D3wg77|EQx%:HvO؛F :ǐ y^KvS hl'm#.Dh^^=#1 յ0` Ig~lֱz ) b=]GsCcla`4ȻPI.w PC<~8uץC]_dfbp/aeQ6<  @`YuW52!$zoq-׻"2䖱#a)\6b&Ejf)G>GOAhrrY@"\*{}\!!aX8?D7Ed=p*M7j(S(LIw; gD!wuk\vUp[@!V*  ė^Gx'OaxIwa?H$ڥcXU E69lD79Dd{7P|Kr O>x:a! kN^Z˖ bzS!(嚬Q7WBP12PC\e5`B| P*> iJ jK 9kKkǻEOh4eyK<0O +䓙` r &&2bb;ʉ4i6O2oT)Χo?mdkKs,2()PU$%Vm{Hvl@NAvN!0*3 +71'(/;?GG]7}6qk_-D߰Ăh̫A&kGAS#i tF̌FK[@W#%j 3qB lcI[#1# wSV"Q0 F( <0.+䳋032| WN[m;zQ)#NnQ't3XrLQ o^\wYWp83fU9H7hr aPNц>z>Qԫi6,N?; <02r-JFiAG$7y7720gonQ0 8t*ůt;xl rV _`6p_?;g3H1y~ť ߿ 2h'0013|zw܈fec`d (U>} f= -d1yGR@m 4ѯ怈m[c?97l z7yMFCϪfICEP?rWfWh>&Э LY3eCtr? nC/&a jtJ]6 F(C.Egv~gea`ab#N " $lĞa6\#>}y oDK+3I^qY3`,Sh#K`cZG,[0v`Cu! ;;?X`OA" w[эhȨ0fRI0"Dcg ]mq7EWNabaWXnC# dp⿠1f9+h '@hE=\T`r<?_FkQ0 F(A23T.[2AЉTuB" <뫧`52 :`>h҉@5g$d-~~҈ ''j>0|z[ ܀Pk 6y!i:/0||{~?ݥkxэh.D#(SA_& dz?l\ Vbxc|#a,2 Z-mݲJ/! fHZr=(`QO!] ߿}v~d% ^ `xDXVىezy  WNNgx7PI(0~"z Z |pjBt6>hgH#o~8EK<@ !`w9 nDV4|!@6КdPe#$(*Yi1D_3<(##@P;0C{r@r ,H8;p`!`갞];ß?Š- yqȪ0h%7ݼ1hUw @#ȟN،2<^ T79DbB:wiSe-ɏW~G.֥/' nscbfextkq/ jx킎401J2hā?Fe`0 N6%F40i; aw9ЋRY?bM4,hM2!s^Hin. t8Ar10`a.Ig3BqJ1pK3|<  j /fxps j͠kt԰ֈ7X9TtC]ܠdcc`6 iIC:+_߀`w` _8bGko }eP[ *"^ VR'l18!iWPGts l:ki7//V wMD|#x)ؐNiрP:YAMAG5Ȉ'#ZΡ*W~̫Qo&/@ChE) Х8__1Uv hk!$7:K1\ߴiH3$CFKCp5CpoM l#3;F}?@n(`gN6.&b6nn8Ç7Gh6#r~Lcc_j~:I2x  l) w 0 j&hT>t @w55|AkAWШ8RG< }e砹 _>bj>_fނ6?+kKG@qzjF 6ӻ 3h%eàu^6 ޽N16aF4l?DԆ4##Bb A$xj ='/lbmHx1Mʙף`Q0 FlCֳ`װ<05dTDzs;{?< n2& jQ* i1xt , ^؃AR[ |*@H||wh{h# @荲Qon2iOPY^ptrx:`tj21\?aP |T,v/,hd͗ Ogd>x ɫ5q Dȿ YIljxO#_z3Cو3H܉@oeQ0 FMŠQb6~}s%mع'6p{313\ R:@x# BCF*^$ Z{ Z jx>nA#p7S 7&a&V"eo^^raprOïe&f d_;;|~H#zH8|9hdP<vg @@Ѡx ~|Sx;tݱxϏ1@?`GP|3`u-j[]ՅĤq+N9I1ݪ6%\xh:i;yyp94OH+Jq? 2 y*4&sߑXIix#>ϨHJA .H}$ue ddњ] i߼A6Vܶ43N NhۣgH<4,S>2(<ވަ>u6RE)H/$ q[Y !!eVp$`NFvB0fbB .(`K8ichQq۳̽JmsuyZ?+yx5Ry؋6$ZTݢUT` )Hm!{W@KTAJ-,}E,삏 ?h D\]u1@ 9Brp|3)Ѭv78`5^6@^剰Ճҿ"vJ~5 ԑ1%$sGv4rRrio _]lvv1T&QP}_mTO(]! ud^,ZEJ^]pܣY04=O^@}L2vD8E%<.Fo$X}1`S-Xoj/bZ'[qpЮwn)d\٬d!;o?dK7/kG1&JK͖r VThu ycӦ5$Ƀ+i&{g0D2 @$ K@8i9D9(H( R M˼/Aj"Yc 9,/DM4_ .B;}.Z 0ѭv6w# ]d)8H~"!A/.g&"ITBPJѺ$nO?h>fxI8D=\d+fvs᱔hT#(RR1=?8A;衽6o>r ŏOD>8+ Nm%S~EAz^fl^6OVV8YQ> ix@d.*5 6z݀&1$Dqͺꪉe *Dun%_>`\V071ij-VԂѝ Q\{|gp^p)TPKj$U)7f PrI? #oWthe!Z. [Z[ݿb:/m4f#86xr&\ <^h<㛄H"$":wq$b$5KLX]AI|ݞZd7X !TK l^Zqb>ދ fP~8(Q#̬,M@95΄L&&R'0N{{]86~sSj M qD]crhOeQ pz(>~1t2e4G\D]ꏡ@-D\Ȥ |8 AhFklSc8;:i].(X)hx~&$dTʾEi|Xz6O}! pwcVuO.<_QS-H9 0A%xS<;]Ξ5( |%*$Ԥ XXو6VX ? X a#ڨ (~޹w;1$62;ev>{=+Ԝ/Jmz3|q8gE?m-~Eɏc"AribCEEjxy_84lV霫*UL vz;Jy*`vw<9v ϯ#'qXpG^땇&0]oWBCp,fuǛew}-tspܧ-}Cgpm<zO ZF lt0x;-= 53G. S߄d3T̖է/`Jt@7A$>U6c#Ef%[#sX?֘0C C(T`YSX>+jZW$*/W `xPԴqX4lY|aDNi L8f 3 6d%j~Y!0`x<XHٯ#V v3uOa8Sj~"INߙ5Kxڭy7F){0sIHtP:):$>88EAADQil5zsT@i)mM;_~p#>!6?)z,wjmN֘+;Ч^B?&ÚܙN*VVYeUŤRb0paqK8c8ɮ_ E^Ȥ6LCߜۜ"7n1s򱺾C} C=XN'# W X)q[K[0˕t(i6+^ PD7aapy;vpp̕A;?`!t{c)V\{~*SMYfo(L{-KaVtuGQww,XSaegs;// Y {.=9<ף8ɪ(㌒aJa^w%.40 aX$˫eHEh:ԖqiX >W1xR'FˑE'^7--fܤb])TMfa(“&j .w' >o!oDƅ"-UT[m9s@ݸ(4$!MoprW   -GMy&1iY2c \S@(rʕϔe&gxFY.zveهX2$J-9Ύcܴ6;>?ָsY&ŴbJ σhFD-hfTlccÄݷT8݉|7L_Nz%Pu>_o^o{u̥Lˆ޿~`y{[~G@(%2>6:QT"d; N-TKJk+a&v5V{2Oa[S\?q,f O^ ǩF3:n?h}ٟxO %F=mKByV"qu^׉ /5`3 [zW8DXuYd:]r ػvݦ0Q -%Kk02  JPԈ )d9$qĮ¥ x㜓Ͽ]/ꪫ_. .*pK[3}tG޽zG$A0(X{ZDx2/;/go&|9^ۗośrR:xtXPDB c6 %nYt$`#; 𛝕+[ˎç$տr(Eۛa'"23_?ĻWݱ^;Ry1;X@NZ[OS[7E_)4UNBR$hf>2&S')67,-0?H{Z:mQ,37J!]\껫7(0c4'R@{}&zH_,3 (R{V\7=O]p'1C% * 5i5뀽)pf#@jkb O7Q5 \|f}-$X7յ-pi@Gt?l,'Ao Fe=Q;Oػ&(zޛLJ2MPZDJ7n\ "PHV;&AbI;3aŅK %$c8̽T */(L7IWBnP\fk3ǹhػ$/Z' vv6"gœݸT6`PRo]y 1V sPZ8%At%uyk]brru?0 \yۏКz yc^ɚ84E66i: rH5~3ɰ몎xaV*y6OJ%R@ ?! P]=:Tx}Œ4_s5K5),Qvc\F*wkhA84><]/y`_w6=JCQ>- +d1n7+ܺQ11b!0#/sn ش}b]oپmYl9\XZNnA6K>7md!Kΰ{;\S=nE"2K i{KB\J'Xi8Œ+fN8jgJ7e }|-̓l?=gg_Wj+wȃ5clmopG'[&0uvveM]J= Iaq}`*O"?exj561ݎPWi0F7&zay.'3q2$8Һ>Gw=o،͸c]Jb^Bo6n}IAX{V*Wv\(oju7)Vq\MX;wZ%*.@?A43pj]`9}@?vZ\]3.çkDTyvM=qN-<d*E1Փ7 ,0heDbޙQ[ z\g.42 he>i)lΰw-fڇFY hHpMa0[_B7.oM]@ Qf ==0`dts8cD,̏p 7 Z;;VM@$J4Wrmd23Fgض0L/8-vȑGl dA>xF TK@0tg1B!8,& O?YZF=a ex[R=>ʕ@S^rpZ8*W'sסNX1/^0kcGbϋZm՛G8zv~ ޹6 DQ8MCv}\K+Z ^tRJ>Dc%4#-c<^3\æ  d NJS ZYוX`hbyb1O<4;^Ǐq8kkg7ʁ"+[Iny`M2l6&)f\W.jZ/v͠]hȨjvN%Qxr%9G:y9c84sAoX=u9j^5JN$Ņ`9^mOm+Pw }Sy~HR&p3Fb޿ ޵6 Dѓı]'m; *! )R@*iv6ܱ uE891q+ߵY,G]j #"%Ɛ^g\U ;(%be1MUhx꥛TǻW52Qjp`AdQV_|f<ݗXG_xP﫲f!ݽ|HhqRwLi n&e8LAkD,Y-uJ11d&Gڂ7.{s3sg>D[ǭ׻8iTw+ſN\h%`s &oūd~#kpG#^QqGQ,|~.~UeCooF$<} #ZsSˇglO!4y"`;2!0v% -wiՆ?LDw ZΨBuBz,cbQə{YÅ9NC,_?PNXCD6NҪ3>"oB2vAcD h(5RKh2* $jXH)5/kR6\RUGjd#/PxU` "Hbz21K8&GvA7(Bxب_pƸ<lEEb4t.Qzy,7v:7~tZo#7VñM`5q, nJVb2;MM'W WT7:k-28$H:dc5Iq=7C7 Λw5f2_Ee1"5| }p.gƛ vۧ_H05?F1{p;u3d,:&b*,2eb؀N6"\L˼GnjTPVW3I%_DgS]`دңo/FR@X@rK[Pov0#[J5'B/X̤$fȚR3 Cz %s tĀh4y*XA}le6kCЀ޽ԕA5!{x,bs4* y\N瀣 $$`㤢vxp "cD=ic#,/2e²+f |s %{dj#^-CnQµBMKDHy$#bh[2"[! 2)䳙uE+g.۽ex-k* MSzxP);C#$%%ucwɝHv; NoVqk' }dԄ7+Su I<m:Glrk\2# X9Q% wpb(d$!AIK|h߀HPGtEQP"̳\ 畕b*>*j}^Af.ZlXbÿP~)lk#?nme"r+pWIRq=_WO$@NØ?!4jcGIg\,u4BBeQm?-iivѰ]-EGǁ4ۆsux}Mr}VԂ|IiiSΦi c;7HM) VBę3 #$ 8R>b_kow1=D eOmYk;}̼s}@ѣxVi׻صy3x= JAɾ蜰vVw@}jPF(E,T.і"vFOjت80ާwoIMPd2:*vT W?lݫ5b@@4݀wؗ~Ls96~^>[[rnf{"ݛ݃036[ҁ3Ȇ˜$]Z(̨vS1u:Wm42C\SAIR<&G( -r BS]- W*%)cqwCuanґ"=i\  ~")VM^gPcM{ 2jt8ibÂaXx3.%_sZte=7T$P&!=fhg<6lJ š@r IXSft1tGK`́^[s٥o[MM˛>.ȼ >}})KӺ^$gV€u' CH|Np*uyo6 /3;Ȉ}CMol,)2$Z ꫰{T0xMMas/u_Ԝ1mwuZч!LRF07 =Y7ǹ8+겔>}*:٥6h"pGG#̣'ȔF֦vCiX-T~ ޵6Dѻޝuʼn!1 DDC|A@M@AA"DQx}rϙw:hIdY9s9S=mpXP h3J A˗0 q(x ߽z=WD4"#}9^g*%@ p^Y'N1 ~ -영!h{;OSQ p~[`+ f}'M<"x͗\8Vzڰe;C;h&tcFvid/1t ,El7,0 హKrdwfHiE&CuAU+@zx^+N_oZjL|:o5O '[<_ٜiV$ =n +4UvԪyx6*,ƐizϰzbI y Yr ̶/{ 2_Lx8;}o铅emU 0}lߣ$10K&R%mOB;/kArB{CӇ)r蘛sm[qK9* ޵6 ѱ}ҦB,<‚?Al) ZhJ6i;s]PvWT%i;̙3' d_ѩcki\x~PI?Ԅẇ,ۗvHOXZn[=Z@=W~ gC@zcA4a49KQhXS|# wtwQ/1.u!Sp0L 6#Ϯwnރoq%4_ǼEQ'I2c4)QU^h`ܚ3Mʳ#x]o)%E-\oV 'slBH P ]@u;a*{DDN!v.{,t';}5/[ȓvԶ5FUiw PUb/lj4V7( Lp$FbKr (|Lt|xX⟤VuViO5:"]ߨ}L) 2)&YJoїI=,W;p\3 _31h%,O־vMa-V5yy"EBAKk.vNZn^nLAQM>Y Ak Jfy9̇#adz<6jJGiAu4>zCjO}=~# ݘH҉y]>cϓU:NۂTf1[Z+wkгs@p+Gskmr>m5R/ QC (CZY;dehH[ 沧K˧jonB}݁GSY\ e8,tSq ,ݭ8<+vrvוOػ((z55QClA?@p…;w+ nAA4hd^s+ABt!!UUus=xÉs(ͣq~ܥh=9q@PDpٿpCΞFS0yy_j0W8Z AΘ߆b!]ثqvJ9]߾C/|3Q0N/0x]8O&9Ap"]`܂Y*6S la2`?{$x$@ g=y.ϛt782z&y[)8nUrʔoV6}ȼV<߰5~#b)d@]!$,l>lﲥh595%$ Z9^M$n RƼ~:98ӹ$v f7A5HZ[UF POh𹺢)Xen`&B.*(,2S'?P$ #Vs#Ì~Ȝ!i Àh}mH7ՠ`i9Q@Wt*ZPq84)"VeD܎F! Pq-n=ԑ7;v#)u.<4ʍy6/ hRV΅*undk>(5xəYC<uH[ZŎdZ>)[yd-1І#4F k=j@SAz] vFϮ'}~-&DM4 i)l=R.p'ec>vQF`FTp >` sK%5vpz몳!ڊMM̺ʠ-$~ڿL>SnZ#q u9{^6Xa9׈ (9*wA%4o0h?HmMt;o6`9,zIBl%x{T~ 4E;8RD7eεq0 %+Y0,Ll|(ZJ?f:s^[@X1% )Mg^ߛwys /N]<72 _Hq|_΀eY\v*񏏉"3CGbH.Pu<渲br%~֨}=^‡@>^Ҽþ4-2>+(@@ߺ Xg10_ѰpcmX'ߌ%[[N (anS-߫kC9e9Ҿsǂ&3/IZ0C.Zc]p R( ; TbamfW˞LL* uWJzYlAA,F,Xk&.Aܯ-5ʪ\M;\{dXx" 6a{=bAdޠ닶ȿғ[9n O3}1rx0_5#=gE-=|VeJ-s(t =:6 y$2qt xjaD V @C+gP;T;]jH~B&cQ͑0%ײ{ijԆc:#_*=D#[9B t>ć9 a .3tr,ˍ Jdb=؇ӬaRg06κx ;?D<}\W/z$JUTpX8T@;hE[ =k?qǣ. /`mU5┻}† =ce lx@/S$D[XT^#] k L#7ͱA wuXrnP\V Zzf93P,  M]eTpI Hg`on^ kRFh#,:{'AӞ, e`u5=ԵP65 _w-;QQtOgĘH/qO0nLS$DeATB`L=sjbB%̣s/?i:f]L.>?f+/l+3FrܺX jsF}A6UfI3rbk1Uf8~|_:ͽ~F @K.Ok[gCXA4&"2v6?APbva͊[ֹ$iK(u1%(4N4rϨF 4$@Ls-Gx7Lj8`$hM {g[Nzm hhTPvИb-+ybmr%,.q#k -1Y؈gRPQܠc\W\.16#n+b8sn9XX4{{<pN=-OG ѩ{TʼnxfoO-zS&HfpYܶj+fFi=cTⲑ7| /o,3J][݅Kr9TdJ #*l34@]'̓ep9:8Ύt=24rպ{}%Deƾ~`v}{>bן?}}@GM8cj_lc7]upw"۱=j#[ lG /E 8^GH( ٓ #Gk"?c^7o,|m*&o,cd%JHƍAqZY(|X\Z ecc <mN ،S,L@~oP[v9gЖ=]ʑ !glc'RYC5 t:\U[D ۉnGI٫Q(7P,eR9x̵Ɖ\gHj%ޗJqlo|"j)]#-Yg'E35I" h 272iO} 9F#ܳT`AqR)ݪK@ǻOEǢYCR+Qsݮ,5jtNBP(h|"E`ĶUTM3`Uoty!aP8l#B qq:.y?u {jL,+(ot{n}E?}_y=. lq"lXPv=(ȍEۜ=zĭfF4saWKd\!y\k~@P~rtN/[tےfWvr҆Y`l'3qh̍m61 BqJ'PAE@HJeq Mp'AbT9#l)y˨$a)d4oKKP&V_ej< iMaS@,8́1弅Ų Y CvِÃވ4&IX&a3d`7Q% jHE Zl SO>wݘ-X,f+@cỸ}(!I=0$̱ƈU$wsj?~)vyгtDrdT/` &rlPCa#u3 KцGʴӷi7~mJc()D֞X8VMK>,UM{) ]{ʊ}ďtC-,g8]Q05c:=i[>M7du*;~%c8 WǺ}Gt C8&o)ZPh5RL^Ԕn,L̗N&wMey&@itd;O>s,P&",m)bC phfGL 59>9&&i>Z+s+F=7Թ[0!ל\)Ɋ7“ڞv Lں.`GW8ki"ΔZ< H.c\_$(OZ^ü=n]&鎖1߹{٩Kb6CXAq&bdq5x"Ņq2#kzI~n~y͎!܃t{%.f~ooӐ.˔t!u)6{J j%*V Iـ=ߖI*А zʕiA|~q3 n&tJ-FM:twׯ c?_w']7(+zAgక0i>.tL'{DZ-ݣ-}_yR*, ɾ M]O*Ò\dp\85E%vWRJg $ZrZCf,ۻx(gXcgh: l-GG9L|LåTlؓ<(66BJMm_[!.X*[fJ %~?xȲ͢+l5  E$Fy[P҂E"ݢ"R)$mK'tܗ0GVl]4NYʵKɵqJ[`Du!N7@YNߑ TB#_T@sE@(n6\}l&Tuk|mCp*fAq4};VAJ62 nv_`,$Ǿ7)`u?g2ʡ. 9պ<^,?-HcJA in9j ֘::#q"BVΕ-t|VáKνހ$!ODq{p@gD :IՉn|{l82=ʒG}X`LF)+B[,IA5HAVX}?HN0,!Y(N[[!]+\$˵#zݑz \|_{!ЃJ Ɣn@:/46$OV"q=&S䰍j1ODkY㈢G!!8 /1Y$o_d|F~ 1@BXּ_T$dlH:Թ|7?h) Q{Xޞ/dJfom>@>ɣCWz~6 (Wego~N.TovyAq!$qn +`}d;`s?;~AMӚU^_3,' gyu㧇?2)1{B7jX}f#!sOB7Jlϓ\8NtuƸ&aKX;׉c; g l"A|V |o vt݉ HFK0`nMw`%+OޞgԍvX^|`A$d qjUnutAoP3_Α÷q aK.N Urzu@#-R`X4Cc $sTy cgZ,2ew/n\jtH7iC1{s.418oF";} ]dm<}h` DXpsh4UUy#Kyrڑ+Mvsw6]6YNIݜc݊bSG\X]ׂ> 1XCG<|;+72E.ȰJm&私 H>mh4=ıҭf3?G듍RgWOkgXn+do) èdJn᷌ȹ>+q>!dǓu۝*VwBZi^ d<^4x.u\BgK@/ػݦ(zmǎiHҡ`(+Vh4H7 Aa5N-8'vG^d̝=%!O0ߪn!OJd@348s,Wm04q"̈\  lf4 P`ᓙjB2=20iU3ٺ@ 2,0U65Kd}d&*pQEv%0p5hcU>0!@t R,Ϣ EdH'P*[i\Up) 9`E ZKdʅ ܀9#S4 u4\(jHwߵyh MMLcL-)tt o* >>Rfr9KƬXl|ɩ+MT }_xk 7/R&j1#@Fy2r&`g (&৭h/n_q'?%/Nt'}HQ,^t̙I^ij_= ҽ׸؛ T-,r^50XaTj\7$3 1tIzޛaA֘IlSEQ>l ń#9q1rB#ۂS$GxY?] p.[6_lbp9jX/\5OOC;Wp-ji-H @9Q˫@P]JEs ܷl|l#oQL/{b^谗Y`62O]#]$HVNo4H2Cr(Ǿ=>YϹ=:lg꫺n"?,VYWf^wO~G@SڧlCT90innbHv&2F5dh8X#'aB,5gן,)V$Bا'_S Z/D'lD@j~ɭw!gm rqW_  @+C&)3)ȋ.ʻU?`lQzzfz^ e+}AvqhdF%@^yud=b4K*0qEMᨒAفW-8LPҊ|W[[@c+ 38$ɥs ""!ŕl&MZ=;ϛ`A#x lfp, ACp{ |&>3.ݞFR9 Y2ADVIC=h caA֗ 7EcQ2INgͺ+| $G}j5QeF&Eɠ' "RV캔3;2sPm\2 }= $`?` Y*01TU4cce~A@NV(кN)QbzVojkYr4a6%lsϲMM-e7[+}ȴUf&bӨ1g7Ȓ)Xx<( Lr1c6YZz-/dY["gN[UtiL^(:.0O)tȠj~O4s:ojd65̓Rى7oD倜iԆb}t|3R` fƳ&Gx.EtzT@:AjYR*Hk΁TI *+na @J Pmp_麕ӵ,!_jxƹqOM prηܛn=![ݓj m{i'1W2~ACyHq%uk|U2hB[985ow}qQϝݝlJMc *E|AEW RA 1M٤IwxϹ&/ .3}3=~|FvlEӋU~tr1n=~6ӅsS׎jMI,v> M4vmz/z%AlWOt4^ j9u:M?k@˸Un*P}#/րn( U]4n8W̧uLk6l34fo;atױ @Ȍ]!W3+T-; Oƚ3uԇagBpcfU%`}(LB* Jg:AC4e ̜$`P EtkyP6W;]PgAO?kd4R >;6o.Z:&/4\cl]4s(q^K v-P˔ @vfdW8s1eeTT88jiBRJzT~xb_vG4b튂X>| ɛӈDsA#mtbdҺ3 )͚JG*2ø뛓syc"Oce>4[5|g()P 'Ն> ٴt^)v+{Hj쌒-MC c7.Ha4`G 1%twjXտk&MQ$ϚL.=낖p3K|4I9¾~gyP@u =X6&S򮦷+y3o `,XoGCX"n*)mfe9IE"`J)b޻oνs>D_>?tp*qZ;K9!y[o?ɿ>,AҦ7?*+hdRv6".@+@SاFS'G|VC|} "ٹ+7e!- Pa}OGi:z%ݿIg<*PyΒ?}]VT3G71:mE(P9F`opks9/\z,(8P$WQD?3>عؓ]p * :Fx%ۃ%P!QDfp;+V2Ua%:&_{K̒Xn Q0啐 ap^с ú:cf.I.*2P6ZBБ/—.F:Ds]0\*#5MZ%Al2Mr:#^,dm-nx:T4( Xql 'a15J $ Լb X_de%x㵦#6({Ld\G&y G" z? VJŇ I&| 9P(m{)?SЄƋu<(X'(:S)jKJ⬡sF>E &Z4z]K $)-1q` ,)h\&=`R )YE m6kU }> .y,e?X~{`별dUo 36ҁqO6L\lVYgh!??Sb) {2<>+I82k-*E>޵6uE}߾~`lDUT@#1`3&|77*u!ĀJUT <'~ǹ{}0@B"9b:k ):h?|sm z]} $5}d F<Ӄ9uqq~ ,w?f6 )$qxI$XVg,&iHW36}δ3Fi׿mǓ: YVIl[7d.&KJm,`8Xs^m/Բ´A$v![VMWGerqKPėW`bι[ i-YSx 6xN؈F6d1V|=y8" R1ZȚzeu`dfg\LqEY HJg +P qu$E4eu+XfNK7y*I]fc$fOy%풇 d3,.u /1'~$D/ɆOv3K4MB:;ymp٤xV*^-"_[3:C.wS4{<``n0V-H}OI6ڼѼV)$(xŊLnul^HMI}C9Iv{x|C*[1Ql _(y,pF왱º"9c=sϹxo^_@S&CsǗI0>(c1~pYx{#gy 198_$۲5l ௻Dp Z-C(xs[iß i%.Oy9F@\rﻷIOA1[Fn_jKCxxne6Dhf<p RYq^(J-~v Q[]Tj`Òں\V[R{|\Ү@n`łEHAcCx]_5_[5Ȏ4/m֯\I2zd`oVjyuyYAKBqȧ ]\(P9d@X VF"kAWzB7*6 Gs*FyZI S2+|"@?)Ja4CTIjNs ; w=p'4u(xcғ}o`6 E0p$ˑ.ȿdk3%N _$O*Y9bv,g: ?Fo]8v,RB0^㙍 l㿹Sɳ@Nἔ`Ȋ7wi[QJrb{'lҬIۙ)tIYΤt&vc'{4CI,(y4C|*}rl}lio)ġ3@edlo W=8K--|~MЃ7waXL-|zr2srVZ0X?9 ^?fU!mvJz;8h0,־hkiX ^A˺M=cmD؉hS|3tkHr9a? +7.p2m]R:F%yɁaI[πX09sג>Fc 4۔?rY .T{ŦSv9EL|Ɏ5v6à%BRc|be4NYݦʶ~nx!)f DZ:wA *hRi2w|kB*4F,Ct|.DT1!]S>f g;Io:q*6|(sCH~HˠMu]Oz輤ztwܹ(x5Lt=OU}g#j#T)dk7 w 1 `SUҗ#"5ԺnAw4RA{%Ζ2+ݷR 4Ը3Sd,!Pus 2ڡG9"2+9ېKFk=,yAI:}{#~_^m)7,Xa.c&]0}&f'hϹyǻf@f; 1%NgLJgI!ؒ!e 4RH2iRs1$m38062W~G(*LlABtsmqhBo.-)--p,X$*ٽ^]NQsL˴~јb/DUN3ǽ9m@M>̜s{]?Xu AV?c'.}l}.^hޮ ?{J/F^6Ju0xn&ڇdD+rHL?E1ΐ nk9<QmL3mv9>C&Њ~':>{!sK7o<"O[|>:?Ӈg@ gqi[mo1k*o$^ӖNI d~*7zНyXH,81;ؠ# گH A7. gn( B RV֎'MH@oHwډp>!Nx"4Au^DvTS]o1Ea ?>Kݥe8(fyP$|!_І+/iXG łe Į3ЉV[?߿:7@dH=>8T@ 0ΙWt7v;[ƪ'0˪cdk1ͺpWdc!6;ri3J]; U YIt!FGggz?tKɃeOfe(f3 hW啉MH >x( б 4 Is h;˹.҆ :]#";עp =2u]mQ:;*H$zrqTZ{6+] EAxifų TNByi?p $w}Y[י~%^7АP~S'`٥bvBB \럂ab XEw[ [vfCPMx @L<@yq 9:G_+qL碐4.}usQ!'78SCTJ-w-@9ѵa(ޔ$kGaoĦJ)f{ro/yCɩ\jawȻަ g;qIT PPy? OR!!UB Z*|'Nl;gH!"Uc7;;so !ݷ EM*E~ktkϊL0Q&jG1x` %k&MDjV5e)W5vQ7`oY4_.z|}MȕIʮi4{'%ZhD%E>!bGS(pP d>fw~2EJqwj]*J(Qjt検isMОY9]YN3.1s$J=dC^ڦߗ"7lP]3x1<M 5؅DsF d}t$RR:M ,̮)3p\4+o!2U:<.* ,G1 obc^Dj%f[P](|)c^)o<>O?c𿦛Q*(j6fSmwc)TBG^;*Q*Lf{c8yVڍqpŐm ilۇ1sg5?h8>E3i;f 94x4szua T ;5W{1a .Tf:Q6ynn4- Z3SE4V4![l@L[Y4dpUƐ}&zx18 "Ers~(>PMV8^U3\qnPZ|ezP2Ys:EPX7Y+RRlhϪͦjت WsÉv2%W6mpP <Ѳϧ'tyJ1А PPOryTw`^ q ˏ@0P69Md4JDZoGZ̙$m@NH;~9ۆ2)Qk)L\sd>HRGtev#~ yYC޽/e[`a>OP\fwu(nL9M8 AD6u":IYaLQ3 PD}LCxmqU(s}&ӳ=}KW壳Jtky$@WOa\^+@yRgtpٓBwJ9?Nm z6(57~57z&Rsr6äʆ* 2 8rIM,ڄ\HUS*r{hUb^ю!u`&]L?j'Htء.-5%z i΄j5BN}]l7t/G,h$%,zWػ&(z `bl̝s'ߺ ~xӢe*|a! 77Ŕ~Ў២sAQcl/2/B.C^\]0~vgf>I2#_thպcD9x(W+mS'wQpGFT(x(+6W.SPx%e׽js 1::1=n*`P|6,KHKfM`Wɰb +NW#Zy8?8e^l|hB[`@&@R hy)vpr ݿL.YcMw(:鮂tpM7M !$DJh[=ҵ;\,$$Z"ԧ F&?wwȧ6O31v&|ȫ箼{i7Oڈ]6ia( w[]`rp^:x@3xOe-ڤ_#k? =mFݐYKs;#gXfZحP (S@Bj 1^BSs}G_Ǻƅ{Rw4 jfJGJfQRt.%ExԝcĺG"1ܕ@WjӠ 6 DAI64w0HojJXg&G Qnql``cP DUOgB̐)c8b?bV8%:'>'=0٘h%LtTa.Y=8@6t]RQb!TSYo\D:*L XL,z 0!}E ڋ.bD# /C'dtV0fA'BpDh\%c0rL!-Pܐ\^db͢.7)2},/gR.PdZ,qV/zsEHW7<6AlmEiJ( P=â2JA dŸ;،8RL1 #Mp+Q.keE_SԼwƌbgGkDHm3dvz0E31`,E[!bLa<"621æ!B74݉c GA={;A4AaatF8FU34-*8- D>\CZtz/;R G )1e #|u:WNvXr)2s!:YM'Rqiqȗ5jT˱WFdWSNZ3Q(  #Fe6x7.AdcԗHO|S"V#0Gk~ cKfӓG19z-O)t,~˻=]k!O2 0.Rԕ)YQ~W(c[=Xh1?9[uy{V$+>YRVvV+^_Dv}xd(OId7*Per~"PNO=o*it2أzn=;8C쮅A*g>m&-buCFZ/ Y` -t+F2Xb')c,nQTz"rL=ƫQcosm4R% AZrZf7k[]jP9$3XRZo_oIP_DAUmm3&ĽLNE`/v:䜵Y?Ѡt<mմ k[ë@ϽMe;kG B،%ԥJΆ'>t^>OdRth[_Ry mt_lUuJ&pMjwA ț_;EIX\j\MՂxB~Kg6ޯUU31`Zx ۶ylKS7zgjP"$h<|1I'; ݌+= j&%k j A8m{~1> J]5+G`n]֚+nf#'V uQXd+T j?Td4~V;ƃ,}B@f8&bCg]L +v 6Jbсa ֙fIn꯵=O#E_K3I:l 6 bcƹodErX0dhv^Q`ɽ[rpqZ$ ~tٕ*b2aI2,(. DWH??QgFWHv(+'B 䩎W #xîQE={ VDA%Wv |XAF+w{GӁk5z~yѹ$ t$a ^38+ٺ[o]4P{7lz;847tn=|smB^ e}sa1Ǖ\tX,< pV+p˩t>~ &ό ynl;zSL7膼{B!Gg&rjOK hH6SX}#;Z~c&4ه?ͣڳW$vԄHZAMlv}MLc%w{#8\dQ KO#ֽM ’:s ME%D~XQ8͆71yh$glX=M7cM(S`@v?V$rY 丕[߆жZhEO1 QEw^7q桴 / $@T GQ4̜ A}#z9wLx |t`^[%]cx}w/r[`OuS&X `VR\*M9:eS״^5]kݗA/7B;WZȪ 1u/7*bi u{IIky:#~ y9Y3^'t{><@bZf龿Mh:8l"zCp>oK~ 0ԑ JЌABFL\@ dI:K8Ff`VkLGOn(M\&-oAL( H uG;<ֱi,=I(*rvQѫދ: eAWR6^qplOMܿϛYIW ݢMG#N^Q=@dQțL3c!uyb)жqpۧ(>&IWA[v"']'H>y𴤷g@f<d2/?ʼnd$^1L"WHOlA3 U/(&fUlcQH{:$׮STQK$.I4 j˘ Zn  zJɕ hї+_/f\' Oo y4ȳgKxdklW`4NT , V "_}˰6 .U"Y n`YŒD%9~XX'"8ý!x)ԋhD:ZJ`s!sew0uoHj9=)aց%78t=99}!0w J''c݃N1 Kѵ5'H䇟Δ輸45{COuR5/Et鬖#tm)ؖ5yMArPVgk٩o7^_,O7 EJJJNC5/<*/ǼːO~&g s{O&w52пU=!:.A4dV5h)&X8FA?yω1?D2P[#l=&tRX8W gڅ%\H({-P6gyq~E2nσ h^9`e.)Y$fУ;W.0Q`bޮW)ɓr2{h%ڬɵ\Z\orei1T4~.U/FJ[ҐkLҊF ǔf"*)%ANQ/t|[V͊D!m|buoI^Kg;3'B@7ajz f@([V6QīPDW0])\f1rKfH,[_f?J{aN,sn٦quN fNi40$9Ʋ  ,oN/^!e:4k qwnT>DkGmkQ{AFԧ KFߢ$pWz 5sZQ˳xʳWvY[S ,7?[ρ9m݁ rS}-`5huX@r,͖OҦvuI9T; Parb޽r@*apИzvg@OlïcЖͬ[$ynYɠo,+G*ʙ'H{B*4X[z-z?^,{^`*}odIr`rL8ecF@T8)8Xgѱdv|:S+>6_B|ZT:DxR ~C@V:l ֨sʵRfG-:zd۳'>;XPvwTz&m\R&3&ݺ3v[? ĒcQvb֝ tow5mAt4XccCt9搃[')h CeG("vI'nR9= 0 KZμ}f+3'$.vcpK$4Q `)5$VTVW+-9Z_#=|j^asvnZ~ PB6u*cuOV9=2SlȑMp "zjA6R0F5hT <$}0Bg>uvsZܟlOJo ko,oC{] '-rܺxPm"&*7% z<_]es3ڍO@p.pAb:}:Ǒ<Mtx _6ÿ8 Q9u? H`ad{]YܰM+SMG\gKjn"|dV嶮4ݯ4i*兕/[Xf%~ k tI7,+IAo^"b62=VȠ 12Y67 u~G^LrΓBFY]m2dRdb.mBRkJ&"ٹdd_\XoՂ`%W[˓3)KW"Zh,597j]Iav-{;4Wl ojȏKY`籜>>[d禵`?ۣZ;PЉc[ nv 넅Z*< U Z9o%+]f ,(/0,:[96z-׽}gFNϥ.{GEkڽFVUܜ;erJ 2oSR mzs nHCjդ&"u )E *y6{$axFfp $muo>:6t[ JUFL8hEwh8}X41hHCJ Czs0o)hd8;ATaHQ&3 cF1qƒ(`x'*vzN}-`0qC!U ޙ6 q|l?;IRh&P'AH *ABSZ5xyf3n b!NUu^g/sT]RO=v1 oܕ''I]k[ZROIklFOY*a 4d|ρ4WI#O#x&+.|Ť!O}/YHm.>:ϕ@̉MNwiL*(Ue h(M-أecF۝p3Dͥ\qLA3+woS,2!ݛ9!V QsD\_k-RE> ΰY~Tڵ8/D62mI\t;޴Xqoegjvw( cb0(Bȇ8W*<{A&g~(S_! -)0hzYv7)-Lȴ ]sQ]bhcLk+YH0bI*E(_21r>?u>x[mG5A8"f>Z]): {L<^)Wz 'V qQCPUQ苭Z[sK5k?A?%1wnrۡuJY'a$z (|{%f;,BxL3 ZZv@8R]~'[Ǐ8BzƁkK!|\4a%=#4WCE/_"$[%yX: jQFuj:%z8l$DԬKln#zЮyOv/ty#gйuC:We&S,?4يsȵ\`>H.]عi7!JcK|PR*bkiܗ\1^Qi^%o>t޿sӮs ݼUDq,|"[cَ)zMv::+m ZX̣'9I a!om,M9x܋χEu|beR8 4#vA[B~rQJd(,үdSņe D 8=L{ )_>jUT6{ /2*(IX$qg({V ˣ MP+}%NF 4؅!-a&\84~hUա,ö9~v2AV5LΎػ6(z׻(%NU4Uy Z *^AN]pϹkI(E &!A+ЃlɤDžTKOϔmHn.Y`OcA9ډ2rҢ:c#aJ8&g VBòEd hMԚ]8\[Nl?z2<-I dQ#IDonK'kPwaJ$R~kn7߉|Ip\ ::{.L7Svv5}1d4uIct5bg>:@m{.r QTz뢠N^(+Qc|!=Mz4LXz<_ge(uD{`}~B ^r|e`Uc5*wΧN9})'ֵg{8¦ܘb=LIfvU {Uڳ ucnj6JL:!V2G8΄F>Ҏ5z G[`Q0 F(`i%/>  ?#s3&ر 1/L4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JحcAc_I4L n H`JءC#`\#W^wqOmU\ح`%wNF4uw33U5mDQ0 F(`!0?lPc$k ԳL###<2 ;vlA0{ N v 7%IC)0{ĸcwo}%Y_}4ڈ`Q0 F(4bPc8/_0$nbk#Ť>lli|`qmDQ0 F(`;zb  E=lj`C=5ԁh= F(`Q0l(ѠF,bcP#& 6JLiCwmDQ0 F(` F1`;Ǐ(u0})5a dPFn0Ďe@Q0 F(`!@# F/A ц>2ka l[@Q0 F(`!^xgQc|XF3x=/ ײ dyt5 h= F(`Q0_ǠF42zF> fh435‡+F(`Q0 F3l# :F,g>yK5`jp?@6G(`Q0 ݘj–sț5*lH5)v u@Q0 F(`!G΁ &>zgFCzhFNvؚq|&h= F(`Q06F*@_NNSH`6K Fѣ`Q0 F(C!Wq`=0C6 F(`Q0 F.5)P Fo$#wRJh#zQ0 F(`/Σh:ȍd#@#^@Q0 F(`! F̤ sabx R@Q0 F(`aFsFXLN<h3A'v@ l(4ڈ`Q0 F(Ԡvn P,6ȍmB Fѣ`Q0 F(C 1<{p5agEc\B@?*֘Ƕr}W@זb0H1r mDQ0 F(` Aj$®>?PpEqp#ۍ,FF[͇#111(1 ׊`QA 6+\qС[ /" !LG~KJU&<%λժNuB[)]߲`Qa Dk!-"""2dhs(ߒ3K|#ɑzvh#zQ0 F(`PcyFo #Fa#Űa1LCh#zQ0 F(`(6kAf  1ئ;vTQ =5GmDQ0 F(` Aj+**̰y`4ڈ`Q0 F(4 Q*ױ 1/4`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$`[aQ$0%ֱ 1/$;IENDB` T'Oʏ`O)DpP 84WNx UQ3&Xdwu9(D@<гFqGXeDq]㽩:Rc.'RL]sOcyr%xm{k`3YbN+/O/Dh=cJn/h,ӿ >?^mEt8.F.`ܩsGj:d}si> agHkݎ&3Y#}d6E6VU7(uIӫZ>Y답V`SfeOT(E"3rb^[QIJȂ(!✏&w=VQwY0JM̘rsU:Ǩ!kKx\+j+G*Zn!3KMwH]潓W~2vn)> my7zE3< Sj^A6p7LvJtp_,$(Wԟp ɔ@xUQQ;1yiDfQȚFF;{^Q6Šc;2v2CU gT^e)i{U|tX4*{d,7ԳeY0 j_&q.1' .ܻ ĉ 6FI.& f3l7]\+g5:NeT1GdM\> ->z*2BR S*4.|6%jKatI}z>Fq7w,8 Y %\pCL0n>l51 |+mӈ\`Ic˺ZQwj7nK>F7dO`@37s}{|Wb)O:{OiCIR>[Ob"9\?SACS?dã~߾W'ɩ [\E ׎,R;t'ܘ*0$`y{ey_D+q bǝs1ΖɈ6cE /<zاBF)wbWryhSGC_a+ r%rzz?SSfV/EU38TTHTir)umnbkRPp}RGCw2~u{\rK8NHHS\3SO\~rXMMEe8%N]?v (qNs:"0Cކ.Yq3:Җͱۭz%w~A~l:{HPA 4ucOY *{v7mv-M~8U1W1=r=k{6t7^6~0}Խ)1t.ohFm}h[Qߛq:,W(:VIe^gά]{aXqZpp#hS]g)E:_r#ikuKHi CPٷ`@ zj'5ŏ뭝:uJ$} K?.vum`}\y~:9ї/İ ^bڂ{^J/h,.d4q g66nvQ*PebMkMYfG{F*c?c}jlt_[wkNw:eL5ui|g5HhIlgC[b0sm1*e21%]K_hnK^;q_83c%Yuyj}>zXB͑כֿ̾g_[Pq6MͺL$?e~TU\2v3(Jyq8HZJta9>>"*FNQZi!t~VuGuQe/ρSUFBį"qbJca<<_Uoza4';%d,'?g٠J?U6_fLg<8r LO`]o#w)ޮOH *6Ql IdOd{ 9Kln؜i89 778ػ] 0, ̍G IV];Rsv0=cTYynsOW0`9,&ƒCUq0jEmF.p'v*!7Vy<:/5Djoe*+WeevEW9v|0:/*=`Ysw+Ss '~'թ1I͏j̨T`jc|1wx^Qhsk6{&Z鋜Rxu:E1 h7dd@N"W@4#>,viށPFҖu"0Х؊t,:} H76aLF:gݻ ê]Nj?,;)\1;{9Uyxrd oR<ё3F?;ރk@ ;+jS:'FwjHCL q CgK6j W dDYR(vM5Ʈ >r[]M sE޻v`/ZaȇIDvv`HN]m^0[ AXҋׅ2Ib:"FX JdL -nBb=%Ȁ}̥9ĭOE% C3=4xgzH޲ iXϋz~9.x7wF'>FVujFR8RѪͽ|;VOoJ8eVz$u$ uVŢ:圝ggKLf*L=}YJ/2RqᅠKzwR{zAㆀc % WB܂۶s!Eis3$&<l7!@-B'U7֏ ^>N<9C֫IJaGBBH"Pdt59!Cmct7ga^KIlxL ?0xчvr<gY]84nt+ %2`]?5r6Neg}ᄀ.yуU14-?zw pR󂇃n92Qp\dM fܞZnF+Ld_Ӥ/6pM{Yܷ;jgզC3ctS}Uq:ˍD0S'GDqD t-_>H6ad+sF2; S0KLڠucJ7K?=f&ޘY\ө H E Vآ!5O@\`h.!׬z³=<".Pz?-αdQr 7M9e =pca:8|_%Y=Y#~Im2PJA uF*mәh/F l墏o,\c&;~ c^r\$0*K~ WS(ï_E&.E60@&F0/#x'V*H?r<?hnƱJ~§H8m #"8}4A$/W)<^3 oD svp%9NnC݀7 `V~=25CmF62 rsVb{=2#!ۧsECO.v+_E%)ʿʲu`X Y >S|@ ۈ!/{$rGީq č.xO6Hw[KIޅ] znLbTؔGzF>x\#}&Tb.==}mF ݷ1뫎^_ 0%GWx_J_bN$]MWϟRP}j}-Brd/PRO2r ~_S:5κ[""F E*)2w,T6o!]mA9EHUSBbX$'t?R~VsPԦmm~J/%2P_ij_I˭su F495iLt27ɬq\ȻT/؄:*|{q4涣OG2)m*->N5"䫘YKhoH}3o^Vf^Zh[2̳x% smԜoy$p SRoT5$ hhȥ8g33] SaדHyS.NuM.7#Ǔ#7X:胈st94}֪^sz%Oʡݐ~Y93wcgDâJ[=t:8IJhAvKXִLř}9D`H?&_؜Pkxq[*5q]#a.LZ ޷*>:,MzDRWxK mb?.yο&Ke{F#T 7rHguA12zQ&uWod\5HO;oTH=T|m\V7i &z* wjӫ{%E*Wsf>UF|3jtQN#8CS6*#8"La .$3}I׭ʼޟ͸qjmIq~[iE*oO&Ȍl( blҧWim׿iQ\&ۘ7%~tG \/kΉ=|ƧBNJ r`9b'gei㲷"& | w`^Xóa}ԦZ!Ϯ>:9A<͵ť(h~C:[-y4UF& Sϫww>}a2cc1ݱFqJѸR1Լzp\$"[}.-Wz!#YָB]pXZyl&]oJgےCdl'/~5?25~Ae֯@8S&3`gY>eGCZ-zbcC sV&sڧWf"*^KqwՍrSힳb˙WɌK<}Y5v["` WSxW?^'HKh]KzYAZuw=lp(X& |$ߘ;íHrzA!EvQ}Sɩ7nbD~Td82} kZ]1:,|IQ1)EVԚ,pٱje:zZqw#֌)r3<ũFS k: \%is$ ?nyv~:;#^9{K잤Sgow b'$t2+O-iLp}-]CB_^D5d|X<";ݯ$FJ-zdS}qR ot\6Gc j}egzˣ޻-ᷲDC1&RAYgR%CuExjmIgGc^t?Nۜq OI҈i׺*[6G)-Z''Y:і`cfSvxƙ`\~Y!sQzy?ܥMRj-qh3=ak,ɼ8KڤxXʣޚWc$^'C)/i1:}>Aw_gq\'DtcmfpOݬ ȑ1>&Oz8S'xS 5yba użˆD7'Ak"9x=g_g-(ZFTY't+19tQMK]WeQj]_Ӵ[$v6Dɶ\}鲡#7D7+21ݔ=Eªq*vnIxtBY3>R%u<iDrR""QG'Lq!.GKyA=p(IS h/@Z0`d/ެZ9Ki9=rL ]<" $ m,D1ި((+~u<,qڷc936!"GC}jg ]P xJ_>S|?s|ʹC+g-fSLRmnsH@5ԅ(4&c -M#4t:q-$f#1} Jx'Q|9f}/ &\0{lF3+KrGM3x>}/e2^`R 0ǢTЅl|XpFv/ΰ1`i,z1<6i N*o0Q1RGAL2e4-A0k|^s ق:NldP%B[7e;oOG b^2uR}kRJR)?U&œ^iU(Qm~qbqPa?jK[P'j:sJC 4mG.;I˾cEDIekO tkZ T|F<䔧>$ů^hu9J_2PtAtEYveJWƚֳژXU 3:V]lXRq/P,u*Jljlar3ܭE=\ V7!US /H[9vnT g\:WzlJK"-1% 0x )W~k|SHx iLUAk#ポU~oK#YLJQjz}ȮΙiZyl;ɺ珋'DLw:|swJW[* 滖^Rjgl˖ӕc40Xʆ)TOi24DEnv9qipQ^)ijfKן=cbT0Y͔}sJGbW>}7,OuA7^GN}b!?H5Y^ėW\F.Ol_昣-]Q0mdm>N2gxCl(sI OH>\|DՕPc?<>Dr%:OI̫ËvHKגs L:ٙX$qG:'~kbx*Gm_Z.ᐼP:/"kx\,^"q~[jlbR͓Rz{ɓ>&4Kjо(N B 8SzQ(S&f/S=q+لǡjeA D,=!qs+4aNnm! s >mkdDW oZ<ϝ]-:G>5StJtoJ(yN3{D ѻF\%8,_F)M<9+2(7 wK(pId$c7LH˹ѷ7o"k-E2)\">=3Sdi,L/$ޭ]\KtLp)nyH~Mq<8i|}rQn9MTPz22m: NRe͓CwrPe#?MMȸ܃i.*2 N&f|L*{gr~Υ"]CORclgW4Fn47#_<՝U@X4A3Ace(@9\Q`z9f W/? N\N/sϸ5 a)D[/R[5L+e{1;Vq !# 5e7Dt#E6R;v{}.#r,ߒX[e'ZIh K_xC)8q%s+rth8V|[:[_sl4(yӯ0 x:^"HK XV5X|VV/#Ƌ‹1:֯۸gtiCa)w 9X^_j1H6wG [gyw˾3M?c4č|>^TY86ClT/7f LUd衯Q{Dn>Ӌ`MG`O=(R,h&'s~,% Oxw >3O!;p زHVcA]%M<}L34x8p`}7OXt>~$/)X*)xG}" pou\,~׸݁e>GK`SZhx |;Q#,Zw [!e<8T.!]Gt/cǎZC{kU./7ğI Q"](ƪA^htSG}ʕM.]RSIGե@ Ƒ9'Il򉲅+\o*U273fR1j}1I1 7jx/ D.[ 㗙.V >.‰ @tl bo >M&A\_&|h _U'Z< WQzejoǗ$`ek]CH)n=GnʚjLQq(6]~dA$,,-аً*5LmӆeR $5dFz3Ў]mgզ[L XINSkXFC7 -&~ } 31WyBC%%n$iu5L iKQ3vX~jҗ W/}rM_%¢󞜟4VFx!)^9`![Klv"}9qIUeL';}WkEf wqGþ}TCP@x괜Ѫ8bԼְwe%m5~W\RljIFP0Hh\-/}AVX 3-mrP'`*+L[\fpQ~mً9@e&aN:."=+wL>,k"ı0Y)ކIt(٧k;ZwvXT_h .c͔zJGxt>w$n:2~@33/l9W{o[Su\W_Y$<}Z&t.T~nw>Mat!ħSdb|O&NY撏mVQs7I$sj6 |tt|Ǎ5Ư&smyid1|&u}c]WFz\@{i8Z'nԝU╩VIv!e.PwקKErG/}yiJ3>4qy4!73ٖoD$| C5y<.xf%X͜~.t.W~ l-QURYsSg+GWg$)VH%cx+pXǍZe4 -Gr !9""Hn^Apy+X@KMMSJ KTX=jnw촉ʄ9/.McJPxB# ̏*k  ]AA! 1}ؔ?] 7'Bˆ\ (B(f\a~B|$?9\0qFwd "go`feo į(op0$ ›s7+eLu6,򬹳=;WM) W&Ȋrs s q2ss3]q0"p537R RHN>N7RMVdӕuGsx拸 ys!s^nZY Zp r[E?#Hb^RP@Oi=ȟڳOr{v, o'Vp/'{"6p ^Ngor|{o?:ꌊ3VyCri88ɰH%PEroS+`.LLrgKs-#LB-1,6 Z3#;B-A V բ4,@54M%&AC-A j ^8ӛ%1b >.`S2nJvޔX%ZQ? ր#;JlɥM&%dϦlI-Y%7%ԖڒݛN%ͷ-)1$dڔT[lKmKbK^ܒrKn-9)'d ]5i~k^S^m@T# mVB!T8Kdh=6~xq&uXVie o5K. Gb `ccx`c7 EKPcNJh*(Y `@U#P. z (yO݄O`21Iu0p`Dt>uS?NêdJ ʀ`U%E Mn&\ HS0^7B.p J~}CCc d\̵@\Kro Z5% "k*|\K-׼\KFIGWYIL[]rȵ+@΁W .9Ve @Y2< s `?97 \sr v9Gk$@΁$sr0ss$@F(L9w1 9JӜۀP~>0Q-@3A ‡5ْ$0ٔX$0AI(WLvzmoMq B B M鈒 8B C{ Հ<H{_#4柞#Z h2, A =捆 Kd$t>mq0}8& aJ`& L x6x%4Gd J6ahp)5@EIMR~(l|.#@@F"zX+ ;`lEzJ_a:96?бڰ0tRPb_{bo0gPW@mc:@/*2G]xD~߱À;tهC0Qy]{@_'!TG#Džx]s'_pgߞCdr? !G!$$qTlv[ob_*?O Giv/OkG=?4|Y+7?O,,,_,_{~~~~~~~~~g/g/g/g/g/g/W~/מ,,]YI#$@B8+dH &7;77>IĿ}$`!,hPwA PAPH!IB zP ? `@ȯ>Y0 <"Bgur6Hhwh;90@8C[Ǡ^۶ڜ0)F<;xo`-B5R[ V=hvٷxC%HBP @nj?U?U4 ol3ڂ~CWQ+؇6TQDtE,C0@45u-/u P !&@Mv"Z` khM 1&N1` Z=Ba5Tj8;1\ #Jwck|7ƿUƌ1g(4AHPͅhQ B` Kw{t ^ @Z0IY*dM <0\ MKKI{s~!Է!4\-9)a-zSbGタ*䎇[m=|8$@c] `*xrBYU xg08+L8U85|K%\KHjP X#A4*`="QEn< C866e`yp4l p$DIz -,$ рb-54÷0\ j@-p +1n~e7s~fgj8տbluTJbCAX!$Z b!$  bъ (!!' % n;=>FaR 4o'8%e6%|8薄p rgvyj3x<3<Al{z3۞ ,i3X,[ VsHGM pdGpGOsϐ$83$7笿B+$]! Zw$0kuWH]! Zw`n Zw>~vwH]! Zw$Nܜ I믐LX,BgH͐\WU  Wk}p`3&%L8# P@ ;U&HXE!  @ XZr@`Go{uCaz& 1|Tj[eލa1pmYl oWwQ.!#AHpQ2Bn0T @@8 [ nKRIM0W~%f*0lN5*Q E59 bAe'JE6lh=6ul`ө6=`6dSN5⛇m6uGAe657['p <u\TѨJ8E]C M+nyϻ|e7ϻu%OfpеgH6j/t˨3(nrbrܳ RO{1{6=2&%w '|/VZxM¤pp3>>>f>>xbrkՈ{ (&%5v>P'#ukLI60)<#Hr0$ьA?O2,S V.6H [ uZ8$l{A3۫vs@[h)%.F9Z ?ဎ ,kA~ij;5L X#~֏،y<?U/dSBDs%$?a@uȶmJ(hr 4Z/m^ =PMo;`Nb4Q\qVm h&fi$s h8wU9 j5dU ]0 =3 * ^XMW\B w5mQ]RCDH@mܲllP3m5=14!@O;bK1;veRI 3oٝy7kf_a)DE~ Π&K|&HrQgjFԧuWNWi%V(&|C\@E†V%#k$F.RyOɠp 94=eK52 =:l.EH.4\ERG_)6iv}4R? <}y l fE5Ѥm@3zjWz8g8Q+*BooM$Hn̠[! ޫqLm: deǏC/'tV"qTQPA_3zx ̼%. Rd M)VNPާc4 E*KS85ꙦZ^yȈ{f݇'2E/("e|A) L%_Pd*"S_PV*>UةloWvjk;F}޸WZYHVk?lo?تQ;^W7e~aZjK5*!O\{ jxgx48.%>"Je߈[J \i3pִd1-z `/3z1B`/'2,H~pfÙNvBޅ, Ĝe,HKRg2 C* wlK)(CN`Fj5GT3e = 1̄U6/7/z0m|7Ɉ(69B(QQAWyTIUj@t\VENvxüh>{d겖uL$3p ݲȼOKb|u^$2Ñb&D>Vm Πm:[!`G2o2C&nsCrC/6xW06}c K_XI;.ٷ.jg,!7ѡSY;rt>Όdxr2ӿ;™cN Z;BJ ?f˧,f"JSJ׃Xtӱbv LjULB)ch %)oj{z)X|ri>IRs|o}O+Ym|7.|$)V뫫6([zJcfxڳg +9^o²߸\F꽼n7_ˇ\E7r}95Et¦ڃDuS\1ݏX߱܇],e:z~#IncX7 8ԃF@ ϬnJFIFxxC    $.' ",#(7),01444'9=82<.342C  2!!22222222222222222222222222222222222222222222222222" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%  !"#$%&'()&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( &=V(Y--P TdkV<|=_TU<OƓ؇~h/iyڲbҗz}:>ZZ#N?7~xPڔwvdXxL/{Q^AEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEP{WxoAx. }=TH[#~U,4;K ;KSj:URję8"ׄ>iZyz}fp\mžIT9;4S=G_2~xKKcZ]SٮX >L<uWk_+/*Iʤ\xR7+lb 3ko߈lƟ~d `:d.d5Fqb|Kj-;Q)LV)$GXr;qi.M;KnhEeaGx?awOsQR˻1+^&VwOah ((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((~6[YmZ.j|\1;^7s"3O[F=xS]Hn(!O}+M܎*qJ/GįWZj 7Mל?Kx>x|W_ ɜMGZ8=q)%g/o?įO5^oNr ?"77u-o #1`Z^"z[)ѢN]ocůjdeR8 ,U;z׿˟?4S%l( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (7_Ymp7P ?V6a]A{7~x/.2i<窌bx<%&c]Yj7FC 0^p"|OѼ1-]7Sxc%{x*LԺxv?>'TWmrRgyf$N_ n y<O^lʰz4h(Q@kq].]a0Q)79Qw{bB\b2M5mVZ@fψ:]O_PM>wP (8Š((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((! }fѶ> ]uύoo\O E$,+XT_Cµ7dFF<3ՆQ76'v )Ěb6ۓ KǾzQjDc/!I%RFF#A AVibZ,d#0W~kIY}mN>jPW^[]Xk}>z[f)v3媜16x>+x|" ?tNva~K[T$PӷeU]f\2sw/4 33`8֕5jܱZ^XJuq\I$XwzO ZndCRuOyz,OOՅQZEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEP1s6p%ĂXX䐠  ~1x\>*fѾjV%hSe)•I(F/،A?Q*͇F>I]v",8M@R-Vmb6X-Tg%k +=t8u姏6IJ2|y_LgמMYo)%Dl`Bo\T [n͋EUQ@Q@Q@Q@Q@Q@NMs2p-񠍥Ꜷ1=+##V x -rT-Z2ٴqcv@#(۪нm2Yhq=)wu.mM_Zqv+'~yw-vmr`+|+@PĀC^HGpzib%zdԻXeRwnߣ=B(@(((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((n;񯆭,n- o6*C0W]*椤-QL(((((((~^2kϼs YͣMmt)\:T9 `[8dPuK{On o#4BO2F@IluzxGΓycPo/vE¡~Hfmuƕ:tZ}C;?  7 渹I +`q2G5xHOjҲ:8oKK-HHf4h܃ >xI45zyN! N .IFApG`xz#'RE_$=7IsSo蕷6G*z_^k:gyaB֮B=2S^2W&7 XuQTfQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQExU#2EA!fsҴ~2_^[ŷoI*B"[ǚ`<ASzx&G0p^I ~duVn9Tq՗ΣB6ƪ&ì}Ǚƫo8A⿌'jV@2-UlVj%KJIz/A]LGѠ_Q2U,I?EqkS `G\uMGGNh,(A\kO2bZIG3+"_m#Ksnݵ g?t'f78ӵ>2)8[PQEQEQEQEQEQEQEQE7 kZ qg ݌ZgefGCy}WZ5()Ria\d''\իF7ǹeU`-||&aZl摐.q]9ghlZFmcANq''Vf2Uն-QZEPEPEPEPEPEPEP|M]7-l( mvoP94N2F򲟡`5FtȈ#Ʀƚx"Gx`kyZI%B0VrmuaJՖln ڏ/?O?qO 2u;c~*xѣijU[iX>Xmi':gb^_v{U]Hf'VY~#^]ʡW⟍T#ZuzZwu:\Hyd ^,^b2NIr2Ki o۶5wQQIK>SS*k#=7q)tUZHXxY\cZu$c}mp"[R2a+,LТAh9Š((((((>7BT2jWxI+[oK_G&Ox7˚O{x9r0#~"y3$i]We0 0{yOm!{-ɎMҷ.U pAōI#V&f!YTFdA9# xAo 3R:oi8+*FDd'vzRUJ_(ck1NJKݺ5_S|>Ղ4C*qDbsG3Oj.hGAH k%$Xp8I|x&v kEngs{lTphb"ѫ&81/$dJ随_JWOt@1 ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (<6{XzB '}(?t3)8_e7lM4=3Jm?b-MG U0yW 8^ǡ|b(!zv}+':ukmᕒHFy)ٯBnmc}0ϸ898 YS ׺Mt,QEg(QEQE֓LfF&44k S%?DF gN_?gF7g<WUU,Z&L6A5>ךx 1*$ ׯcg|mfITҔt{+RX9]WoyZ Y7$$vɗ#rIcV. |cFqs -+z>iqr'֨PzK );ՕY*_6xաO ~'+nso kh'\1ץ _&?IY LX#i?#uSJ%xHc's1 >ϵyg~/MmrmL "XL* |V$sC ˖;&}Z3r߮3_Dž":eM [dۀ? NXh[8e<[/mcIXwҲe>Jг/ b*6֒6o> Bla<@o>xMo6nm 6?L׿pE-qKI{Tx0)z󭯋<_{n`BՁOQQ X7{7q*?5cgW6w?J3 ۞?cѓGc÷O܍ݳj_v=,Krf %FII`>p=It %Ӯ"E/pa"Ÿ׌PYQ$Բ ᕁ 8w|tS8 *0((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((3 ޖ"OA,KCotPRif p$#$k:M{GteI)=]WSG̘NIŗ*էCF! Cݜ]0D&y85L5WJ\L6m3v?i.sƼEaxpxfijRmN@J[7^ixo\6uroIv9XUirSW2Rֱr䤾7_~XKw--Yǫ]o~߈06~UxAֻ o-< u#.V&<55Wvm9a| }? H0G*WYͷ (U.K#+/!OUbºB`qhM\ӝfiV]rYهdsӞÐ {F-Og JD"yigw ջY#l Wԟ /IU+0}n?*ZTiIkYٶ?W+ksJvX>QEQ@ $mO>MjazFDk]As*'ZJ|Ul4ş9iozKI-?C+|!O[q3|]u坶hQ4R 4r.Cy>Kdx0K]8ꇩι:{Ef5J-rU%hj8x灾"˥k]bnHsGGg"iUX'VUuW,U <ڠ[pDݛ߈I%h"? sוk~M؍lNOҢ&{y~O[V?ƾ){FuH*Y lQ]~$i]r+[?O'4:J,lpéqC߯Ze ֵs#HN9=:$4.G~+ FX/zr~<;6yp.}s} XcHE" =) +JT8j~TU5ecWSZEl$:(8((+I?0KHRܠ1BG>0Z|5L3G%|goZĖP̒*7ufw<)Lc&->{>?awhxnCanq!8>ĺTs =z.Gk; B.)uSȌuǩ\Ӈ֦tSC:󔛍-̋Dž= M̾j{g׷zs:ѴzRǧZ8*ʬc((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((d㯥s4LPT {;֧mIc+GįgiXs|EW{9F_DjRxNZ#5ͺgolv>BDCh*t4]& +D+Wjl:U54g}+s ( ( ( Bx?Wi."!`cV敧D3"mYq;73œ>X+*|Zmnl.29ETd5z/ğK5w4i巐:.8$8:Ӹo [ ^ס ?,_i[%c]3넔BQYh(((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((Mq\QEv>QEQEQE#6?4fUX琢q%cQHoٺG6%'܊[Ze; C 1qI=ȲuMG#?i쩻[V%;_M}O6rJ*6*'L{%`W\^\53tf8'E`08rQ3{QEh RX2:#AiQߊèub)VJz|'o'#^xKPyb] ʳA< c"xWOHD"B{fr V s];5Zr7 nJeZEEPEPUm).IQѺjd`4wG{kC#>t$>6Wjp[H$T:ktX62ۑ_~Cad|_θcS>eXJzKtיQEv6QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQE42OLumǍ{g7:?yۣ~ =k|[bl\=wO\Ws]kG,qb/RqYyDcU%c2 . XE P=ZТJNMŠ( (((>0]ig;) 2!`q70~+zaKb$xgy6) GՇ|_H4O_lEDoхQ_\XQEQEQE_uY[y%䱲bxK=Nq_@^ VIEdQ. %9O{~MhTk$3qhࢊ(((:1^J0֬>DJX}s"1kz$>4s2d~5ψ 7Z N 4^wFԠGЩկ=wZ,τ0G`UЩ e`*]7^ahŠ(((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((*V3Jv l}4 &ݑ?Y5_[h q[д]OAIRMx'?ծpb܍:k5LJ\ҕW>;ӥW:(B((((G[KI(#;`rx@?BSP.oe \JҸA N=|˭T!dfrsA!l{ھ{иC ˇw˨k/AEKĶ\G 8dT%cz LwL(`QETKo5pJÏ6EBV< Ǡ隊i=ඬConmhRNB%/kX),[P90=C#x 3 ]*}QExpQEQEQEQڊ(>t륝Xj3fHvԜ^krjoi^,)5y&E-[pk F_ $W|jlI&> m}:D&aUd7FcgG"erkqPuEjK4# ( ( ( ()jZ]͌6Fϸx[4]i2"O?"k) >=ߩ&1^3r_Qj7^)ʃK]gQ@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Fkgʮ&rw򢪬V_K_2xGm|g˦ڍ֊&u2 Ur=wZ֭gm{O{=sSTm12KQYԿye2O}nKRh5# Vbj'<|;Pڽc/u JS}H",7?>+>krm:( ( ( (k"$ vG^,.U$a^QaPH30ȑ&'ޔ!ݟA#Ǻ+((((/Mn28Xw$P&|F>HtWeiOpu t-/ٍ"E<nA?ݯ7U8À Fg^=\e_wrjT[_ nOo+ I'>՛E7~z$An-䳑&n;>y \0կȫs ]V1=or/kQo^UZ81_Xx>A'4t3=*i]~jځ,dt vPyj?s[uB-gI<C/}a2_Aq1 cVqMٳn%QEy|/Z?xP v8 PFA)f -kP]+U}+Q-쑲V?a 5?62Hk?FV(⾂5Bm,9$GZfTOoVg.Γyr᧸Y1dC(((Te6-dmއiy8V"C+?H0_\O+;}UAF'"+> hdեK=:(Š((((Nq9]-s0 Ea_?AI"JIvgZėz̰5#c%*x+?PM Ÿ Sycyi^ґw_Nx-|7F.diFPuګ_ouj4]~V<"SF}gx*VLsfGVRA]H:BŻնȬptiF?k[ 9wS5yY~QE (>qhxuD!֯P9)97:^z zGm $A {Av8=:pԠ0"Dĕ>XUHN:k9KvtaFm{E\qGņ;?I0bLāI$ 4,S˷a2NQ9aF('9EJ%d#"Vfm2F (a, >ٍt`PFF(jqn.;|!w=&y%cΣ>2 Ru }R 9kyr:<ybOKǵȯ5+q0l8O^+fX9([ܤjlҌ`Q w4{}/=}uk~'.ј ےJ<u:úFjlbm Pzn}Ϯ4H$#.`g#\.i<{gw1&I?Z#^5bz'+ӅFzz><2?ZZvr4?Zƺn]5ͳePH%y9?Z+\JsRV#zٮnPe&m<k"Z/0)?Z%]xC`#yi,nU9m|+usݴ&Da+dGA\QȕQ#Ne%*Y+-lzYnur dk^$4Wԯ\í~\\UhS ʪOۊ`ś%e۹3)YEaMnL>bG#?c`X?Rs_SЋM:@Pp8@X]rM'ǺxIZy&Bv0T;c:j*4*'0*&KД֜yy|5*߯xƭ].uGw ȱ!= J&Lpk~(xw".#R: y''? 'X_k[ޡD#+JpɨumxGs3=(=((((5PKQ]ǬOb#ľ O] Ok[Ŗ#h漛W;p3e ^k|]¼=(ۿ}''+7QVO]gN Υu_OIxú £!oG5~o&񶷮jRHcB:T1xZM4[Sk2\2YNI+]K{D/xpJ%64V}#x 9ְh CQf>A">"ڐcq5}]?P_k:&W`('cgZT-;]XL7 ]F6Zn鮇ڙĝW_rg#>Җ)A^Qg-:=ū ¾Q%K@Hi?;yJW}󒸍44|en(&I !'m?\~ViIUKtQEjpQ@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@s??%MtDsA41txo|P[d~~? R.名X‘Q?O=/}^7W6smko-VRF|Oҹ&l> *+GOAϲE;U+ `U}Q{ßkwJZAd8,F ^ž0t_ŭS$>Y v$G"2#{KS?sd9Ϛ73ae;;}oz׈E[+gP0:vl;QW>#=xR=4j1,{r ψ<)jekXr'+7B~(sv|-kG]77;b sӜC ЇCZֹZJGW>zN|-LY乻*F1zd0R+?Z#dkU:2Q7B'ׄ4 A"Y+%Clpdzƌ"ڶcOTqIյ&X"i#2 y8(oio/ {z gW חx:6T|{xBo Y z7 ࠃKίI|$SX?r6]Q:ju3<~S:ҊMM^ވ(ϒ ( ( ( (MKEڕ` ¢ +\a-]֦eVVLg+J6T%qNNX,t0m % W|4DK TpF2sЌqjh+ƥ*g,rֽ+_𽕍5rҮ#0yRxy }kx1r<%H_{psOm|;P\[x!xOY|YqnIVk?o ]}i'QKQE8F&#ՂNp 8?h|3.=gbq1ۮ{WҾ&X\&7㛫]F-3}Mkǭ'BxL6L;1ϸcS|T+mH.y؆ڑݴbE=A1Ϡ|./3!!T4 rOz>$[O$vr8"*I=2d9Hp̼:F=y Rc*NI/$cF9;]==t+h((((OlTw}aU-e@Ԯ ˶Bi=taj-seڼH&TgVտ̹HIӯ 5|7| Kr2Xy0)6}k0xQmZey x"[F~dذq{viiX_D$A {j\(LkЅ8h+*w?Qv?()tFQ7B⿉R4fͪF1q^=quᔍʟElWiU2{ȾoLqn9qSDɨڝQk~x5ao~1|7IOE8CGDW|[ݺrY8_L Fh7zמY\U o%3,!i.wNG'_K]X_=ͼѲ`f6ADcJ }MTbN?ѐsT{z\E~]8࿍ϭ}5~qQEtHQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEW3Iψ_M\O'>! CwGx@#g9υk5k63Hb\aNFx$Sg#o>k\r*u]vPOYM(o H YI. >*zľT=BC׷!X\G,& w.uPK{;nP-f G)!F2 :ώi fNm#DO'ng=J̭&?g~k[c+S}ۆ-AԆ8I,t]_IJf1xRIZ ⽲f'+*c$l^*?3AdbvʕMBNz6,Ҿ"K+~?oֶ+C ЇCZw4 (Q@Q@>2#’l  HU|ڼ ?!^wnVs+*?x ŷ62ڷ+ :䫥h?S2+E|QEQEQEQEV'p.UDѨ̌J^’RVg-> w vr܋d& r8$*!Ϝ6]GΊi[~V{}Z^%Z%sLڪ_qłR$wݒH'57k*|@I9r}ίh >9N>+l^OB I&u,'mL9K;W2:)27sӥmYU;o3袊Db?/ W׾OF_!h?1i+ g-~+xk$ywƩ$]> id(,p']'-*]>eB~ VaM]r`w˓݃ o?ںwq=a@II,yҶ,ᰴvGO''k% 8H. QY|+UdV-E瞀QEQEQEQEk_k3`Z髃w<9xNOˡ1t a-2'٫+Z G+-^`䴅uo |zO{k~5qh%P:n&j ׵}6yt#*$ɷ=ҡ45fc>f5DSdV, qjոо [ZO5ԎilTI/xVTtUQx)k)]8^ώ8uϊbZ4 [C͛][K.(%cNk|UxJ育ևT|QEnyAEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEP\,¼N&鮖2`<`4ϔtgt.%Z(*eg\dT GpN"Wџ`X?إ~fҷNrrqz>urAǎ,>9_E}`BZϬSG5/9Dc+H:f+JKdI#*OxWqER}sX3N-\FJJ;;ȥ.<赭(P(((@<59X*ʽ۩#ڼCi.ԡ ۆVmErbf{>OZ"q֨iVrIJ)`d`Rw<'f-QLAEPEPEPEPTp|#&Tw+ƸǓn8)\t8Xk;]4B2{a\~ɖOI_a[ "!fh\`ŝ'^o^kIx N$[dQNf'Sx̹|(3klEw0q_[hnbAm?_#BQ␑py__D!!,U+0{Vi4#Ȟ(;Š(((((Jo7GX8%u z@#3|QK#IcW..VeCjXk-zσ=2Ю-՟I$*WLUUNS{(faEPEP){Kf~#kjVcB>R>WG.ǩe<6US溽տCOX:Z 㔿uu/+诰ZϬQ O V}Ú?`<_/RߡG-?(Կ|é^%u?jWz: :JWuG,.K!#B .+<4-qZ( (((((CUU[N^[6HF*%N|7>cO.l*[9CJ=oC5_]JNT' '()>GW\}~4Kk-_8|D"V[PJdm9w~ROjӊ*KH$HuQ_:wQ@Q@Q@Q@Q@nK[ihX=03^#M{rќ?wuxIm߷0yUh`2/orHԐƸڟEeW{WEWaEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEÞ=V]bQb0ޯiuu-6݁tW_ [ rfCJ+#.tYO'lr&bwZIҫk<ʐQI?G1_Qh/öj[" ¾Xb?/ Wǁr/F^)Փ_>[iFYS?eO11P?Qtg?#}ooAu{6&PwZIo;[k C8$`ט|%2iEq'=O#"58)#*2Z(9((((W5{xJ;2[;gMBp:N57pG ^+k=h;l>fe+x?iþ%ڬWt I)Ҁ]ć*+YNHN z`k{[lặ}B$mp:zO/ᮭoKD0#Uq;NOU[̩KO/se=j4VP2XA8x֓GP,,\8 3qVKn&mݰX] #ʜw W8x{-+->Tg!8&p;b?t`Y+Ja +^Q%8tAER4 ( ( ( (pk~+뭨pvm=m>1x߅5m;R,\e=ҸozݗϧR_{ȤIcY#`*AE>((((cUbNNے [ȧW$i-mr)ڻərw{p:w>(8خjs}/~N[[P:! ڥ^he}..OهF ^|ZG1TsjxV~1JM3%*2٧QRmuGšh(mVWc0WH pZկŞ "(PQEQEQEfv`Z>1I9]H'~}k:834 9W> ұzԞ3]?w?Վ+Š((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((i+ִԬ?0/Q~#wRo451u$׍xL}?Ch.wSߟ*j Od|]LTen[-;[嶕pqt|*Wv5K)Vu\p\~\ֺ~ԟ8 orvV?=pq9u:XmMuMuOS+@(((ɤ .H%7c ^Nq4دF#H֒8"9Ǿ׀1TviyWٳϔ+ xTG<_Ս|_U|)%Us+ڟgE~z?bErFF+O>vU3+Ήp} /RXxIԨyn'GU@9$ Oev[e%ƻ$ odlQ?Q]FY_ȗݧq1tl}G K IP*J(Op(((NOxV ycje%wS5Nex -SoOS3xT:ާKX2n~~(9=k/C5ok׮gE_Ïa"ZCjFH.Fq?kU*)T=xipU(=sN/00(VB)k>(((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((i /I'Gr.񵧅 @5yP#c#Ԟp?SOֆֶ3, dX`jUfBWO:tkxWl]=FeO؎5oD7R=&X3_U!"3.|篓u{ neIP8bF}< }Dʒ}w"G&E`}>b?&׋!%C~g_yg0jj:j[mS> ZyV^H kbL'ߊW-l\ ԓ?(CDw\/ao&.m9T9 Ğ#8qW{E̜T>T'у+b*Zc ( (f8'_Jy8^m㟉h];Hf TTj:p:غwzegm<+%m叩ZO'biGPv~' +Rj򥣜sAӞ=N**Hx=#۹kP8wY._שJ->C16vO|Ġy`uuh}"8tԜ^7}Y4)$ z,6Hn@9Q젶6ƆU"vrkwᗊ5wiquPO(9&^ox|Xyqwfv"޽cjųi P{x5 IZfkJx|Jeug-"3Ea^(55⬱IJ |I?PX2:uB:c sNx?Ͷ7=A$=x )-gЕ9{ъۣyK "9Ddؠq\{W*caF3эtV+EXbgZWcJ|_/s=*^ߥvޢpդz'f;Ͱ ~aޟQ^ៈZOBm/~uT4jͭ5 X!=ס>⼛ğ o-%i9>A#bDn\~έ a{I4V/gWfagytCq@Gv<ˎKv3":\a [wy"A#e:rAhk:pDrF*nopy+YObUxTVV/L+,6q0)G`{V|⼌os1Z]Ⱦd ĹAX :b̥ׄPn2o[uMBdѭ>mߥIhviQGV=mꉻC:~8U۱tT.ZqmGANxuQ0Gʹוk5 h-DM&F##m_y'߸e|=}>j{ud$xCa%bg3I+ 2Y#]b,A\r=]/pöX_/$:DHc8` uWYEPxz9 7NI dnN{M?ܳϪx$ؤSm}>8_j01Տ5lC쮻^_~(cj C8#<[oy|Id]??*B6<WcҦeSS6u}owHHQp)j J'/}^ÏyOE6=M;⟕yv4BsZScWSb"UEQO+ Dj4JҎ1T-LdžJm,{Q]Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@ ~utI.Min4ԕLr̭!jSh"xzizeb'C!8# hI!BmצGlaRms q7mWw迤`? ugHԓPKVu*"–4½JueJ=1>ni wykq ̰Dw:q я!Mp/_s5*\n4ĶӮt AA+ɮt5Ynt냩QQS  <܁WpF`+T[_EEs=ʺD[>[c8q=9SM]teQE ( ( ( (2u:>ViIeȯ6> > b+ z ǶiNFOZƥ u>$z< ]_qm F6~=tڄEWR\|n냐Jΰ/U^iVH%69? !9}&'9/7VHKjgٟo/\ԓ?X7?uAoJ?LȚ\S+UxՔf~&M/Rs/OέrrB)ߧwGR{xP NAץYoG'5bߗp}U~fxöZp@Iu/G<6BfPN3}k5k9ٹ\ QV`]\.ϒ'UuyG¶j̗tâ\ƅFH2.Ic^lk*v~^ӂRy}d'<~ڧ$7RM?ji%Ԯ"R2?y'O51C4GEE ׊kFL8`ƚWg+>4Y\/>tf۰]X^#F{►Z*Dž[VɷQEQQEQEQEPHg-Pp9 Ȍ#F*x{KS,"Y؜Qܒ@xg]r֚MDVIш )cl`u8SKCu[kWH&xPmolZ(1B@%1WXƝ|?WS>SN;t`?08~IE R &n{?"u[Q$5jmw{e}AhRxyY]PcY[ X'sJ)hIbptk_srÞ* oT^Uu ˔aFQe;N¶N88;0)QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEx?% ð)=b?i.iJ#$3ȒO/|2X꺾̑ƊBH툁QvZD{-/4{(}A|_?_|2/ n?P{o>?//jx m:ߐ<݀#4Lj҄M$|uW-Q[pQEQEQEQEQEQEQE?\4ԜcA&?w[M2C qBnh +Ͼ;ȻcW!G:mėVYjDCrc1$8:ҋ&һ~hQ? ?:3G~_\Qh'RBhZQNP_=U#ß AæXj$P>p Ew}xt'A*H`x>դBAq<:_-ZYCx _*0UDwb$-bEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQE|F7іo:-mp0[KU>"?ji5Rܨ۫7PJrSrڱ¤QLAܶuNi3A̲s‚@ 68 n-K@Ίb;'{qWڇ/|T1cP@>Wxk6˿,z\K|0C0TєcC kMX켗藺V4fxXd"dgO M-x\zŝ#C7hOuk=@[-OXUASlnd\y8'磳;ς??q^^55^%|cwqm.+ki](`(((((((}Gk0AGk_zlzW4X+{::^#Ӧ\@þ+&o=Ϧ("l#^sor͸TkK}ǷV a)7g=Hx4,[j.ђrN=&[u{xdF#"WJCƕ (!EPEPEPEPEPEPEPxwK?D5.i']CI_j?-d~u/ŰultV{ ;qI5ʹj}-0 c#;IA^_ED$]7s4Jǒ'' \)E4>Uhx`øSSZcIrSWWZjs-֋sؤb귨0+w8Rr!- ggӘ+\2?|pExm^M~yC?q@p? CqNx̊YNa]C5~S&o)/º>{~EQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQE|g~0>Ȗw -JYr"[ {p Qq6іsZ V)ki9v}mBQHmxU%dV_=5x PփkS\ݩ'%Zb]䒹sIJm/8$O:χ/im.iUXaԷ: S^?en]_Ǻ>kĢ;c< ?4SHѫYI VmK"i_'bX?] ©1n,zU5h:rV[hծ GAq^^30" iq^]|3 (9(((((((W i6wKqw,ȅc!V rzvzyoxVG` ~5oUa5~%&V?#88=+WM_qUOH|%g.=*pDڨu?t:V' ktyufMw (EPEPEPEPEPEPEPxsK?DJScQk"_r+[SYk';|4Fmm1qqJdYÙ VdƟ|}i5T[+f*9ui'9 6HqYQOncFv0x!dd04 El|E r̰3Hr ÿi5+mgw'u+tnx4nC&pF2QC4~7Ry$5$C)'с_ºYuz.1+G s9bw>Vt` .sNNKzQVsQ@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@/E|OِKZ/|7~)Zu;f#9FA{wǍ|/YeKm]\Ʌcʕ&&H=s37AR?sqjSSjsi-SW'^gR~GJ>I sYHZB|SBG!>)JQ?uN-__žևzIkGڤZ+ǀ,хP3y-|␸>'?@H :gzXסyVչͯH???`їt=[G[Tӧv`3`d ׬V4I*`((((((oj5KTFe`8~"k$?/hc畏~/e#?/4v0"ҧg4l׊8,(_3?px#:'kk=cŷzVkE6gyvcө \ZzVMC% Ejtk՜=>l'ëJQEz'ąQ@Q@Q@Q@Q@Q@Q@M;ܟ"J߇Wi_k1]dwEut]KXд,'.ud183Eyׂ|Uww4ft4$dԞhNi;t𧵡%ZGIHB|R?R('?)]߁-__ӏ V>O n,Elu[̇* =z8E7T/K?8FWQʭlUJn3}.#Fs |Yqͽ}6+'XQ?{ s<Hs=;[4dg$fZ"5(((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((ߍooVt~/ubU\_9Us[3zuWB' "Ԟ'n $ k+ܩ+V>3Nsq?0|=Ƿۖ[$ROaY~#^Gqe%ITY mvvTRu9c+~lL"WxǮ"A?qS^F|W#$(Ye>~=Ǻvk߉ct!T,#㈃%#bQuʺr=3ŏ/-ٺhě߇?tdG zĤ?ͅQZEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPnzxg] [7 _Aj¦=L+?~KQrKjC':U\yu)oQwo6'niGUrNO*Ak+O xrG:%a9T$Sd{]|r71ǥ|yJ3WWmчIiǦqU58.ha)ѯs$m>6z3nsUI\X zi,8{(zJFIFxxExifII*C    $.' ",#(7),01444'9=82<.342C  2!!22222222222222222222222222222222222222222222222222" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( B@'DW݂,A(@h&N Z|+i8il>{2=gc/R{9>YvVW g8#rт"1PI!a)K K~&)nWw>*֫TRv=V@A"Š((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((} VNIx61TiS*]*r€ڹ8Jz-{rGǺ.n5)N 8X6~iV^r[nrpF "jz0͹B|b~yYWczJ=wVrn˹YU###9n?8C2m~ c< <]-]OX.oKoq +=4.2#R=^,(;IX6&xRf(7 ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( qmk<D5=2@9{a\FsFaH?{T^g}cyn;3U*VV?RVQEhp GҭhW/c\[ߖTp=p\6*|+*B=%# q.1'I8QExg!EPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEP cO+š,T[9ȮoƒmK8 **c^j)MG),ii$َHGc%Ė]KxQ2ZZD*EaHU_?@;WZUQ]'&սofH֦^kO iP̘>Q?Zŏ냩~nB+r?:WOyr)qu,G. ֆ/F-H cUOyqǭf-HsWNU'ޤ)T(ܵIhO66ۭ^2;u 1y_f][[id0)$ @Nץ&[vcy,G}Wiu>Hb2XJnY}ߑ??+N? bR$#ofQPkn%-QH(((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((sREPEPEPEPEPEPEPEPEPF k:#c,pݯo'8yfu'\ tgW+XdPƋY}m8rAGQE((((((((H>}iI"I(@ړccTt( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (0<_ _I;X6 f7נ1̍U#5(Yy2dc$to 5Wq>3JPU=yk%N7y:8A֠0o7sM-0+AP=Pӟ-XĻ*q\%z^h5Qb^gt@OnH\?ӯEJKWn8bWcxvݏ+((((((((((qPWW'䏏TUFl<, 8DVMx GcWN:y]ߙQ@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@ W+;` s!s1}l'\iI" He ;x&\m8٦sV E.vO+? uV>g&G'cQMdlV7N$Sk$pN1AR2~^N^SO]y1xVϜj$JŤox% OW'RTBEB((((((((LZ((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((3( REPEPEPHFiiˁ@ EPEPEPEPEPEPEPEPEP$#ҙZmq@7s[8Y麕lzmӓoB~_Dz+ҰZB2:V W81bItNfe֥y0`27˓ϰTCQ->{kxIꃅ`H UjZZQۤI8A=jnldr 55 eYQT=ߞam?&\ZrdzWeQ&o1oߎ7u5W$sSZS!0]BNϣz/AQEfwQ@Q@Q@Q@Q@Q@Q@Q@ }ii:`Z(((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((()AQ(((=hz` Z( ( ( ( ( ( ( ( ( (<ݸEϓst铷f(м[xuart?o/3u۲,Ҕ_W: zy$-F3\8uNxtG$0 ]')7d[S|1Z:_ÀQ"@ckV\JPȸt~9oƻ!w5-Y.[j>(2 ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ("(((((((((((T)G8VFBB|c;ۛP`$@x\[kNZֽܟ4o)G~`tYv|]0p'hoțmխ[ExQoBץE4l!ğ洇@3p,R3VjdEg0QEQEQEQEQEQEQEQEQEQEQEQEQF)0(~Zkp\mfK3m;RKS0@I$œҕ9Uzթ{\|Ya PKF(Xdoyj^K .X A1opxu}XI+*c|Rs$ppTZrO~kأI'e&B (r rpE}\~XJΜ=Y5=lӨQE ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (Җ((8Qf( 1##H=G=(qY}DF gF [>JQ=Ȯšpg,xlҷIҕ)Kt)QEQEQEQEQQĥuUN1@%qrޟ7s7<͎U:Yso~1m.0q$ZqGe,W=$Ank[pHPFLǗy.Tg,8NI:] y\h$Һ[z e[l hS{IpJKOߢ[NN@(((((;RdW^Eq 7W1 f 8?DF摾 W?gI]x 3V[+g挜:Enr ȪѝJs' 4>(@QEQEQEQE.l>D ^$p:umҼ'2q%۲d @쓟Ͻzy:C͉ksɤRvu֎cz]Z.T홢Z_%xKѯy6Vq:\"FF=?Kw6w2K-NH} c.kvF-WEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPQ@UHc;'*KA cngPEP/]Oc('c^'x+^72Ir?+3Q歇]^2H$ ~{xj^^q)O bnMMwHwMr V O\q Xm")m D *Y(ֿ,o#+z(F;mؙfXݟ'Z3?$ĚIrPHbin2}A'h vWf)޺ w^?ev&vIcWN^┙ˋ*tդa>'cPXVrp є?bq"o 7B*ԔfhTR-zEFBgas)I%iR0;ad'<N1W+ϒ[~GY=q\ֹ @Œ"?W6?Niѽ<oEGmU?1^R0~ӟ;uXodb|P׵~)72?/1>dkzCO'WvνvNX,bz$HU(kFJq? y=û_sMei5n9뽿6ɮN{T]j;EUUomhTPl_uv&( *U粶dG"t~FRP5&9;χiqF[@LG>)f僆m?RF z8MOXʅ)ogMkg|wi2[)!}뷶QikS"r?::f5O:F=FY~aa{Gӣ_L]$-1?u ױM(o~y?yV𙭥[ o]BɎXa\U*+yi|zK1Mĺga.B>}~V\[<ӕ98YQE2FeHǵe֝Z 3I叠W=oO7+nne2JN1ݛ֩hEvg?ҼS5B.)qp_\B&~w#!{jF5#G]g|)m7Fm姖H!7;c]ͫײw0 iZ֜v! 2}j]hVwYb>z"+ߦ]YaH^yX6xkTo˺_>I#ՁEТtkQ`t׵y͞wO!嚎ާ)NO:xLS]Au}|h<|Utt [L 0\9s=+W mu>rsCo]ƉXx~mt|1'^QwQ\#XQ`*==WI7}ĢX#4ԯcWT X`@mTW?Wt]eϹ}+ͿuxsG.?Xt;>3h6]9@cSdؿ/Ey.?Xt]ڟ Ϲ}+ͿuxsJ>4w3h:Vvpo;X2=yթ'ҳu.V{kx捸"Ey+H1Idk? OS"ؑ}?hgWM$Mix!$xnzW~uZ-Y<˝}G*R]baOKKuDRЇG^!ýLir`[ ތzB:bjږn O:YIk[ա$E֩8]>|S3T}\O%-g~zk=@PnC؎;W+|K6y+#<>q^F)ŷճL¥JU`V׹i_($#O_om|6J%{\M溅v$u5SV\4Idm(8Š(()#iR$@dt?;q7)mK+F,cV,Įx[hvSrpp;Jҝ)vJЧ,jXOJ+KkKi!smg+ҋo_& ?::ȯ͸vJRGUtJXOR+Mi#m(9EXeXr=_(JV;ԍExZ)8N4 ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (#9|F6^fg䢒}/ +sŞ)2e`Yw?^s/ ^Wm{_-%n\ժkvpܱxq{h/ԯே F~ 8 ߉oSj;x"Xpz (qUx*1#0jgy?ul!QEjpQ@ ?{ #SH"¸_ M_0u_x~ΔQE|*(QEQEVCNVCMngSg^} s} }"RŢ)QEdk:`wЬ;~d?Sׇk^955؜1ʇ=}A95CTҭu>[+đJ0zz­?{=<2m~+vKmi @Gl^j Q4In2G ״iڍa H%yJ?՚,5V愵O~fQ]QEQEQEQEQE!i ҤzfSg|MiSd0[sQܩB*q$XO_RI$xɪڙ%fK<q: |$rk܇ Xhڳʇ˨RCFx4 (AKIE&3OOֵ0B^m x6#aURIW?|:-x'g{%BO9[G )I ER((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((h'RA8[[ NQ>H߯C/U^[+Y>nV-/>'xKhvWԟ{=o t6ayyݎ?0+kW4q)N:Eywc袊((p? '0?bqX'V.gI9ELqia*u9lg Pqkm.湹G3y``YPpS||__Zyx@8 xT?/So}akqW‘?;Q4tM_*w9i}OAOAO;قY}OAO#wShN`_qƟ LJլ+&D: 3㍪Ae3Yn[q[7Gi~e'a{Ԭtj<3읙^@VvEhZdL 3sqx*QQE((?irXݦAVQ^] Z'ú g#$ap9 {Ao҅ݪu{kzv&:kr_w ?99cխJ|ڢ':tz`sҵ⤎,VxjC((((CUYdLXB*j7#'ދ)Hn"~P}<ש|ZkSs2g&C DgS^\kl`RmmQ^aEPEP0 ׬-4adYít>Qvn !>69:,|y"g)BeU~J:05hVj-3)QV;S(5 ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (ВzWjQVS"0^H+eEZ^F᥸,]N=,Aܾa]: `F:_6$b)$,W;< dFeQ܁?V PJ O$'߉$f>Z$|QIԾƭQ^YEPEPEPEPEPEPE@|Cf' u?`N5|([7oX7uݾAX#_H`;sfFf+[t5ڈTtXE=X(_Meh< ((G /$*F;j{`oBڤ[d*}j%8^N0q<\>"h@\^jZ[%q蝺 xj{+[;жYÝs^O`xܜsX?[K𽑶*σ4s$>V:fMN~?Sa(<ࢊ((?Tt>>MM =g^$70Du PS6t#S\׊!x!CY0ϧ8#ӳGcAʝUxIYycGQV_"^l W?+#=GNZ+:{j6ے,1=4n/| ltݐǥf.^TR]G? wZX56UO컶8t,} `Mz(F}3xհhKZ~c袊(##Sx70klmS?!aϥ{}ant)#4HC]03qʟ\']zD7~%e"F<U%G #h< ((((Ys1pHVC\&R{̢`֜cEGϙovD"^Y',r}A`rk['>*yO>j_ hY23, m;uҿY8L dHQ316[[][ChYkKp>PpJXJ8O*HJ( p֯l >2G,@<~cc^MfS]=ALȲ.ᑐr3Wg K[]B K{_4+@x `#F;qp0WqapܒܘIM]u>w: G)ǫ#E88]uyբUI4ROR>c~S%iGK(s((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((f7r+Y"])+ *yoR}Iڸ_ ,V`ME9&X\,E]E}꺓Z0;)'N$Do#goRI94ӡNy+y6npt5K%J+s3^(#5i#5)4/=b,\Dϸ =tW2I0Q`zb? $dwFu#b|]kf~fqВmQE}QEQEQEQEQEҰ_W%XwH6wobj_4BZYAʽD 8 MMFB1Jw8'&׎Q$#xDtoON (XyduHv'@R5+i aTC4(@QEQEQEQEf/A-XFӑz{WIڒITg(;ٟ>xτ;ق;2xNN1[ _<7jFPF9(TdH;=/ĶQ^,٭e^{<-kC?-\d~58pZ4}N̰5a_YA]>tP:Q]Q@Q@  i@O5I9kۈJ~)?5n&\H$=x9Bu"ݭnd -7(H3FV"R)b&s濨I[ 9LIq-4F̸w8'6][WyrOn_LxJe8tJ9m /a!#)JqxWĻy-<@,@"k>2/o.d?P+{Y0eEYXNQE{`tɮer3ǾZkWd>#Y&2c 8#lוM5unBh 42@r$2R+iW`xem$Q#8=3lbStebESS Z»L6Ő,?VgO#zy"H5@t|!dd 4v&V. &$A"2lz^93 ,3IJc2M%UO:m2c ;y1?T.8zXӎ^/9%DP㎵xfM?TE Ya |8I7JqTg_( ( ( ( ( (wE񥘀bؗQ[-:}y? #yjzܣfs뚷8Cqe_+^N+Š((kOA>׿O.#| 䯨˺J{i7(RVGLbKÃ6s -GR[Sxk$o7]>vqf#+K~*ϾFt[W}7.<$}E| o_?HnK~*ϾFt{e?h->  o_?Hnl??g %X#?-> gl?>~$o7G%X#=͟G4JߊX#?-<57.<~{Ƒ{XA5ؼ҆:[^/k~"X5yX4џ!#*I#}k?3^[m랼 .糕QXOuWqEPEPuW74lW)"1xSeZB8z_>_C5,ߧ0y!vg",^9qOEE٨))=DFʮ&?}UkvC$:򿀕TE3:(b_Vc0+wo#,2|5Ā~?S^c^^IHЕ5gRW ~sC>_eE(+> }?)#s >k$cUd_μN pWKU#lgڼ5)<*md1F/ӝx7bydA|J?S_kS3Y=@@۶׿OZ$^)?Ob>J_%rJ<_%:y?}o=urHSUbO5fڬ׺nB# <]jjL2$-?(д?௒?'MVݓ_&~ǻb;_}ki?0G|i?5hʴ쟚4}~=TwB~` O +*~ki?5h{WUd*~kS3_ O ?-?+OGUd#gנE OҾf.yix 2@#9 _Loa]t*GU7>}(((?l C RGriCS^90/?׮YIXۻpZ5cϨZZU=s`pkdsA' uw\ʉ Y~)[Ms$zfAޚ(%8vytp7KE131i(y! ezSRM]ԧ:r䚳>í.8-vZzx{`*Od}]]5[=~i;x?KsDh=3ި&fww1ha(~l>dHO1 ps.?f#_1@U^T{e }JώGlʀ`:7??*F6qbxs #!#F B+<_Gbb5-U&$ؾ.+q<}CWj'̕ZK]zy67Pџ0_6 n5`ΐ\VWb SxY$F܏]%Oa3|ا:CGal*>$ƾm_j>bk69tl!kn#@35cA^V/$eW%Q_:wQ@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@/'{8FQ^]bٍȀS*Kz+si4%#>RKZI;r!CG ^kc+xٕ*+P]۽Z}ۿ뚍lt2;E9٩ q%`,Q]ȱ?Jl2$~yT~l)'GQ[J,'0+kp*u{ZDӭd缌+vHYI'iŽEehרּ 9#9 Dɼ!un>גOlJ׸2SŖW^"qQ B6nF+šKul[ʥ 8TF~>|߈" [AFyoK5ˉtBmay8Nq<#MixkEuIE9#k8iiS[<}Qa+'kϮK$BD =^m9Dž%c!zע^UmBA7TC) uNC}ۚi?¸߆խ+}~9?slԵ]_ķpmDm-ncFX_~EA"TcTIm;E T [m{+wdIMg÷^Z42x+7BERɞ6[DL{WǡXj]0ǘ2}.W($PNt[?ğ:'^sij26_S]+"OV;k='I6eC 1nY *8U>6\o:RWNzwE|QEQExI^R55'yI{G>}?e?rWQ.(?e?rWQ.(͡5#^q\* Q _ZDžrk?-k?.QEoKw~/hs8M3=Gv#{S*Oc)a):]1/5+Բ溹~2@oz "c{ ][ %UOа]9ghi16lGTaמ81|_A]íKiec#69 p0G t#5w!G4՝*3Th$~Vn<+${ke 2oZjw>(Я'I, Aр;׼Z_z\G,[,<+Ú [+S<1~#L$=ן8J8\U'N4&ݷ߁2|?M#j;] ;H?ef(]w|+vosM 4r(`Pk|qp'Ƿߝ9۟qTIk3U_Vc];Y5mWcuk^%X[ɶ(%1Wiz[G4N(?>8xR(mD@Ly֐*'燺H):ޕ,|̦hj "G"p+~g{5Džt &}"IO{geD?̟ȊXj}gxYaWmuyڼ[=)bo#g>v{xW*l@@ϟnT$}>{]xPI=`E};ۓ{2Z[hݱTg X;YXiljQEhQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEU$Ӭv˵O^®@k:յh%~Lɫ:_f>f1\.?Sg ~3?'Ω8fb P [ y" V_2/I$|+A⮔1*xG:²R%tVW*ҹC[VZ}gmYȐ(ϯꗅͯaͲ3n?5z[՟ҏ-8uQRjQEQEQEQEQEs4 k!P\WsQ(,,2H# nMv3 =KD5GV׵˫TQEt QEQExI^R55'yI{G>}?e?rWQ.(?e?rWQ.(͡5#^q\*`1 _ZDžrk?-k?#M[[{ H8%nK%Km6dF>y1J;{}y=,_xklNzI!*ƽޞ >n'ƺدbNp9.sqc `kەw9?YL$7P pEuN qqgO V5a>Q}:ƅt,߇M.eguqiqk1 /! 8OBl|5uibӜDP8#8\>}XINSun_[_ I헱SXS3HҚN+ٌTUzӯQ՛g5_ A`%gːtC}q_:#*6)"8e?CWk珉ri~?T4PBV MJݏltxvsWz?~4mUDxo*㴀`c.BJ~ `WWFO敕]zX_b?¿#ҊJ+>((((B~jFzrjD/=+tf>#5ay$6/\}\ݞp(QXQEt QEQEQEzW8#ǺsMQݒG'p<?y5†KyßZri}G16Σ/V ӕcmVA3\[Gl-n} K(n0.ʟL{צ9@{:J梹E:<Wkk|sy8I&fE3ƒ6QZpZCl[NTc$v6>SMkM%9O]̃9A#AbVG:0uZ=ҿLqCp=Of뷷7:K v+}x;Fr8 H̟׳jKWl-PƱ *6ҧ~Kk袊@(((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((1 Z~_S>j i/6$9D[Qe`3'uJ>6jm->a}*™\4[K"'BQYMpk5W'%nSیjuN\NYnVN5s?vj/[a)GO<~_^iGJ^g/WO|exYIx30`p8=C^:<5ዦ9/`7AG< ̠?'b_`N+sޗ}a}! BzU }zY2VkZ2TKejpF<=w?h[l|%UR.?^Q Tz^kEprs?Ռ_zL(y?m 'U1oN8uqVuiBN8}!ŝVGiꦷue: aӠtm_*i_5m㯪7Һ0_<'~/0U?ѿu!0UiѿgWxztҊ ( (Vf^߷"Oδ,oF3& qugά10#ޟ$z6XU7^k.;(q њ:J(P88#`KaM׹P8W|j[Iu$ja(_קն:sU**(ԝM+P:h:xX/aG㊗zgG?z5ݱIMo,n2X AlU \kb8HGnWMN7N(u'>_ˏdmQ/lQHbFZ򯂖̋󵬌X˂$A{L8t*m?3='\\ZƲhPf^ $On@Aؾ0+ϝITwthƒj"EEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPGl÷7Jb/m~eǀ&U!X2^*GyQ lY2v9+[oU2v9+[oUٿlkO|go?5U\cf>Zꖸ7 X7PO`Ys+Aim'X_FtBѰUϧ@Tz:Q qi{ ]hE$rO^`'N{3|XU;([>*Q[]6D 7R{2DžCj5ޑۥtˀxGOG.H8lp(޶l3rrWs+[xc$ UV4]gJMB\!F#Ѓbhר|m;,M΃7džD?uǨ#98?"5+wjvJJ.Zx{FV55+gem+r@p:2O|Ey5poSX5ϭEѓx.~|鰷 '|Kt5$Osp縑bYMox^,Լ֍HPG,8,85"dR>9~ .#^_>:}+]+F-|uS}W~G?G>Q '9GE%b0.-7ik+!KC\6~[Ŭ_pkĿփW|XQEQE^!tߊq‡upb k xSoa$rc'i@' P,`q~ZEMm=i?v>w=W :+(((((5dxۺK8Rg9'hwk'D͋>ba=i]9ηvs\غFHvUjy )T 2FƙēR ?kkL5 Gu!cY㉿\_):9SckNxˤY'tMw4Mz5Mhs)ej:!~~~K_f3N^l¯݋EWQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEbj^"҉fi1F]O2Vkc96̃B*klBtj <|ۆy'׭^~鷧3]TjS+aQwM%1XźcV}EmBYb{k@<G99㭻tBằ16c0WǛ5qFN2c8o͍Ki}ՊXMk3cMT2 Z9(6=Zk޵{MBu,,HH RI<ҺA_jI T(QEQEQEQEQEQE/h:tdRQXrfᦻ6S"~䃪8ֽ}k>'RVoI4<=n{W5hH#+S `;F[>z!8\K*_[YT?#uo)%$yU΍GNj*ĮkOA>׿Oغ?ď#/'iuE\#/'iuE^mmvOM|`q^\A,-TUlMՍ-fˀN@_L H7'bj:_[:ѩڷ<&H &wG!㌌zM':**zD`T{|R߶ >A_JjzZnW|ҒMM#W3.sxĖSL~j"k*wJO·O ǒ:eHWN\RgV׿OZ$^)?Q$}OB!pRg?Һ?wwsz 61NOoCK_W[\Q:U2= Gf}^Z+3^{b h#eˠ!]0w= Կ:d?j7lWK1U,y $8xp:ю6(g5]{>&OC!Ҋ(@JHh$komyl_KAᨻԗ.K&+((((((aҤ=))0>n aʙ+cP^f:ס|bYR+UhNJ/¼\Wj-י_nX7 %3W:^IgƑq>Bz?TA1vԟIL `sN;_$Җwrz_33ׯ|X$i.{3d=HÎcz_-eK.Fߪ =r?:GZmi>iWMPI<}kEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPVVk2Y^²Fáb=jI1r s~>;eGDq~yt/Xx]X!"j:ma%+4 ap}Ƶ _O]&䵐m~C5cj5Ϥ|tW3 ^㏱IxSD[yH9O'ӭu[unOM W2=A(7S[ƴqʹ2;t`>]RT?Vek24 +8_D9 /k8iZ2+|DPRvp?Uϋ+g^?K?Wj9e¿l olk?4(Oß?p2|[A[?Z?l s_'iQj8i`}[>-|[A[?ZOD9@ / ?4(5?_ x_-VV[>-{"~qs_{X/_{[K%цC))'s8$0|Y<1a#5lofF }VOb2 Aq>'ƶz9.!  }޵oIXYm6V=8a"ڽI-)l;s+< lAEipL~ע^uP*>Vx#=jņcGZo()rޟ^ڜkt8Mͣm/#U_p}Xzojn.hg</A)d꧑[ #X\w쮧)Uu oxfT.8#iGJ} YN7^ 4_{[+>067Mu*`}mJw<*R-HEFaEPEPEPEPSIG<[M"X⸭k⎃3C>N`'czZݩEC'5Co=*1d=z+s@KefVXuhP~xYJkR8 6O_厯G9-犾$}$RW7W?k@,/%픢Y3x:uco|+}I|F2kR x`X " { |%Z30\Ԡ{4n$78Nc@I~WWL~=mqr'x m/?'d3^)5WM.XءKI(,{P=5c'#ʋR)Ԃ_QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQE▪]2ڴk1 (%@ `3F}GZ@Q@!t-# -Q@Q@4BDy5Wz>dW:A'ӧ'S6^4 Ȫ^&*~w_ֳ|.%a即1=p~tϟc;ZDCrZֵWuĖO$1ND</Da|fg?kox[t9BpK6R𾇦kM.&Z5^T/>}lx_Y;_x!QCT:laoΦ( Z)I4 REQE'4\@Ω"n`BIO:~uz|acK|9^뷺%.#sg<$rδqV8jQH!"1#1ʿe{O'<6bf|ʹ$l*75>5- -na ڬSqzhd vLyaW1z3ZК<]J񬚢1ju!vM}?;C !t'WjJ/!b9O1'~kī6&dUH䷌mqLl `潬,NTu.t䦕ՏAZS^{|I gB%X >W өk- ex剺:6A\WT:nVgu:Щ^KL-r+3Qh((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((Bp s)bPEQEQEQEQEQEQEQEQE' wn7~%kکjP[iP݄6F"*G9**G-j55ёhڔ:k sGZ]?x%.'ot]ۤrUols^S<'mɖPGNb^3|sVAzwhvQEny!EPEPEPEPEPEPEPEPEPEPEPQyR|ͣvޙjиh$) P2)rOAw4i~7LMUTAa:ݯ^ajh"4i$l0Q:څgJ|\ucdϖ_ޭF0dlq3@K?* &(էT 0] yXgldmpN"bKO%\B^KSM%GMa2sr=o`@zVMW7nUgҵvѴWۻ:9ym>#UoʳQFIFT^w|/{$O \21N&W<nJ kFuN \&7Sm+ KFzd{4bsꘪ?UwTQEnyEPEPEPEPEPEPEPEPEPEPEPEPJ4(((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((('O ( ( ( k N ( ( ( ( ( ( ( ( (C<'ri+֥Q,Fؖ+Z=g"g~]>-"b aF);=˲Ky!abi-.>g ̥ddjħ–[sv܏i,~WSطx5_IG^e-~ORE5Fb^QEQEQEQEQEQEQEQEQEQH)h((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((( Z((((((((((d fHԳME=ս -y*=?]]`G>ŎH椐곝F(l4JS8HsR=kѣJRgf9F?Xڱ'Vga#.Vp{;Za9IbpXr= MX>rUvB~H^k>)EPPQEQEQEQEQEQEQEQE܍w0(( 5v4( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (8oRu=6`pyPii-vul.?N]Enu:/*W'sAM#c!g|⚏O8zם%f}sSLZ(QEQEQEQEQEQEQEQEQE $"})hGQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQE3/aFVtKi<،n*q&>lN芐HKfpu|?k{/[*w\8Ƿ|UXS]_c/?캷Uv>j2n}f'B [o)MHcIֶ':75ƼUi)ϻІK< gWG]PuXVDc#0(X7 xך${^ؤo^sּdګui&ʚ]zmD@7>JE ((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((XwfUg,: %O.hɎTvFk8^q|x\7Qy1Wnn5-^*ƦUmhU\y.Oc1]:ois>lȫK!F_Q褒EwSShOٳq{XHi~[q\&>[ˏ]WV5b&U}O8~袊Š(((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((5x ~*[H:u?-wgeom7Q5\d1k|4jųΨ:;v7-Y_Z\B r(W8JX;;hR$P@XTa72z"O늭+Gk m&zF*zq9etRk:duI?ٮ kdF Z2< #0ma#B}QEAQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEFN9ax+}#('8TT>=\.dY]яr#:k3rmк&z8iSsw^Ƅy\- +YVg G$W.WxȷvN=]?DզlgK818 A""%1'2#!O!(-&B$OlrV}$b$ c۰| bAb$?Hz+ r[JB$ʏ`O)Dp/O^$$R$@ ϬnR$Ou>,8{(z 0e0e     A@  A5% ?@ABCDEFGIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica ?  O ;8=;ALARA and Occupational Exposures: Experience and Challenges$<;@D < TJ. Lochard ISOE International ALARA Symposium Tsugura, Japan, 13-14 November 2008 PT $#  t   $        Content of the presentation$    ALARA and the quest for reasonable : an historical perspective From ICRP 60 to ICRP 103 Trends in occupational exposures Radiation risk at the workplace in perspective Concluding remarks ~YZZeZZ?;  .B4    5First stage: prudence  Recognition of stochastic effects in the late 40s "Taking into account uncertainties about the risk and the irreversibility of the effects, it is prudent to reduce exposures to the lowest possible level" (ICRP-1950) The limit is not anymore a guarantee of the absence of risk ^3P>1   <  6Second stage : justification  In a context of uncertainty taking a risk is justified only if their is a benefit in return If there is a benefit How far to reduce the risk without endanger the activity? As low as practicable (ICRP 1-1958) On which criteria to ground the decision? \P^F+]:  +  70Third phase: economic and social considerations10 1 Recommendation to keep exposures as low as readily achievable, economic and social considerations being taken into account (ICRP 9 -1965) The reduction of risk must be compared with the effort to achieve it Need of quantification for practical applicationXn(E<1!Y  8$ALARA: balancing costs and benefits  % The adverb  readily is replaced by  reasonably (ICRP 22 -1973) Introduction of the cost-benefit model The decision process is reduced to a few parameters and focused on the avoided dose Attempt to integrate social values in the quantitative framework (ICRP 37-1983) 6A'n   9 JBeyond the cost-benefit model  ICRP 55 - 1988: Return to a more pragmatic approach: the ALARA Procedure ICRP 60 - 1990: Need to consider "the magnitude of individual exposures, the number of people exposed and the likelihood of incurring exposures where these are not certain to be perceived (= potential exposures)"in the optimisation process Equity issue and the tolerability of risk model Introduction of the dose constraint concept for practices to limit the range of options considered in the optimisation processZnnH  $$((,,00[4488  FThe tolerability of risk model   :'ICRP 101- 2005: broadening the process  ( Optimisation of protection is a forward-looking process aimed at preventing exposure before they occur Optimisation is a frame of mind always questioning whether the best has been done in the prevailing circumstances Consolidation of the previous publications and broadening the process "to reflect the increasing role of individual equity, safety culture, and stakeholder involvement" JngrFb    K& The ICRP 60 system of protection (1) &'% &  Practices Justification, optimisation, limitation (except for medical exposures) Dose limits Individual dose constraints Interventions Justification, optimisation Intervention levels o0 S     $$((  L%The ICRP 60 system of protection (2)  &  M& The ICRP 103 system of protection (1) & Planned exposure situations: situations involving the deliberate introduction and operation of sources. Justification, optimisation with dose constraints, dose limits (except medical exposures) Emergency exposure situations: situations that may occur during the operation of a planned situation, or from a malicious act, or from any other unexpected situation, and require urgent action in order to avoid or reduce undesirable consequences. Justification, optimisation with reference levels Existing exposure situations: exposure situations that already exist when a decision on control has to be taken, including prolonged exposure situations after emergencies Justification, optimisation with reference levelsiZ220  Z.  $$M((,,L004488!<<  6I  "$$((  N%The ICRP 103 system of protection (2) &  O#The individual levels of protection $  PFDose ranges in ICRP 103 for dose constraints and reference levels (1) G  QFDose ranges in ICRP 103 for dose constraints and reference levels (2) G  GThe concept of dose constraint   &The concept of dose constraint is used in conjunction with the optimisation of protection A dose constraint is a source-related restriction on the individual dose from a source used prospectively in planned exposure situations which serves as an upper bound in the optimisation of protection from that source The term  source refers to any physical entity or procedure that results in a potentially quantifiable radiation dose to a person or group of persons Dose constraints are defined at the design stage using past experience\[@@@ @ @F@@  R+Constraints and planned exposure situations , Occupational exposure Usually set by operator Small operators may need guidance from regulator Transient/itinerant workers need special attention Public exposure Usually set by regulator v   HThe tolerability of risk model   AOccupational exposure: number of monitored workers (UNSCEAR 2008) B  R#>Occupational exposure: annual collective dose (UNSCEAR 2008) ?-? ?  T$<Occupational exposure : annual average dose (UNSCEAR 2008 ) =  -AOccupational exposure: distribution of individual doses (ESOREX) A   K@Occupational exposure in the nuclear fuel cycle (UNSCEAR 2008)  A S:Risk associated with ionising radiation - Adult workers - ; I8Occupational exposures in electricity generation (PWR)  9 +9Annual risk associated with the average exposure in PWRs5  Annual risk associated with 1.7 mSv (late cancer after exposure using ICRP 103 coefficient): D = 1,7.10-3*4,2*10-2 = 7,14.10-5 Annual risk of lethal occupational accident (immediate death): France: 2.86.10-5 (2005), USA: 4.10-5 (2006).^$?.]     ?$$((, , 00 448 8<<&    @PDetriment associated to IR exposure and annual risk of fatal occupational injuryQ ERadiation risk in perspective*    The average level of radiation risk in the workplace is in the same order of magnitude than other risks for workers The upper exposure levels, particularly those close to the limits, are significantly deviating from the main trends as far as quantitative risk estimate is concerned Need to pursue efforts to reduce further the exposure of the most exposed workers in all domains = systematic implementation of ALARA >t   TLThe way forward for further improvements in occupation radiation protection M Engaging a reflection on potential exposures (use of incident data basis) Developing ALARA procedures and tools for dismantling operations Sharing experience to diffuse the use of dose constraints Enhancing radiation protection culture Strengthening existing ALARA networks Favouring stakeholders engagement the decision making process A remaining unclear issue: the situation of outside workers fJA:( &@<  I!ALARA and dismantling in France !  ;The first operations at French nuclear installations and NPPs have shown: A lack of ALARA culture, notably at the level of the formalisation of the process A weakness of dose estimations for the preparation of the work A lack of reactivity of the teams when the first data become available at the beginning of the operations Missing records concerning the description of the installations and their life time history The non adaptation of "classical" technical procedures used for operation and maintenance The lack of commitment and engagement of all concerned parties~KZZJ R? G7#> $@$F9    ( VLThe way forward for further improvements in occupation radiation protection  M Engaging a reflection on potential exposures (use of incident data basis) Developing ALARA procedures and tools for dismantling operations Sharing experience to diffuse the use of dose constraints Enhancing radiation protection culture Strengthening existing ALARA networks Favouring stakeholders engagement the decision making process A remaining unclear issue: the situation of outside workers jJA:( &@<   /lD,.=SU^`h$-:;<sx,, L Q ~ e|HH(d'h ,  ` >y5fw:q ̙` 3f3f` www` I$nIȰ̙>?" dd@?nKd@@F " d@ `h U n?" dd@   @@``PV    @ ` ` p>> P0 D(  l P C 6Afond-cepn-ppt2" A <Ɠ$ "` p T TCliquez et modifiez le titre L B 0 )% "`4 T vCliquez pour modifier les styles du texte du masque Deuxime niveau Troisime niveau Quatrime niveau Cinquime niveau4w  C 6@"# " 0P T \*  D 6 / "x0  T Z*  E 6 $ "`P T Z*   M H{? 3"`@@ B  s *޽h ? 3f3f $Presentation_CEPN  f^ Y@(  j X C 4Afond-cepn-ppt" C 0@t* " T l8Cliquez pour modifier le style des sous-titres du masque9 9 M 6 $* " 0P T \*  N 6`.[% "x0  T Z*  U N`/$# ? 3"`@ T TCliquez et modifiez le titre  V H{? 3"`@ Y 6w$ " Pcepn  B  s *޽h ? 3f3f >6`h (  h h 3 r 4 8c8c??P   T0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography X*   h 3 r 4 8c8c??   T0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography Z*  v h 6 ??  T h 3 r@ 4 8c8c?? @ T vCliquez pour modifier les styles du texte du masque Deuxime niveau Troisime niveau Quatrime niveau Cinquime niveau4w  h C x@ 4 8c8c??`P  T0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography X*   h C x 4 8c8c??`  T0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography Z*  H h 0޽h ? 3380___PPT10.s  8 0 ` (  ` ` 3 r9lT 8c8c??P   T0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography X*   ` 3 rElT 8c8c??   T0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography Z*   ` C x HlT 8c8c??`P  T0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography X*   ` C x0RlT 8c8c??`  T0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography Z*  H ` 0޽h ? 3380___PPT10.s}O @\( lase \l \ C @"7U T l \ C w*C  T H \ 0޽h ? 3f3f___PPT10u.soE+D=' P= @B +} O p( CBCB l  C B4A  T l  C B4B T H  0޽h ? 3f3f___PPT10u.S/u'+D=' P= @B + O 0(  x  c $17AP  T x  c $cTB T H  0޽h ? ̙33 O *(  x  c $`_iTA   T r  S pdiTB  T H  0޽h ? ̙33 O *( ; x  c $lTA   T r  S lTB ` T H  0޽h ? ̙33 O *(  x  c $lTA   T r  S lTB00 T H  0޽h ? ̙33> O ~(  x  <A w??0p w  HZmT ? 3"`@ 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  F,   HcmT ? 3"`@P8___PPT10F___PPT9( V___PPTMac110(   hnamd` Arial&Monotype Typography    hnamd` Arial&Monotype Typography  (Evolution of the ALARA principle wording0)(, ) H  0޽h ? ̙33 O `0( vcaa `x ` c $0`mTAe  T x ` c $nmTB`  T H ` 0޽h ? ̙33 O Lk(  Lx L c $mTA  T B L TDԔ? 3"`@B L NDԔ? 3"`@B L TDԔ? 3"`@PP L HmTԔ? 3"`@  0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  aUnacceptable risk    L NnTԔ? 3"`@ 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  ^Tolerable risk   B L TDԔ? 3"`@    L HnTԔ? 3"`@0 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  hAcceptable residual risk     L NnTԔ? 3"`@`0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  Z Dose limit      L NnTԔ? 3"`@ ` 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  [ ALARA level    B  L TDԔ? 3"`@P    L T &nT ? 3"`@00___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  eIndividual dose level    L N,nT Ԕ? 3"`@P 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  `Optimisation process  H L 0޽h ? ̙33___PPT10e+D=' @= @B + O 0( ; x  c $9nTAP `  T x  c $;nTB`L T H  0޽h ? ̙330 O  d0(  9@ dx d c $nTA` p  T x d c $nTB0 T H d 0޽h ? 3f3f80___PPT10.tuA O O 0hO( 5 hx h c $@nTA    T  h 0oT 8___PPT10F___PPT9( V___PPTMac110(   hnamd` Arial&Monotype Typography    hnamd` Arial&Monotype Typography  nInterventions 0  DD  lB h 6Dd!"afF alB h 6D|"& P` & fB h 0D" @lB h 6D"- m lB  h 6D|"` ` bc rB  h <DjJ"`  P   h 0poT" 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  f"generic" optimisation  2D    h 0 oT" g 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  Z Optimisation   D    h 0 oT"] }0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  T Dose limit   @   h 0oT" 0 - 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  YDose constraint @   h 0p*oT"@` ` 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  cAction/intervention level @  fB h 0D"-0lB h 6D"  lB h 6D"   h 06oT 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  Y Practices   D  H h 0޽h ? 3f3f80___PPT10.uu/e0 O @l0(  lx l c $AoTA  0  T x l c $BoTB`p4 T H l 0޽h ? 3f3f80___PPT10.uuƖ O 0(Pp(  px p c $LpTAe   T  p 0UpT 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  kPlanned exposure situations  D   p 0@\pT P8___PPT10F___PPT9( V___PPTMac110(   hnamd` Arial&Monotype Typography    hnamd` Arial&Monotype Typography  +Emergency and existing exposure situations 0, *DD , lB p 6Dd!"fF lB p 6D|"f P` f fB p 0D" lB p 6D"m  lB  p 6D|" 0 lB  p 6D" P P lB  p 6D"-- lB  p 6D" rr   p 0mpT" b= 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  \ Optimisation  2 D   p 0hpT"= g]0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  Z Optimisation   D   p 0zpT" 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  T Dose limit   @   p 0upT"`  0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  YDose constraint @   p 0pT"  0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  YReference level @  fB p 0D"lB p 6D"- = lB p 6D"  lB p 6D" = H p 0޽h ? 3f3f80___PPT10.vuH O `"tH(  tx t c $pTAPp   T b `0 "t#""FF t NpT ?"e0j ,tProtect individuals from public and occupational exposure& r;GGG G  G ;  @` t HPpT ?"K U 0 ^C  @` t HPpT ?"U K  \C  @` t H0pT ?"K j0U  )from a source, in all exposure situations*GG G G GGG *  @` t H@pT ?"jK U  ;from all regulated sources, in planned exposure situations <GGG G GG <  @`-  t ZpT ?"K `0e %Dose constraints and reference levels"&&G &  @`  t ZpT ?"`K e s Dose limits"  G   @`B  t B1 ?"U 0U B  t B331 ?"K `K eB  t H331 ?"e0eB t B331 ?"K jK B t H331 ?"j0jB t H33o ?"`0`B t H33o ?"`B t H33o ?"0`0B t H33o ?"0z t R^jA"Fig 3 left frame `P v t s NA $Fig 3 right frame 3H t 0޽h ? 3f3f80___PPT10.u O 4,p x( n~ xx x c $@qTA` p  T  b  x#""c`P . x <*qT?" h`X___PPT1080___PPT9h`j___PPTMac11D< ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica   Individuals are exposed to a source that gives them little or no individual benefit but benefits to society in general. Exposures are usually controlled by action taken directly on the source for which radiological protection requirements can be planned in advance. \ 4C  b   @` x <qT?"   1 mSv or less. FB&    @`B x <LqT?"\  ld@___PPT10 V___PPT980___PPTMac11 ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica  LIndividuals will usually receive benefit from the exposure situation but not necessarily from the exposure itself. Exposures may be controlled at source or, alternatively, by action in the exposure pathways. 4!Q_  @` x <LqT?"\   Greater than 1 to 20 mSv.FB   @`_ x <bqT?"#\ d\X___PPT1080___PPT9h`f___PPTMac11@8 x  x  x  x  x  qIndividuals exposed by sources that are not controllable, or where actions to reduce doses would be disproportionately disruptive. Exposures are usually controlled by action on the exposure pathways.b ! >  Fb  @`   x <`qT?"#\  Greater than 20 to 100 mSv.FB   @`  x <cqT?"# qCharacteristics`   @`   x <qT?"# %Band of constraint or reference level&&b &  @`tB  x 61 ?"nB  x 01 ?"##nB x 01 ?"\ \ nB x 01 ?"  tB x 61 ?"tB x 61 ?"nB x 01 ?"tB x 61 ?"H x 0޽h ? 3f3f80___PPT10.wujW5 O ]5U5|4(  |x | c $qTA` p  T 54b P` |#""@`P | BqT?"^`XP___PPT100(___PPT9ldf___PPTMac11@8 ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica  < Constraints set for public exposure in planned situations T="      ;  @`# | BpqT?"P^  1 mSv or less. FB&    @` | BrT?"^80___PPT10     ___PPT9     b___PPTMac11<4 ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica    hnamd` Arial&Monotype Typography    hnamd` Arial&Monotype Typography    hnamd` Arial&Monotype Typography    hnamd` Arial&Monotype Typography    hnamd` Arial&Monotype Typography    hnamd` Arial&Monotype Typography    hnamd` Arial&Monotype Typography  ,namd$ Helvetica  I Constraints set for occupational exposure in planned situations Constraints set for comforters and carers of patients treated with radiopharmaceuticals Reference level for the highest planned residual dose from radon in dwellings Reference level for existing situation resulting from accidents: residual dose of 1 mSv/year@J"      /  $$((,,004488 <<'  A    @`% | BqT?"P^ Greater than 1 to 20 mSv.FB   @`  | B?rT?"H@`___PPT10@8___PPT9___PPTMac11 ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica  ,namd$ Helvetica  1c Reference level set for the highest planned residual dose from a radiological emergency : 100 mSvxd"   `   @`&  | B@rT?"P Greater than 20 to 100 mSv.FB   @`  | B2rT?"` lExamples  `   @`   | <]rT?"P` %Band of constraint or reference level&&b&  @`nB  | 01 ?"P``hB  | s *1 ?"PhB | s *1 ?"PhB | s *1 ?"P^^nB | 01 ?"PnB | 01 ?"P`PhB | s *1 ?"`nB | 01 ?"`H | 0޽h ? 3f3f80___PPT10.wujW$ O P$(  Pr P S `rTA   T r P S ЀrTB` 0 T H P 0޽h ? 3f3f80___PPT10.t0 O 0(  x  c $rTA 0  T x  c $rTB ` T H  0޽h ? 3f3f80___PPT10.zuA O T(  Tx T c $FsTA 0  T B T TDԔ? 3"`@B T NDԔ? 3"`@B T TDԔ? 3"`@PP T H QsTԔ? 3"`@  0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  aUnacceptable risk    T NYsTԔ? 3"`@ 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  ^Tolerable risk   B T TD ,Ԕ? 3"`@0 0   T N_sTԔ? 3"`@@0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  Z Dose limit      T NphsT ,Ԕ? 3"`@@ 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  _Dose constraint   B  T TDԔ? 3"`@0   T TpsT ? 3"`@00___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  eIndividual dose level   B  T TDԔ? 3"`@   T N0xsTԔ? 3"`@ @0 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  [ ALARA level     T NsT Ԕ? 3"`@ 0 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  `Optimisation process   T NsT ? 3"`@ ` 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  F,  T HpsTԔ? 3"`@  0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  hAcceptable residual risk   H T 0޽h ? ̙33___PPT10e+D=' = @B +V O UUT!sU( .{5  r   S psTA`  T Nv ` L !#"6* `L C  HТsT ? 3"`@e L@___PPT10 V___PPT980___PPTMac11 ,namd$ Helvetica  16567 (5017)*2   @` B  HsT ? 3"`@ eL@___PPT10 V___PPT980___PPTMac11 ,namd$ Helvetica  16360 (4756)*2   @` A  HsT ? 3"`@ L@___PPT10 V___PPT980___PPTMac11 ,namd$ Helvetica  11100 (4600)*2   @` @  HsT ? 3"`@2 L e4228   @` ?  HsT ? 3"`@w 2 L e3910   @` >  HsT ? 3"`@ wL e2820   @` =  H`sT ? 3"`@ L cTotal   @` <  H sT ? 3"`@e   c565   @` ;  HsT ? 3"`@ e  c476   @` :  H tT ? 3"`@   c360   @` 9  H`tT ? 3"`@2  c160   @` 8  H tT ? 3"`@w 2  c180   @` 7  H*tT ? 3"`@ w  c140   @` 6  H5tT ? 3"`@   u Miscella.     @` 5  H@tT ? 3"`@e6   e331  @` 4  HKtT ? 3"`@6 e  e378  @` 3  HVtT ? 3"`@ 6   e420  @` 2  H@atT ? 3"`@2 6  e400  @` 1  HltT ? 3"`@w6 2  e350  @` 0  HvtT ? 3"`@6 w  e310  @`  /  HtT ? 3"`@6   sMilitary activities  @` .  HtT ? 3"`@e 6  e869  @` -  HPtT ? 3"`@ e6  e790  @` ,  HtT ? 3"`@ 6  e700  @` +  HЬtT ? 3"`@2 6  e560  @` *  HtT ? 3"`@w 2 6  e690  @` )  HPtT ? 3"`@ w6  e530  @`  (  HtT ? 3"`@ 6  oIndustrial uses  @` '  H tT ? 3"`@e\   g2592  @` &  HtT ? 3"`@\e  g2442  @` %  HtT ? 3"`@ \  g2320  @` $  H`tT ? 3"`@2 \  g2220  @` #  H uT ? 3"`@w\2  g1890  @` "  H uT ? 3"`@\w  g1280  @` !  HuT ? 3"`@\  l Medical uses     @`   H#uT ? 3"`@e \ e660  @`   Hp.uT ? 3"`@e\ e670  @`   H09uT ? 3"`@ \ e800  @`   HCuT ? 3"`@2  \ e888  @`   HNuT ? 3"`@w2 \ e800  @`   HpYuT ? 3"`@w\ e560  @`    H0duT ? 3"`@\ rNuclear fuel cycle  @`   H@ouT ? 3"`@e  h11550  @`   HzuT ? 3"`@e h11550  @`   HuT ? 3"`@  g6500  @`   HuT ? 3"`@2   Z  @`   HuT ? 3"`@w2  Z  @`   HuT ? 3"`@w Z  @`    HpuT ? 3"`@ qNatural radiation  @`#   HuT ? 3"`@q  'Number of monitored workers (thousands)(((  @`   HuT ? 3"`@e` q i2000-02  @`   HuT ? 3"`@`eq i1995-99  @`   H`uT ? 3"`@ `q i1990-94  @`   H uT ? 3"`@2 ` q i1985-89  @`   HuT ? 3"`@w`2 q i1980-84  @`   HuT ? 3"`@`wq i1975-79  @`   H`vT ? 3"`@`q hSource  @`B D  Bo ? 3"`@` `B M  Bo ? 3"`@L LB N  Ho? 3"`@`qB U  Ho? 3"`@ ` qB t  Ho? 3"`@qB   Ho? 3"`@ q B   Ho? 3"`@B   Ho? 3"`@  B   Ho? 3"`@\B   Ho? 3"`@  \B   Ho? 3"`@\ B   Ho? 3"`@ \  B   Ho? 3"`@ 6 B   Ho? 3"`@  6 B   Ho? 3"`@6  B   Ho? 3"`@ 6  B   Ho? 3"`@  B   Ho? 3"`@   B   Ho? 3"`@ LB   Ho? 3"`@  LB   Bo ? 3"`@q qB   Bo ? 3"`@ B ! Bo ? 3"`@   ! H 1vT ? 3"`@r @___PPT10 V___PPT980.___PPTMac11   hnamd` Arial&Monotype Typography  ,namd$ Helvetica    hnamd` Arial&Monotype Typography  @Miscellaneous: educational establishment, veterinary medicine, transport& * Without natural radiation (NORMs)4nJ#n H   0޽h ? 3f3f___PPT10u.S/u'+D=' = @B +V O UUTVU( gXwFFFFv4 r  S NvTA` p  T Ov ` _ U#"6* `_  HXvT ? 3"`@e _@___PPT10 V___PPT980___PPTMac11 ,namd$ Helvetica  29540 (2040)*2   @`  HovT ? 3"`@ e_@___PPT10 V___PPT980___PPTMac11 ,namd$ Helvetica  29723 (2223)*2   @`  HsvT ? 3"`@ _@___PPT10 V___PPT980___PPTMac11 ,namd$ Helvetica  14360 (2660)*2   @`  H~vT ? 3"`@2 _ e4310   @`  HvT ? 3"`@w 2 _ g5370  @`   HvT ? 3"`@ w_ g4660  @`   HPvT ? 3"`@ _ eTotal  @`   HvT ? 3"`@e   d56  @`   HеvT ? 3"`@ e  d53  @`   HvT ? 3"`@   d40  @`  HPvT ? 3"`@2  d20  @`  HvT ? 3"`@w 2  d40  @`  HvT ? 3"`@ w  d70  @`  HvT ? 3"`@   w Miscella.     @`  HvT ? 3"`@e>   d45  @`  HwT ? 3"`@> e  d52  @`  Hp wT ? 3"`@ >   e100  @`  H0wT ? 3"`@2 >  e250  @`  H!wT ? 3"`@w> 2  e250  @`  H,wT ? 3"`@> w  e420  @`   Hp7wT ? 3"`@>   sMilitary activities  @`  HBwT ? 3"`@e >  e289  @`  H@MwT ? 3"`@ e>  e315  @`  HXwT ? 3"`@ >  e360  @`  HbwT ? 3"`@2 >  e510  @`  HmwT ? 3"`@w 2 >  e940  @`  H@xwT ? 3"`@ w>  e870  @`   HwT ? 3"`@ >  oIndustrial uses  @`   HwT ? 3"`@ed   e850  @` ! HИwT ? 3"`@de  e803  @` " HwT ? 3"`@ d  e760  @` # HPwT ? 3"`@2 d  g1030  @` $ HwT ? 3"`@wd2  g1140  @` % HwT ? 3"`@dw  g1000  @` & HwT ? 3"`@d  l Medical uses     @` ' HwT ? 3"`@e d e800  @` ( H`wT ? 3"`@ed g1000  @` ) H wT ? 3"`@ d g1400  @` * HwT ? 3"`@2  d g2500  @` + HxT ? 3"`@w2 d g3000  @` , H`xT ? 3"`@wd g2300  @`  - H xT ? 3"`@d rNuclear fuel cycle  @` . H0%xT ? 3"`@e  h27500  @` / H/xT ? 3"`@e h27500  @` 0 H:xT ? 3"`@  h11700  @` 1 HpExT ? 3"`@2   Z  @` 2 HOxT ? 3"`@w2  Z  @` 3 HZxT ? 3"`@w Z  @`  4 H`exT ? 3"`@ qNatural radiation  @`% 5 HpxT ? 3"`@u  )Annual collective effective dose (man.Sv)***  @` 6 H{xT ? 3"`@e` u i2000-02  @` 7 HxT ? 3"`@`eu i1995-99  @` 8 H`xT ? 3"`@ `u i1990-94  @` 9 H xT ? 3"`@2 ` u i1985-89  @` : HxT ? 3"`@w`2 u i1980-84  @` ; HxT ? 3"`@`wu i1975-79  @` < H`xT ? 3"`@`u hSource  @`B = Bo ? 3"`@` `B > Bo ? 3"`@_ _B ? Ho? 3"`@`uB @ Ho? 3"`@ ` uB A Ho? 3"`@uB B Ho? 3"`@ u B C Ho? 3"`@B D Ho? 3"`@  B E Ho? 3"`@dB F Ho? 3"`@  dB G Ho? 3"`@d B H Ho? 3"`@ d  B I Ho? 3"`@ > B J Ho? 3"`@  > B K Ho? 3"`@>  B L Ho? 3"`@ >  B M Ho? 3"`@  B N Ho? 3"`@   B O Ho? 3"`@ _B P Ho? 3"`@  _B Q Bo ? 3"`@u uB R Bo ? 3"`@ B S Bo ? 3"`@   V H xT ? 3"`@r @___PPT10 V___PPT980.___PPTMac11   hnamd` Arial&Monotype Typography  ,namd$ Helvetica    hnamd` Arial&Monotype Typography  @Miscellaneous: educational establishment, veterinary medicine, transport& * Without natural radiation (NORMs)4nJ#n H  0޽h ? 3f3f___PPT10u.S/u'+D=' = @B +V O UUTV XU(   r   S yTA` p  T Nv ` L U #"6      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrsuvwxyz{|}~* `L   HyT ? 3"`@e L@___PPT10 V___PPT980___PPTMac11 ,namd$ Helvetica   0,7 (0,4)*2    @`   H%yT ? 3"`@ eL@___PPT10 V___PPT980___PPTMac11 ,namd$ Helvetica   0,8 (0,5)*2    @`   Hp3yT ? 3"`@ L@___PPT10 V___PPT980___PPTMac11 ,namd$ Helvetica   0,8 (0,6)*2    @`   H yT ? 3"`@2 L c1,0   @`   H@yT ? 3"`@w 2 L c1,3   @`   HKyT ? 3"`@ wL e1,7  @`   H@VyT ? 3"`@ L eTotal  @`   HayT ? 3"`@e   e0,1  @`   HkyT ? 3"`@ e  e0,1  @`   HvyT ? 3"`@   e0,1  @`   H@yT ? 3"`@2  e0,2  @`   HyT ? 3"`@w 2  e0,3  @`   HyT ? 3"`@ w  e0,5  @`   HyT ? 3"`@   w Miscella.     @`   HyT ? 3"`@e6   e0,1  @`   HyT ? 3"`@6 e  e0,1  @`   H`yT ? 3"`@ 6   e0,2  @`   H yT ? 3"`@2 6  e0,7  @`   HyT ? 3"`@w6 2  e0,7  @`   HyT ? 3"`@6 w  e1,3  @`    H`yT ? 3"`@6   sMilitary activities  @`   HpyT ? 3"`@e 6  e0,3  @`   H0zT ? 3"`@ e6  e0,4  @`   H zT ? 3"`@ 6  e0,5  @`   HzT ? 3"`@2 6  e0,9  @`   Hp#zT ? 3"`@w 2 6  e1,4  @`   H0.zT ? 3"`@ w6  e1,6  @`    H8zT ? 3"`@ 6  oIndustrial uses  @`   HDzT ? 3"`@e\   e0,3  @` !  HNzT ? 3"`@\e  e0,3  @` "  HYzT ? 3"`@ \  e0,3  @` #  H@dzT ? 3"`@2 \  e0,5  @` $  HozT ? 3"`@w\2  e0,6  @` %  HyzT ? 3"`@\w  e0,8  @` &  HzT ? 3"`@\  l Medical uses     @` '  HzT ? 3"`@e \ e1,0  @` (  HPzT ? 3"`@e\ e1,4  @` )  HzT ? 3"`@ \ e1,8  @` *  HЯzT ? 3"`@2  \ e2,6  @` +  HzT ? 3"`@w2 \ e3,7  @` ,  HPzT ? 3"`@w\ e4,4  @`  -  HzT ? 3"`@\ rNuclear fuel cycle  @` .  H zT ? 3"`@e  e2,4  @` /  HzT ? 3"`@e e2,4  @` 0  HzT ? 3"`@  e1,8  @` 1  H`zT ? 3"`@2   Z  @` 2  H{T ? 3"`@w2  Z  @` 3  H{T ? 3"`@w Z  @`  4  HP{T ? 3"`@ qNatural radiation  @` 5  Hp&{T ? 3"`@p  #Annual average effective dose (mSv)$$$  @` 6  H1{T ? 3"`@e` p i2000-02  @` 7  H<{T ? 3"`@`ep i1995-99  @` 8  H@G{T ? 3"`@ `p i1990-94  @` 9  HR{T ? 3"`@2 ` p i1985-89  @` :  H\{T ? 3"`@w`2 p i1980-84  @` ;  Hg{T ? 3"`@`wp i1975-79  @` <  H@r{T ? 3"`@`p hSource  @`B =  Bo ? 3"`@` `B >  Bo ? 3"`@L LB ?  Ho? 3"`@`pB @  Ho? 3"`@ ` pB A  Ho? 3"`@pB B  Ho? 3"`@ p B C  Ho? 3"`@B D  Ho? 3"`@  B E  Ho? 3"`@\B F  Ho? 3"`@  \B G  Ho? 3"`@\ B H  Ho? 3"`@ \  B I  Ho? 3"`@ 6 B J  Ho? 3"`@  6 B K  Ho? 3"`@6  B L  Ho? 3"`@ 6  B M  Ho? 3"`@  B N  Ho? 3"`@   B O  Ho? 3"`@ LB P  Ho? 3"`@  LB Q  Bo ? 3"`@p pB R  Bo ? 3"`@ B S  Bo ? 3"`@   V  H{T ? 3"`@r @___PPT10 V___PPT980.___PPTMac11   hnamd` Arial&Monotype Typography  ,namd$ Helvetica    hnamd` Arial&Monotype Typography  @Miscellaneous: educational establishment, veterinary medicine, transport& * Without natural radiation (NORMs)4nJ#n H   0޽h ? 3f3f___PPT10u.S/u'+D=' (= @B + -O [9( ?)D l  C p{TA` p  T   PX 8#"B6   H{T ? 3"`@r PX8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  u0.FB   @`  H{T ? 3"`@r X8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  u2.FB   @`  H{T ? 3"`@ r X8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  u8.FB   @`  H`{T ? 3"`@ur X8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  v30.FB   @`  Hp{T ? 3"`@r uX8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  z> 50,0.FB   @`  H|T ? 3"`@ Pr 8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  x23.FB  @`  H|T ? 3"`@ r 8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  x45.FB  @`  Hp!|T ? 3"`@ r 8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  x53.FB  @`  H.|T ? 3"`@u r 8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  y384.FB  @`  H:|T ? 3"`@ ur 8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica   20,0 - 50,0.  FB   @`  HpR|T ? 3"`@ P 8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  x32.FB  @`  H`^|T ? 3"`@  8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  y141.FB  @`  HV|T ? 3"`@  8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  y104.FB  @`  Hr|T ? 3"`@u 8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  y311.FB  @`  HP}|T ? 3"`@ u 8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica   15,0 - 20,0.  FB   @`  H|T ? 3"`@ P 8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  x80.FB  @`  H|T ? 3"`@  8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  {1 545.FB  @`  H|T ? 3"`@  8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  {1 412.FB  @`  H0|T ? 3"`@u 8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  y928.FB  @` ~ H|T ? 3"`@ u 8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica   10,0 - 15,0.  FB   @` } H0|T ? 3"`@ P 8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  y653.FB  @` | H@|T ? 3"`@  8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  {1 529.FB  @` { H`|T ? 3"`@  8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  {1 369.FB  @` z H|T ? 3"`@u 8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  {2 058.FB  @` y H}T ? 3"`@ u 8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica   5,0 - 10,0.  FB   @` x H}T ? 3"`@P 8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  } 10 714.FB  @` w H }T ? 3"`@ 8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  |11 073.FB  @` v H`.}T ? 3"`@  8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  {5 962.FB  @` u H`=}T ? 3"`@u 8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  | 7 333.FB  @` t HQ}T ? 3"`@u 8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica   2,0 - 5,0.  FB   @` s HpV}T ? 3"`@P8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  |11 188.FB  @` r HX}T ? 3"`@8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  {6 197.FB  @` q H q}T ? 3"`@ 8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  {3 267.FB  @` p H0}T ? 3"`@u 8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  |11 549.FB  @` o HЋ}T ? 3"`@u8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica   1,0 - 2,0.  FB   @` n H}T ? 3"`@(P8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  {2 551.FB  @` m Hp}T ? 3"`@(8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  {7 973.FB  @` l H}T ? 3"`@ (8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  {4 709.FB  @` k H}T ? 3"`@u( 8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  |31 194.FB  @` j H}T ? 3"`@(u8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica   0,5 - 1,0.  FB   @` i H}T ? 3"`@BP(8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  {1 190.FB  @` h H}T ? 3"`@B(8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  |16 843.FB  @` g H}T ? 3"`@ B(8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  {5 824.FB  @` f H~T ? 3"`@uB (8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  |36 288.FB  @` e H~T ? 3"`@Bu(8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica   0,2 - 0,5.  FB   @` d H ~T ? 3"`@\PB8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  y591.FB  @` c H-~T ? 3"`@\B8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  |11 375.FB  @` b HE~T ? 3"`@ \B8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  {6 066.FB  @` a HH~T ? 3"`@u\ B8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  |22 450.FB  @` ` HV~T ? 3"`@\uB8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica   0,1 - 0,2.  FB   @` _ HPn~T ? 3"`@vP\8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  y762.FB  @` ^ Hq~T ? 3"`@v\8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  |45 324.FB  @` ] HP~~T ? 3"`@ v\8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  |44 953.FB  @` \ H~T ? 3"`@uv \8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  }353 553.FB  @` [ H~T ? 3"`@vu\8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  {< 0,1.FB  @` Z H ~T ? 3"`@Pv8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  zNORM.FB  @` Y H@~T ? 3"`@v8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  yNPP.FB  @` X H~T ? 3"`@ v8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  ~Industry. FB   @` W H~T ? 3"`@u v8___PPT10F___PPT9(  ___PPTMac11 ,namd$ Helvetica  }Medical.FB  @` V H~T ? 3"`@uv n Dose range  B   @`B  Bo ? 3"`@PB  Bo ? 3"`@XPXB  Ho? 3"`@vB  Ho? 3"`@PPvB  Ho? 3"`@v\B  Ho? 3"`@PvP\B  Ho? 3"`@\BB  Ho? 3"`@P\PBB  Ho? 3"`@B(B Ș Ho? 3"`@PBP(B ʘ Ho? 3"`@(B Ҙ Ho? 3"`@P(PB Ԙ Ho? 3"`@B ܘ Ho? 3"`@PPB ޘ Ho? 3"`@ B  Ho? 3"`@PP B  Ho? 3"`@  B  Ho? 3"`@P P B  Ho? 3"`@  B  Ho? 3"`@P P B  Ho? 3"`@  B  Ho? 3"`@P P B  Ho? 3"`@ r B  Ho? 3"`@P Pr B  Ho? 3"`@r XB  Ho? 3"`@Pr PXB $ Bo ? 3"`@vPv 9 N`T ? 3"`@ro@___PPT10 V___PPT980.___PPTMac11   hnamd` Arial&Monotype Typography  ,namd$ Helvetica    hnamd` Arial&Monotype Typography  @xStudy on Occupational Radiation Exposure of Workers in Europe, ESOREX 2005 K. Petrova, G. Frasch, K. Schnuer, S. Mundigl4yK-pN        H  0޽h ? 3f3f80___PPT10.K:u\7 O 668Jl6( c r  S ,TA` p  T Q/n   J#"."}xyxxy C H0T ? 3"`@i  d0,07   @` B H`;T ? 3"`@ i  d0,07   @` A H FT ? 3"`@y   d0,11   @` @ HPT ? 3"`@ y  d0,42   @` ? H[T ? 3"`@x   a-   @` > H`fT ? 3"`@ x f0,63  @` = H qT ? 3"`@  NR154   @`  HsT ? 3"`@i  e1,2  @`  HT ? 3"`@[ i  e800  @`  HT ? 3"`@Oi [  e660  @`  HPT ? 3"`@i O m 2000 - 2002     @`  H`T ? 3"`@ i  e1,4  @`   H T ? 3"`@[ i  f1000  @`   HT ? 3"`@O [ i  e700  @`   HP T ? 3"`@ Oi  m 1995 - 1999     @`   HT ? 3"`@y   e1,8  @`   HT ? 3"`@[ y   f1400  @`  H)T ? 3"`@Oy [  e800  @`  HP4T ? 3"`@y O  m 1990 - 1994     @`  H`?T ? 3"`@ y  e2,8  @`  H JT ? 3"`@[ y  f2500  @`  HTT ? 3"`@O [ y  e880  @`  H_T ? 3"`@ Oy  m 1985 - 1989     @`  HjT ? 3"`@x  e3,7  @`  H uT ? 3"`@[ x  f3000  @`  HT ? 3"`@Ox[  e800  @`  HT ? 3"`@xO  m 1980 - 1984     @`  HT ? 3"`@x e4,4  @`  HpT ? 3"`@[ x f2300  @`  H0T ? 3"`@O[ x e560  @`  HT ? 3"`@Ox m 1975 - 1979     @`3  HT ? 3"`@ Annual effective dose (mSv)*    @`#  H̀T ? 3"`@[  'Average annual Collective dose (man.Sv)(((  @`  H׀T ? 3"`@O[  Monitored workers (thousands)  @`  HT ? 3"`@O hPeriod  @`B   Bo ? 3"`@ B ! Bo ? 3"`@ B " Ho? 3"`@B # Ho? 3"`@  B $ Ho? 3"`@xB % Ho? 3"`@  xB & Ho? 3"`@x B ' Ho? 3"`@ x  B ( Ho? 3"`@ y B ) Ho? 3"`@  y B * Ho? 3"`@y  B + Ho? 3"`@ y  B , Ho? 3"`@ i B - Ho? 3"`@  i B . Ho? 3"`@i B / Ho? 3"`@ i B 0 Bo ? 3"`@ a H HT ? 3"`@JwH___PPT10( f___PPT9H@B___PPTMac11   hnamd` Arial&Monotype Typography    hnamd` Arial&Monotype Typography  ,namd$ Helvetica,    hnamd` Arial&Monotype Typography  ANR15: fraction of workers with effective dose higher than 15 mSv.DB =  B H  0޽h ? 3f3f___PPT10u.p5u+D=' = @B + <O vn'( 0$ r  S P%TA  T { b `  &#""j`b   <)T?" `   4,2 x 10-26       <-T?"  mTotal    <AT?" P `   0,1 x 10-2(       <PNT?"P  yHeritable effects     <`YT?" `P   4.1 x 10-24       < \T?" P  oCancers  *   <0qT?" ` Detriment per sievert6       <tT?"  b tB  6o ?"`nB  0jJ ?"`nB  01 ?"P `P nB  01 ?" ` tB  6o ?" ` tB  6o ?" nB  0jJ ?"  tB  6o ?"``   00Tp  0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  [ICRP 103 (2007) 2 > ' N@T ? 3"`@ 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  pAssuming 25 years at work at the limit of 20 mSv the lifetime risk of developing a cancer is increased by 2 % qq*-  ? H  0޽h ? ̙330 O // 22r/(  r  S @TA   T '|    #"."}xyyxxy`V  HT ? 3"`@Xm  c1,7   @`  HT ? 3"`@ m X c415   @`  HȁT ? 3"`@m  c283   @`  HӁT ? 3"`@m  k 2000 - 2002     @`  HށT ? 3"`@X m  c1,9   @`   HPT ? 3"`@ Xm  c506   @`   HT ? 3"`@ m  c265   @`   HT ? 3"`@ m  k 1995 - 1999     @`   H T ? 3"`@X}   e1,3  @`   HT ? 3"`@ } X  e415  @`  H`T ? 3"`@}  e310  @`  H *T ? 3"`@}   m 1990 - 1994     @`  H05T ? 3"`@X }  e2,2  @`  H?T ? 3"`@  X}  e500  @`  H`JT ? 3"`@ }  e230  @`  H UT ? 3"`@ }  m 1985 - 1989     @`  H0`T ? 3"`@X   e3,1  @`  HjT ? 3"`@ X  e450  @`  HuT ? 3"`@   e140  @`  HpT ? 3"`@  m 1980 - 1984     @`  HT ? 3"`@X  e3,5  @`  H@T ? 3"`@ X e220  @`  HT ? 3"`@  d63  @`  HT ? 3"`@ m 1975 - 1979     @`3  HжT ? 3"`@X  Annual effective dose (mSv)*    @`  H‚T ? 3"`@ X Annual Collective dose (man.Sv)     @`  H͂T ? 3"`@  Monitored workers (thousands)  @`  H؂T ? 3"`@ hPeriod  @`B   Bo ? 3"`@ B ! Bo ? 3"`@ B " Ho? 3"`@B # Ho? 3"`@  B $ Ho? 3"`@B % Ho? 3"`@  B & Ho? 3"`@ B ' Ho? 3"`@   B ( Ho? 3"`@ } B ) Ho? 3"`@  } B * Ho? 3"`@}  B + Ho? 3"`@ }  B , Ho? 3"`@ m B - Ho? 3"`@  m B . Ho? 3"`@m B / Ho? 3"`@ m B 0 Bo ? 3"`@  1 NT ? 3"`@  0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  F,  2 N T ? 3"`@0 8___PPT10F___PPT9( V___PPTMac110(   hnamd` Arial&Monotype Typography    hnamd` Arial&Monotype Typography  rSource: UNSCEAR 2008,, H  0޽h ? 3f3f___PPT10u.p5u+D=' = @B +} O 0p( 0B pl p C `TA` p  T l p C TBL` T H p 0޽h ? 3f3f___PPT10u.4u[+D=' P= @B + $O @ (  l  C TA` p  T `  c $A /??py /  H`T ? 3"`@y00___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  e3,5 mSv 2 &    HpT ? 3"`@`0 b 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  W3,1 mSv 2 &    HpT ? 3"`@p0 b ' 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  W2,2 mSv 2 &    HT ? 3"`@ g 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  W1,3 mSv 2 &    HT ? 3"`@0 R 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  W1,9 mSv 2 &    HT ? 3"`@ 2w 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  W1,7 mSv 2 & H  0޽h ? 3f3f___PPT10u.c5uF+D=' = @B + :O PD*(  Dx D c $ՃTAP   T r D S 0׃TB T H D 0޽h ? ̙33 O `( VNЛejbO l  C =TA  T l  C >TB` T H  0޽h ? 3f3f80___PPT10.uoB ;O pX$( {xobtvcaa Xr X S @TA  T r X S `TB`` T H X 0޽h ? 3f3f___PPT10u.S/u'+D=' P= @B +$ O 0$( q r  S 0F~q1= ~>s+\oqu6\?q_K_';Oi8_5@p#ELQJ'|>|[DlŽ3Ot&KWIRJOR{F w(n F[;#6Jq@ v:@Eqh-!)JmJy{mZȓHSf `px]ix4䕽i>06ۃ%嗲-; h.ּ\ r>K, Gwdb:)pn>8߸+,1V|}r;uOkfs'p`*MU VM l~vsVhnߒl7k4W_~kIx懲9W-k/#qQy|f|1#mXz{܈SX. 'C[lkT$^ьߔwZG%;S򴓥6I"mgt KaeTr =G1ErE~B-i\kػSi}v7(=LV|ZgV#OOz 8LCY9KzC{( 80mrtww=?ݫ3lGcp @{z4RdƑijS<cϥpMga}ĥf?iu#Iw`Fu m9~| Ć>vz%dx$}PcU0(dP>V?65ry޿ojj2ݽh3o9P?H?g~힫P&~C9WFw^rOr$1MXFC|ԿIOY`K諆w SW}؍~2_b֏QI~κs@cdž׎! vE ʼ*no5rMYu '7lly;$5 -mtWzbhL^oSKy-nP.ZQܖLzv +&X8ZZg' UB{~&络;]A,'= d/GhO‰z/1U<|2Һn[`#.d X۷wE[PS1H2tA,bNZC|Weꄭ F 1vpm&CP_͞U]3sgԙHBVVgjej~ְ}2ag-|rfcu`,mթ|Y a3e0ʆuY31B(ѹ 9|c}KFra5H 흉d8pe}1I4id-pC9kvJꛫ=>ͪp0'D3bS"0L [ Se Ssf;ٵ3\]:k~p] K0KafegOܑHnGb?cLfDǬ`0F+?ƕj/U\U]Z>6yfssk]4?e\_Us UٳDX,yirÕjK Ko,|j_ Aa'yYG]і`4%슅-獑 [|VHBMoo3(,P绖{p!t&WEsBYF9tGlK؋D:'Mcߟ6>B*YõA٢LS-F Y"Ϟ&񺃕بPE,gdM5RDBC:.6& Xvy49Uo#d|efp]CCR|Le !,ex}+xYU"c+gԞf )-A~Nm4tLDO>(iቹyce4a(@1M-(EU\Χ/x&%nm=2Pscw>tNTAx _u&3.ԋOS;Ed{]x2TۙvϾnS`\ëb(cUX/w{1|w u ׶Ξy?$S?#dx[d?︾|sȁe1};>phc{h _K |W03^Y\W]_sQ'n ,/Ϗ1ϭ8⛞F~39%'pd^8 esaug/`@hyO?:w_hC3 ρ@(Y{G)ߝQn M!S'ߝG(ciY4YmjDj6}Hjɞ_*G; G|n揮G|_,cR2u|p_:Gd/wW}i\I+c/h>>=I7Ա ViN?>' a/K]5ssW1ZeSC`e0b0AciOYn?c<=a(c,9 zL)ᯣS_~*&cq.3 ݡTB+Y4>g$]޿I&Oq{rg^ e=-٩ӎl=z_V=^ ˮ;RӔ ~e\^iF=BF4-is6dp\R룁iice?ULȱ2ս~Ȍy( =_ ,NK͔|G= ߏbQu<5 GvŲrI[(WQN%Xhc-dOwc䂏=*D{DpSyOٿwJ=hZG-=+KuN\% ]S"4@szGUtQtķM^1G9U?}n/3 U3O3 \CK |A~1Yw"`d?}lZK9?eoOu8C'0I2U2+%e2.8[ǎ@}N5b 2W!w9{\ʜa2e+hg*ޖhg Y լ5"ߐX k 3W*rܸIWպ߸1|^584kphA#t:8wv6D(=B j MK,9ߧ-x|$օoDaҬG*h|J"񵨴)$d.v|8SC^2wi/F倿3qXHlggM%a(qePt 軈'QrfJ l> 6Pslyd.4χb8|8z><@/_Pa (T(0Qag'q(t  4>S5CaT\= 1 p@L!)jA$bӥ R )ҥ ZɄ~CP "]D2! jA$b娊P "=z] ԂH&TrZɄReD2!#t)Y ԂH&D2!tD2!sDP "r]-jA$bXΧ ZɄѥ ZɄ־D2!cu)@L8]F ԂH&*]N ԂH&y_@LպT@ ԂH&d.$jA$r.D ԂH&d.L ԂH&Z]Y ԂH&d."jA$r.^ ԂH$̎T/Q-'9Eߥ7 8ORy\s70ߝ](gZi-ڴ׮qHi"[q5nKk4Qwk2IVDt84C:5S:5K+mccd_Ǿة -(`B$ҪBhTBi!iQYT/QңH,h<=~swf\뾯=}:CPAP;xװ끡8/ŋ|ʏʏx\³_sDLa%!Cx_6QY>Y|^AĢ RR !4TATAETAEg,\Nw(RR!8[,ZHHo=|d3 z3 A5H"%T ATATAeTAeɝ\_CKCiS[пYL8 lYAOg"΄ 2!Fnuu6]5 t= $~sͦ °lh??(IaM}V5:$)Rq*4Ico pyH5 z".[PAEam8Lm`o&x+j0*>0*1Q"JN@`TwGqRL^Jچp]ꒁp }*-MNSYܧL}* i1(fm5Ne#9X0[yQ :èTF-UDZD> s6BgVbfKk‘.,VNJ.@`ԋJLx/&X!LtdCWA7}\ ʀ!^x>ԇ.G%>7iY%AI}SL%.Ch*?(GCI(ᅨPR9QRJcW(J(Q(%#%>ԇ~7R#%xG(.0Y3FchOݐcGch}f!!ا c]Tgw";c#6cGcL CcZ1{1v4Ǝ;cG?wcǸa1T僉`l1      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstvwxyz{|}~Lp J08)b{{7?`׵eط,A>KQ?! el?b׊eR~{1 䴀 &7&`۟#(y \D@f ?}0p5ppU3%b0P&}:`"~8*jVQ>(d9P""sC%2pyhcg[6֐&~ b6cn+;V@cG_9w6/c`YdEZSEo[]i0 ل r%̴D#ЊO&6#w}'kzb+FFxN JmpO\-eu{cر~vSJI]5:^D<%6}=\`z\UZ#gQ=ᐧ |S'kxZPJyӸphϹ{hۦ N$d[r}F)?Ge K-foର:Wbw%0bŇ#_Qtgqze#;kt3޴ 㻵5Y3Թ/|pnQę='6:Z/b'}P,sءF`v%d=-6S8JiHv/w5}\ :{6ݫǂtWU/vX4q67i>U;(;LvP_R2Ԛc^^PJ{ qЩ:4AKcF-XYNŋQa6^iq[5^ q*PXOH29$Huqgrk߬MĜQp"O*Ri1whq[40r6ؽy6~ڍ;iNO?F~5a0?:'4J6f]RM6vdoJ`U-Y`lIؿʎ5Z6![SoYO?6:LOw^󭮬dr{IgODGu_bD5 =hq ;pQs3\)Ncz%iYD븵lU)֬_nF^pTIs|d.0voDXdĦ.9u+)=Q2Jb֞Ն/KkyyD u ˵ˤfOy \boV^Kb\|N8|S\oWi.$~ڬ=@G{8[~MgFs$;-D]tEwmXAb׊gm޹y<$Diu:e wg>Ϙ6dFj #]VnR}ӏ-U0ڽ&c敺{}օ}x)Kŋ7*5.t2K KPE扮 Q|J Z]f _[2"ShHƭw3N6{$\!ͰH,C;EtMK"TixVN![QdEkN )MJut^<3W޾#"Vҫ_*'y9-ƭh`e_|gIl#oB;YMӝ]t[~,٣i:.ߏvѾ9SbRrW3] 8]ԉm*9FEƥre ;YuȱӃc`Lj Zp!WYsuLnnPeYZHݶ5ȉ|I%M0ЩܑlJң83/5jvl"KUѺQY& 7qO/Y.*+d@|Jt/$!|XS2ɘ*Ñ k&>ܸZCjbg!ɽ{Tjgf|JfS;2s֢/XjpF)sKJ+Z^z[ʨ<4uG[\qg)]-]k6*OnNi=eg9P]UG*WPֳBQi#C|nRxj=+ݝPDĻ0*|yp+ ZWL]+/K3LW-SsߝzF),@ޢ`ed==Vּ݆GbIw?sl׈0Tc>GmMXRxbuMXb7MM_ #=~!ہ枷ң Z︭8b'Q|'^&>홛2a ݄R  7,.{+H̪%T|=l?1,2rA-z+U l,o %¸S=K nC\V:\?z'ch֝=mNs']'H%Pػ23 4֗VOo+Q.6#ݯyg[؆RC_J/ΣAqktgMT=Fo{lHIB3N7VBF=2҆W0x@|#*T_Wucp5'm<<1{TKQO pԬG6rdqrѺƞ)0аk*eAg/Ҳv(?|~22o`xh}(>}{P-)#dccrmLcOMDT|] ֪&O>?>.71-l@Ru#B2_e9mSQ"<\rc!Qlb;mϾ͐.ܯbY  yc,(s{U;M`{͘{oh_p>b}$8Nn]-*AF1~3>FV:8(9Đ!W\!Cb)YJ"fo69/DԜMAL+=}UA|czUnvq WYY6T>AJw)2fQ?H8ba~<*_d>0lEЌßGʌ7^-@(M$qT^ %yY3Yg Sˤ=]1"yT0dl~e|ǎ`!Fa+~AG"b6evbHWL tP,<ą(^,:#%O>܅~PCnQ;1Ҧ{oAc%;m|4t6:Huv#p08LJCP:v$:ܧMo<”d>/jE2.FOaSeuucv }JXo]t5J)46-q<>acm4hyM/h~snkxLƭgIt5_ +E]j%k喙Pù RNupD>MFE>m E# 5<<&+m''Wo yXx .6үs>lܤf4TVQ@7+ݪn7X#%S)Sj#gwagGctPËj ,w36ϗzEX"P۷p1]gRD )Z^U7/ta$Kĺ'4-^(xSpCxM5X &Pck {o?d,>89{蠲zC,Uȏ '֭ npvýF OD#iOooQ8IeLe꿗HZhOV|MLE7@< N'^z B["_Z* CD"b%6uC-lj;{"fpF(hr$ogݧD1ЈZm.hLLJZ EbGZv쑰Y`ve8_Yݯ9fH$O+ SݼE2g#/U,@E331B%^vʑ(X6$2ƒ%//ur QM"\%hX#1KTD1MiPC|.Ѵp)RN, g[^Nf/ÿA"VxK7>fS#l~/%'#ٚ}Ɗ#3+IV+ .?T\]9E_\,졎78 ~͛!*ۑrJ᩻[LoA p. Gh;/^UйfM}K\i|J1E) m11 1N,KQlqL])hqh0 *`}(?c߄pU ge<-B>We7cˋ7̢2i8MXbWH}Vx/xIXga@ 9i޵:c%R4qqIM2x;6,َoR7Hw= .0`-zB̌NT%[]I!wBl$p<zbܨnIt:F\B+nT(6|(O2Lh$lU:LAr919UcLt&"' {=]^^~/2"1O@bxRqꎓr$|)H/vnߺ+Kp`BeY""͠BUX沝w} Pxg874n/dmT90=n] {K0d LH# k> ^'U -;;hye^;B1H 2Rglqxԋy`Yl~]ܖd1 f܇T`dg LsMnjlX,[MN&EK%Er61{%Rz".="XljO`G65DN,) }LPT3!_cHeNJ+ 6TNIlzg☻" "Az# iNVwhnlvl͛,7 A5&M*r p [@ -΃29'Pe)(eho r=[(wBDqs.%+[9*C)[:AnvYY$(tr9W/MSݱ49 a|n񉤲[44/mW KHs"huIɼfŜ1IUS |~-65PWN7`*ke{ݭA\d:"mA/aX1a4|𥘑R\X9kJR0l:ub'aepϡjҫSNcJoIơl|AAr) zb'C GC7rR2Dab3Uf$宪/5B(c=^D1}fOO:v_4"̌?9+4pY'r5fH|洶l/f["2^<' o6ľmaldghFr=}՜pyP]`~?l%A7iz]5Vn8lmTFx&crIy6RGWٺUw#qu*Į^Qh@u]}ӓw8r#;' C.,~!YڎK8b,4,m0{x`b".WNXq: 6߰`hG;Z/iw"ŋKZ?Sfg,{ V6(W: .pv޽!B}+ fO#zIAh7-ogc iv㩎y/ZȽʍWHB؆ :ՖǧGE}5Lz񅺰 ijOYZ"^6n#^cUp5>sN ޼jBG%d%_R:-Dor.^emǩԨ=MS+4/>~ΪvI`q"j͸>L3W5G/Yk6I^?Csc nv'-4I s]v[]O<s$=~ӑrޚ(PzdV|C/=nSǛ-M}Z=dv߯WX4]C)U>zݎMM{ _ymY(J P"P->| ].zmcEQP. v#n͈[eqRLwL ?=.#m۟枷|>q!E|8a䣧wAS^[ Jgcc w#,wu'\70};l4jsJEC;2gvμ>gԱ~*j͂b$~o^3{  bT7ȸBZn-Δ((R#JmJJbm9CP)~џa (q~f]~k-~az!4ѵmd]gE~)ԇo! ^l,kawYNeW,N]70dPvaS-cH9 0#8RAЛy,I1 bSMfy<3 //l8Kn'Qޱέ.rKܥCg5CrSCk#j L"F_#W+ݼo,7܌mb'jexqz $v.߾L`R1,mB28wY$o[5P _ܛP˞gK:V82+(c8e;* gwh¶L*%:y T7lYo1ヿRd6_z3D6dzšS5mǖ8XFM!'=mM";%5YIFݓ7`N;z%>9С:\ZfE*ܐzX41yd^Dݒ,1- +r:H6A.n/jAec~'̕ogi%Ч_~6ao dMqL9JeAAe/NDNSeVeIC͢Jlf_[, bIJXsGښtS3{0eh/֟߂i:8>{:+'=bfh:7~:Hs;f}fXa:*WXžGW>1+SYCõzs^ЋpCz|.qEv3Ia: jqm6:]*ג0p"?N}|,~}wQ :ێԋd,H8Q-ǁ; rIXR}`.- 9>v싡QZD` =E7 ֞ OE_Y`-F+TJi#rQ$2I[Xcvp@>AI j}TYpϚ$>)n߉wuV i%NOL'Y*#kޜ~V#u]ΐz==)Qݾ<5Kq!;I>wEېY.y!ZQV$D:Fpj  MƏl vݯ.}2'^Ċ2`*RmOijmd6H308VCu`".F›/^j[,(aY^]i_5U/0rLCӍU ^YxܜR(FGZ(]=x>wGh}vdp&kSDIRPu?,U?I{<֝jodnlTU)g5kZ6L8" - D> Sm{ '"wwdl+ YTT:zB>͇{ q u:Oqk6?9lO潭Sodgbk]iwK۱,/Q}(6_Z~ʭ7Վգd-s%`tiI<+Js?ǓEd{bG1co6/ծHS|7x]ZZB(2fb<:hy.q9Zeo)~ /(_죈u`Ht Hcvq!`X KM?2b*g"qח$y{8uc:!EnC/e)= -n[A͗͢MVbwJdTZ}j_`]~9qe]),WxfVW<6*B6''5mJ$VM{=,x, *6%C7rjVuȺjvS]S2l]3nL}Gh;ucK೏a }qT층3C0vnnmi hq 9l0N^/K,Nط=`6(C!08bw+BqqSVU]&us;wsčs`YWc;kS1K;s,cƞZf-g"gEH[ۙg~c3': ?+á9`!u@~QrkmrËs}yI@n2 eo8|0 gW +cg0" ( AchoWpq÷ b!omy7 @:Z~/|Wv0gLK .W%_@x`\P('1@ L@Uf"Xfn`F``ad;HJmXtex44B|\091p€Ql*D~D0aPù9sg9r@lƒ!s M 79>ov|\~7a g(߯@atMWpOml LgQy9o`5GG`0#@\$ ߧ^W κƢR$ŋX .6h AHA@H"dR5@,bR@, xԟN+6gXlI"׀5Q@6?l58c3g1YD5kL@N +;ڳ[ R1d phDg}ll0߬BAF@#)UUo6-ۆ]h?Ora``[ @&;ne)An!7#@}_-QDD/k@ `=gڿ a| ?`I ?E HRba1A( bc?; 1"%CX!R,@Ya(!A;Z(T=@A(.wF)38gT( 8?H?]]ˆ"!Wv;Z]ζ`cSSk3sr|P =}[Ao_'ő.a0JJ7pyO~?Pw(+ xB!zބз_g@B8Bq:?<\JCcxT, ] + /^'` F^@@"@ ؖ| {zQ@Y@_0-/ȣCUII["@7+@>b`0Ag>:~E> e|jK>l=R@h;z@IJH!!d$ρMe2P7y*p~M6Hg +MV$1+>A_%&!@l("eH:5;%]n.. a |\ Qkl] 6trtqs6?' g~V>r#U7` ?÷6!#!Jf,7@]WHCBBE CIa}ȀȀrgu뇾7ƹ.g }/@}ʑ:/[E՟FPG d~ƅԷVO~'|S9[!@婟==?Fc~6" G1l; ~stcol{6>^782iqn@0?o}O _0p@:$XKBAAfK 83o+*F`^wgehjt6,l`jۺ)=BձR@HYN?HӿH=3 ?{N/mX)a@([ gwjp ސ?ދ4d=A HDx]{pTy={wW@,d@E (ł46/!-Fif%LvQISԱ=c'8ۚgN1;JwJ{?wwywνgRt񙿤ZE2e UYz(ɸn( ! < 3 d=&T4t p L,lp-|+׃灿`Ҙ|x!xx1E&e9i nDw׀#w;™_Ydg|N_ru:Gr8z(:y#M7Zx"3rƚ?<~cm0y|M<-1}IBqȱrZsmk_o/w&n56Y!4)O%җD<1cذSEOnMB. K kWr=wfWޯ߂:RKd=UG'dyv\F1INtLe|Όq8n /=$Q.H ;귫߮~ٴO>O>O4b=|K=dn&jWf5OI=UQzW ZiuGӺ6#QEɡH~7QB=@dN.&<1eM\xǒȬ5{Z!lQjXB{跙7 B6JZT}l\'<\ V9:O,~0o; 60? >~ 8Ce>W/? q)̠#X1H/&kw=y}/g),6ǘ~/1V ɚ%5oJ@-c8f ԒI@-a9HaqDz"!`>;JpODNYjP#%$*_I 噬1U)M>[]q~FTܕqjjgEOeMw.jeW"쒫2o$ШZpٚ%ÌFR%W0cg1JqԼ ^a~#a,&9Ha4 '/ېcrzRrQ_{[嶒 ƀrMz!Z{EKȂJD^>loJ={ȨB%QLMp\ceOYL̇tAn+ Ia^>F\@FBo0gNb$[I QQ)MrFo%)cgћ1p%kBR.QWS7#%z,kBR.ћS3z+)..QO!Fz+"Lk&7,儰GUk$d7BIBВGU % -da$ =Ւՠ%VKcZ-HznK&MKBKU-Fd펑8 .Mօƣ\g>h/uy]wh3Qr#^[Cb s-~iVwɠNc#0G!ܟ R/`Wq8[h+<r3vec݌],YQORb ̮Y/WY@֓|3x.xxQoSց;;9Yy9]oXoY>5gx9~/^qhnݱ6+16uH]_޻$ܬt#kn+sj9/wRs 3',<1i:T<*^mR;Aw?t!K ~ތ?Ef5h_) 'LھXj9\Z. 3#zQޯ6m4̓уg\;zpKj>c'sl5,1~?ЬRݯk*4_=?oP*qg5{7< J%y0sdYf翧CkUFOW9FG;= Ljf[9v@/o'Y֚y+e Yo<ͯXH[[)% -O!͚,}#L#JtD@}3= Y/1?Un_(C`M|FOR=M\H_Hq[3 |چq|߱k6'? ={L *ׇ%ڊBsϦ[׎rmv\%>﬜e>9m/:y[ҴfO>O>O>O>]E*nU`蓗x{^wޟ%?D3Ie0O ?y/%ɿiwsX͍l2}4Yv?oU*Y)D4O>O>O>O>}. cxp^RЀ3ÿ lHbP  @AL G@;b `B&V=A@IKR@3C5K^Q`ShVXap|2*0> '296 []F668Sdʻ _4 8 't( ?@  / "Feuille de calcul Excel.Sheet.80BFeuille de calcul Microsoft Exce ՜.+,D՜.+, L    $,4< D Présentation à l'écranCEPNd !  )Arial Helvetica WingdingsTimes New RomanTimesPrésentation_CEPN"Feuille de calcu Oh+'0HIh     'Prsentation PowerPointCyril CroteautMacintosh HD:Users:cyrilcroteau:Library:Mail:Mailboxes:Mails:Chartes.mbox:chartes.mimeattach:Prsentation_CEPN.potJacques LOCHARD376Microsoft PowerPoint@OF#@znM@KV@Y'VXDGZGPICTGR HH HH  hv0z_[ݳ_[~}Z|\]k˚ڬޫ#ҍf_[޷a\ỳXց\]k̛٭߮ эL_[޼c\tˇWڏ[]k  Нزᶘ ֿ (ǍD_[k\lǖW[]k䚘ס׻ ֺ&č?_\xn\fW[]kΚأӽ ֻÿ č}wr=_]rv\cZwݪ]]k"ۨ×ƙַ.č~ztnf_YRRMJGECB3_]mց[_\uް_]kľ߮˘ɚ׸þ }xqkc]WOLIMWDCKW_ctDE0_^eׄ[]^m޷a]k"¼̙߯Λֹ"Í#{uohbZUNIGFGDIKVX\~s[ӰE>_^cڎ[\ceg\k0ſ¬ᶘќԟ׷3Ŀϴռ0~xrmf_YPQJEBIEIOJcYr|uDȯtwGEE_^`ܛ[[icj\k@¿ƪɩζ⽘֠ס׶F½ϸ۽˳¦ ÍA|upib^UMLEGAEOGHTXDr|Ƀ㠮ӹAt\r_bSSHACB@A@EEDCDED`__]ߠ\[k`f\kdʶоưޚաʿgſŰڳҼ朻ĸÍ;zsmd^VSLJFHCNGOUAe^nsXJÛ}y}raWSQOEC@B?C@A @CEBCDDEC=@DC>__\Ǿ^]pc^hkf`_^_]k4ÿͿ®7ݾMްũ«˶7¾Ծɴ±1ɬFɝв΍X}vqkc_TTOGEGBOOibv`}JǷؘvFpvKL]GJDBAA?AABB@BA@=;99=5<8849E::@EC@AEC;;_eid_^\__^]^^_]k2޻׿̮,赯ŲD٨ī5ܾ֬α-ԣޱ>Ѳŗڍdzsmh_YSMLIGCOGHRDqCMÏΝgoLZt_RPFEDCE?A@DD@CAA@@>;98AC865?A:5285=;447@54:EBAEA>@@_^_]knĿó巷׾Ƿl`YQch4ĶܭRpհ粬q½ߧΰλbWQJX]0ǜIcϸџo{uokd]WQNHFEGUUMcbp{Wc_^ntOƅs]_nSNHFEBA?EB?BDDEDBC?>=<@>1@A@ACA>;>?BA53ABD_]k>ܹĿ7UAw{q[vGI64I5)gM=]鸩Ͷ<¼Ԫķ7rL=jmfRi@B20B1&\vD8Sҝԥ>{voga[SLNJBqfnTU]ak^}tf›dJ{q_ESCJHDCAC?B@CCEC90CFGC>CC<<89>3/=FEG?;?E>46638D=43454676CEDDB?Cρ_]ksÿͬʹøyztFJ|8GVo_XUE,.3Wfdui[Q[ ˷7Ž›Ҿ:@EDE>6>CE>=>DD;34677554 55@EDEB?BDDAE_^^__^^_^__^__]k9½Ŵ֪హ۹B١("EՂ!1@'3-w3((W|_A$&MYVRX 䫫ʷƳý¾̘ٟӪ}Ő% >u .;$/)l/%%PqVA'.DDEDEDDEF7)32;CEDDFFC.),29;7--;><<>FED:569964 38DDED@CDC=@E__^]gjc\gjceih^_gjf\_]kYʴ୶ҼɷwciȈQ,5up+5+Hn[)ncT.7;#)ȥrlRCMOQe 뵪̽Ѻ ĻyڛȮjY^δ{J)1ixd(0)AcScXK+4u5!&fbJ=FGHZ գŽX|mhb\WRMDEDEBLa_paYRI\j_bQFUJDCD@A@AACCDCDFE@. +BEDDEB6$(?@BB36974 8DFD@?BB=?BE_n]]k̹֨jWaj21K`q3.]SMmPA,Yh5Sef5-A2+!jT(B⽦|M8ADI[οԱѰˤپ鯢͕_NVu^..DVe{/*TKDaH;)Pv]1JZ[1+;/) x_L%BR٬ɺZMABBCCBKlT>daivZgNSGDAB?BBCECDEEDDCCACEEB>BGA66>BCDADC.0:6=D>7.@F?6@AA1'BDDEC:2.#! ;FDCCDCCB?*0EB;BFE=:< ?FCBD7454884 6AD=85M 6SUPj@D)WξD8=Ez̲'·䴪֚᧚ɿٱܻܧᢘܾսŪnmŶШnMQanxOB2,kZ("!5fa0,*$8F2KMI`9>'Nvz=37=mݸկϡNDESB_lczpqVEWLEDDCCA?A?@?@@>;9BEEFD<>@=:76679BF=?DDC?:9=D><20CEB<.%$8CFA-1.( 4CDEF"4# 1<;6DDECDD@><<,C:4469AC9439CEDA<_]uzfvӪyoȑohq[kŧuOd''!;mN.CW@#"CVY\Vyi#*WW8!]չW9AZe𿍤¯Шᬟش޺ܥߥʺݳ}ժhG[$&!5b}G+=O;""=MPRNl^!(NP4 TN4;PZڬ~ѯܼNDED`ZQKC@A@CE?=<:9:?;54578634@EE@843496BC>@E=8756>0)&:BCD8/<@;#$'+@FDFEDEDEDA;;4(;C">BEF?:<@@>5358545@GD:46;AD834=FD@>5_ſlmin[k!պֲƾ_ΖA>\IXK3%?3)*$%PW(*68%*TQ4YI[ӣì~`B8${Ѥe뼫鵬زղţԤ֤ ڲbֺܾ;8SBNC/#:/&'""HO&'13#'KI0OBQvÕpU;3"p۽ѐZթԢJABAA??><:9:9:?A>704:AA81122112=?6201=04;@A=7321082 )59<:0%/+*+%$52%,55(*<; 1<95B@<84.;51:@305@AB@625>A503>A>:63_\bea[bddƆ`\_c`_c`]k ϴֶTspBA@cG::@mْ;B>;;TjsB:@FI:CvfٵĸMkpQslq彻ѵݳվ ̾Wki@@?\E::?eƈ;A=;;PckA;?DF9Bm_ǥyIdhMkd΀iӬ aVVUSRQRY][SNOSVRONOONPW]]\\RONPUYUQONOPO\RSORQOONOWUYPTTGBBU_\D;:BW][R@B?;;OXYC:AHJ=B[]^]VUUQRX]\XZ\\]]WLUXRRYYXXUNU[Y^[ZPT\]RNW\[XSOPk_^^__^^`l]__^__^_]k 1_[^_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k_]k33333333333fffffffffffZ_]k  333 333333333 33333333333333333333333333333fff fffffffff fffffffffffffffffffffffffffffN_]k 3333333333333 333333333333333333333fffffffffffff fffffffffffffffffffffK_]k333333333333333333333333333333333333ffffffffffffffffffffffffffffffffffff_]k3333333333333333333333333fffffffffffffffffffffffff4_]k33ff"_]k"_]kd_]k3333333fffffff_]k    33333333 33333333 3333333333333 ffffffff ffffffff fffffffffffff_]k3333333333333333333333333333ffffffffffffffffffffffffffffف_]k333333333333333333333fffffffffffffffffffffӁ_]k 3333 333333333333333ffff fffffffffffffff=_]k333fff+_]k33ff"_]k"_]k"_]k"_]k"_]k"_]k"_]k(_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]kL_]k@_]km_]k   L_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k_]k_]k_]k    _]k   4_]k"_]k"_]k"_]k"_]k_]ḱ_]k   _]k      _]k   L_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k"_]k4_]kU_]kd_]k   O_]kL_]k^_]k   g_]kF_]k"_]k"_]kl Microsoft ExcelDocument Microsoft Word<ALARA and Occupational Exposures: Experience and ChallengesContent of the presentationFirst stage: prudenceSecond stage : justification1Third phase: economic and social considerations%ALARA: balancing costs and benefits Présentation PowerPointBeyond the cost-benefit modelThe tolerability of risk model(ICRP 101- 2005: broadening the process ' The ICRP 60 system of protection (1) &The ICRP 60 system of protection (2) ' The ICRP 103 system of protection (1)&The ICRP 103 system of protection (2)$The individual levels of protectionGDose ranges in ICRP 103 for dose constraints and reference levels (1)GDose ranges in ICRP 103 for dose constraints and reference levels (2) The concept of dose constraint ,Constraints and planned exposure situationsThe tolerability of risk modelBOccupational exposure: number of monitored workers (UNSCEAR 2008)?Occupational exposure: annual collective dose (UNSCEAR 2008) =Occupational exposure : annual average dose (UNSCEAR 2008 )BOccupational exposure: distribution of individual doses (ESOREX) AOccupational exposure in the nuclear fuel cycle (UNSCEAR 2008) ;Risk associated with ionising radiation - Adult workers -9Occupational exposures in electricity generation (PWR) :Annual risk associated with the average exposure in PWRsXDetriment associated to radiation exposure and annual risk of fatal occupational injuryRadiation risk in perspectiveOThe way forward for further improvements in occupational radiation protection "ALARA and dismantling in France OThe way forward for further improvements in occupational radiation protection Polices utiliséesModèle de conceptionServeurs OLE incorporésTitres des diapositives!(V^j_PID_LINKBASE _PID_HLINKSAAd     JE!"#$%&'()*+,-./0123456789:;<=>?@ABCDFGHzKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxy{|}~lwDocument Word.Document.80.Document Microsoft WordP/ 0|DArialNew RomaHpڄnHplRDHelveticaRomaHpڄnHplR DWingdingsRomaHpڄnHplR0DTimes New RomanpڄnHplR@DTimesNew RomanpڄnHplRg,. @n?" dd@  @@`` h 2QZ +o _^X`g%#(/"$ 111"31 K433xgW)W*.,0:8+a:    ">""%1'2#!O!(-&B$OlrV}$b$ c۰| bAb$?Hz+ r[JB$ʏ`O)Dp/O^$$R$@ ϬnR$Ou>,8{(z 0e0e     A@  A5% 1   <  6Second stage : justification  In a context of uncertainty taking a risk is justified only if their is a benefit in return If there is a benefit How far to reduce the risk without endanger the activity? As low as practicable (ICRP 1-1958) On which criteria to ground the decision? \P^F+]:  +  70Third phase: economic and social considerations10 1 Recommendation to keep exposures as low as readily achievable, economic and social considerations being taken into account (ICRP 9 -1965) The reduction of risk must be compared with the effort to achieve it Need of quantification for practical applicationXn(E<1!Y  8$ALARA: balancing costs and benefits  % The adverb  readily is replaced by  reasonably (ICRP 22 -1973) Introduction of the cost-benefit model The decision process is reduced to a few parameters and focused on the avoided dose Attempt to integrate social values in the quantitative framework (ICRP 37-1983) 6A'n   9 JBeyond the cost-benefit model  ICRP 55 - 1988: Return to a more pragmatic approach: the ALARA Procedure ICRP 60 - 1990: Need to consider "the magnitude of individual exposures, the number of people exposed and the likelihood of incurring exposures where these are not certain to be perceived (= potential exposures)"in the optimisation process Equity issue and the tolerability of risk model Introduction of the dose constraint concept for practices to limit the range of options considered in the optimisation processZnnH  $$((,,00[4488  FThe tolerability of risk model   :'ICRP 101- 2005: broadening the process  ( Optimisation of protection is a forward-looking process aimed at preventing exposure before they occur Optimisation is a frame of mind always questioning whether the best has been done in the prevailing circumstances Consolidation of the previous publications and broadening the process "to reflect the increasing role of individual equity, safety culture, and stakeholder involvement" JngrFb    K& The ICRP 60 system of protection (1) &'% &  Practices Justification, optimisation, limitation (except for medical exposures) Dose limits Individual dose constraints Interventions Justification, optimisation Intervention levels o0 S     $$((  L%The ICRP 60 system of protection (2)  &  M& The ICRP 103 system of protection (1) & Planned exposure situations: situations involving the deliberate introduction and operation of sources. Justification, optimisation with dose constraints, dose limits (except medical exposures) Emergency exposure situations: situations that may occur during the operation of a planned situation, or from a malicious act, or from any other unexpected situation, and require urgent action in order to avoid or reduce undesirable consequences. Justification, optimisation with reference levels Existing exposure situations: exposure situations that already exist when a decision on control has to be taken, including prolonged exposure situations after emergencies Justification, optimisation with reference levelsiZ220  Z.  $$M((,,L004488!<<  6I  "$$((  N%The ICRP 103 system of protection (2) &  O#The individual levels of protection $  PFDose ranges in ICRP 103 for dose constraints and reference levels (1) G  QFDose ranges in ICRP 103 for dose constraints and reference levels (2) G  GThe concept of dose constraint   &The concept of dose constraint is used in conjunction with the optimisation of protection A dose constraint is a source-related restriction on the individual dose from a source used prospectively in planned exposure situations which serves as an upper bound in the optimisation of protection from that source The term  source refers to any physical entity or procedure that results in a potentially quantifiable radiation dose to a person or group of persons Dose constraints are defined at the design stage using past experience\[@@@ @ @F@@  R+Constraints and planned exposure situations , Occupational exposure Usually set by operator Small operators may need guidance from regulator Transient/itinerant workers need special attention Public exposure Usually set by regulator v   HThe tolerability of risk model   AOccupational exposure: number of monitored workers (UNSCEAR 2008) B  R#>Occupational exposure: annual collective dose (UNSCEAR 2008) ?-? ?  T$<Occupational exposure : annual average dose (UNSCEAR 2008 ) =  -AOccupational exposure: distribution of individual doses (ESOREX) A   K@Occupational exposure in the nuclear fuel cycle (UNSCEAR 2008)  A S:Risk associated with ionising radiation - Adult workers - ; I8Occupational exposures in electricity generation (PWR)  9 +9Annual risk associated with the average exposure in PWRs5  Annual risk associated with 1.7 mSv (late cancer after exposure using ICRP 103 coefficient): D = 1,7.10-3*4,2*10-2 = 7,14.10-5 Annual risk of lethal occupational accident (immediate death): France: 2.86.10-5 (2005), USA: 4.10-5 (2006).^$?.]     ?$$((, , 00 448 8<<&    @WDetriment associated to radiation exposure and annual risk of fatal occupational injury X ERadiation risk in perspective&    The average level of radiation risk in the workplace is in the same order of magnitude than other risks for workers The upper exposure levels, particularly those close to the limits, are significantly deviating from the main trends as far as quantitative risk estimate is concerned Need to pursue efforts to reduce further the exposure of the most exposed workers in all domains = systematic implementation of ALARA >t   TNThe way forward for further improvements in occupational radiation protection  O Engaging a reflection on potential exposures (use of incident data basis) Developing ALARA procedures and tools for dismantling operations Sharing experience to diffuse the use of dose constraints Enhancing radiation protection culture Strengthening existing ALARA networks Favouring stakeholders engagement in the decision making process A remaining issue: the situation of transient workers pJA:( &C$ $$  I!ALARA and dismantling in France !  GThe first dismantling operations at French nuclear installations and NPPs have shown: A lack of ALARA culture, notably at the level of the formalisation of the process A weakness of dose estimations for the preparation of the work A lack of reactivity of the teams when the first data become available at the beginning of the operations Missing records concerning the description of the installations and their life time history The non adaptation of "classical" technical procedures used for operation and maintenance The lack of commitment and engagement of all concerned parties~WZZV R? G7#> $@$&E   VNThe way forward for further improvements in occupational radiation protection  O Engaging a reflection on potential exposures (use of incident data basis) Developing ALARA procedures and tools for dismantling operations Sharing experience to diffuse the use of dose constraints Enhancing radiation protection culture Strengthening existing ALARA networks Favouring stakeholders engagement in the decision making process A remaining issue: the situation of transient workers jJA:( &C6   /lD,.=SU^`h$-:;<sx,, L Q ~ e|HH(d'h  $O @ (  l  C TA` p  T `  c $A /??py /  H`T ? 3"`@y00___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  c3,5 mSv 2 &    HpT ? 3"`@`0 b 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  W3,1 mSv 2 &    HpT ? 3"`@p0 b ' 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  W2,2 mSv 2 &    HT ? 3"`@ g 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  W1,3 mSv 2 &    HT ? 3"`@0 R 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  W1,9 mSv 2 &    HT ? 3"`@ 2w 0___PPT106___PPT9B___PPTMac11   hnamd` Arial&Monotype Typography  W1,7 mSv 2 & H  0޽h ? 3f3f___PPT10u.c5uF+D=' = @B + O `( VNЛejbO l  C =TA  T l  C >TB` T H  0޽h ? 3f3f80___PPT10.uoB ;O pX$( {xobtvcaa Xr X S @TA  T r X S `TB`` T H X 0޽h ? 3f3f___PPT10u.S/u'+D=' P= @B +$ O 0$( q r  S 0""%1'2#!O!(-&B$OlrV}$b$ c۰| bAb$?Hz+ r[JB$ʏ`O)Dp/O^$$R$@ ϬnR$Ou>,8{(z 0e0e     A@  A5% 1   <  6Second stage : justification  In a context of uncertainty taking a risk is justified only if their is a benefit in return If there is a benefit How far to reduce the risk without endanger the activity? As low as practicable (ICRP 1-1958) On which criteria to ground the decision? \P^F+]:  +  70Third phase: economic and social considerations10 1 Recommendation to keep exposures as low as readily achievable, economic and social considerations being taken into account (ICRP 9 -1965) The reduction of risk must be compared with the effort to achieve it Need of quantification for practical applicationXn(E<1!Y  8$ALARA: balancing costs and benefits  % The adverb  readily is replaced by  reasonably (ICRP 22 -1973) Introduction of the cost-benefit model The decision process is reduced to a few parameters and focused on the avoided dose Attempt to integrate social values in the quantitative framework (ICRP 37-1983) 6A'n   9 JBeyond the cost-benefit model  ICRP 55 - 1988: Return to a more pragmatic approach: the ALARA Procedure ICRP 60 - 1990: Need to consider "the magnitude of individual exposures, the number of people exposed and the likelihood of incurring exposures where these are not certain to be perceived (= potential exposures)"in the optimisation process Equity issue and the tolerability of risk model Introduction of the dose constraint concept for practices to limit the range of options considered in the optimisation processZnnH  $$((,,00[4488  FThe tolerability of risk model   :'ICRP 101- 2005: broadening the process  ( Optimisation of protection is a forward-looking process aimed at preventing exposure before they occur Optimisation is a frame of mind always questioning whether the best has been done in the prevailing circumstances Consolidation of the previous publications and broadening the process "to reflect the increasing role of individual equity, safety culture, and stakeholder involvement" JngrFb    K& The ICRP 60 system of protection (1) &'% &  Practices Justification, optimisation, limitation (except for medical exposures) Dose limits Individual dose constraints Interventions Justification, optimisation Intervention levels o0 S     $$((  L%The ICRP 60 system of protection (2)  &  M& The ICRP 103 system of protection (1) & Planned exposure situations: situations involving the deliberate introduction and operation of sources. Justification, optimisation with dose constraints, dose limits (except medical exposures) Emergency exposure situations: situations that may occur during the operation of a planned situation, or from a malicious act, or from any other unexpected situation, and require urgent action in order to avoid or reduce undesirable consequences. Justification, optimisation with reference levels Existing exposure situations: exposure situations that already exist when a decision on control has to be taken, including prolonged exposure situations after emergencies Justification, optimisation with reference levelsiZ220  Z.  $$M((,,L004488!<<  6I  "$$((  N%The ICRP 103 system of protection (2) &  O#The individual levels of protection $  PFDose ranges in ICRP 103 for dose constraints and reference levels (1) G  QFDose ranges in ICRP 103 for dose constraints and reference levels (2) G  GThe concept of dose constraint   &The concept of dose constraint is used in conjunction with the optimisation of protection A dose constraint is a source-related restriction on the individual dose from a source used prospectively in planned exposure situations which serves as an upper bound in the optimisation of protection from that source The term  source refers to any physical entity or procedure that results in a potentially quantifiable radiation dose to a person or group of persons Dose constraints are defined at the design stage using past experience\[@@@ @ @F@@  R+Constraints and planned exposure situations , Occupational exposure Usually set by operator Small operators may need guidance from regulator Transient/itinerant workers need special attention Public exposure Usually set by regulator v   HThe tolerability of risk model   AOccupational exposure: number of monitored workers (UNSCEAR 2008) B  R#>Occupational exposure: annual collective dose (UNSCEAR 2008) ?-? ?  T$<Occupational exposure : annual average dose (UNSCEAR 2008 ) =  -AOccupational exposure: distribution of individual doses (ESOREX) A   K@Occupational exposure in the nuclear fuel cycle (UNSCEAR 2008)  A S:Risk associated with ionising radiation - Adult workers - ; I8Occupational exposures in electricity generation (PWR)  9 +9Annual risk associated with the average exposure in PWRs5  Annual risk associated with 1.7 mSv (late cancer after exposure using ICRP 103 coefficient): D = 1,7.10-3*4,2*10-2 = 7,14.10-5 Annual risk of lethal occupational accident (immediate death): France: 2.86.10-5 (2005), USA: 4.10-5 (2006).^$?.]     ?$$((, , 00 448 8<<&    @WDetriment associated to radiation exposure and annual risk of fatal occupational injury X ERadiation risk in perspective&    The average level of radiation risk in the workplace is in the same order of magnitude than other risks for workers The upper exposure levels, particularly those close to the limits, are significantly deviating from the main trends as far as quantitative risk estimate is concerned Need to pursue efforts to reduce further the exposure of the most exposed workers in all domains = systematic implementation of ALARA >t   TNThe way forward for further improvements in occupational radiation protection  O Engaging a reflection on potential exposures (use of incident data basis) Developing ALARA procedures and tools for dismantling operations Sharing experience to diffuse the use of dose constraints Enhancing radiation protection culture Strengthening existing ALARA networks Favouring stakeholders engagement in the decision making process A remaining issue: the situation of transient workers pJA:( &C$ $$  I!ALARA and dismantling in France !  GThe first dismantling operations at French nuclear installations and NPPs have shown: A lack of ALARA culture, notably at the level of the formalisation of the process A weakness of dose estimations for the preparation of the work A lack of reactivity of the teams when the first data become available at the beginning of the operations Missing records concerning the description of the installations and their life time history The non adaptation of "classical" technical procedures used for operation and maintenance The lack of commitment and engagement of all concerned parties~WZZV R? G7#> $@$&E   VNThe way forward for further improvements in occupational radiation protection  O Engaging a reflection on potential exposures (use of incident data basis) Developing ALARA procedures and tools for dismantling operations Sharing experience to diffuse the use of dose constraints Enhancing radiation protection culture Strengthening existing ALARA networks Favouring stakeholders engagement in the decision making process A remaining issue: the situation of transient workers jJA:( &C6   /lD,.=SU^`h$-:;<sx,, L Q ~ e|HH(d'h r'^d     .  !"#$%&'()*+,-/0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~DocumentSummaryInformation8h Current User*,  !"#$%&'()      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrsuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstvwxyz{|}~     JE!"#$%&'()*+,-./0123456789:;<=>?@ABCDFGH%KLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxy{|}~http://www.ineris.fr_ndJNESJNESoJacques LOCHARD